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Abstract  
 
The strategy of the adaptive immune system in eliminating viruses from 
infected tissues is the activation of CD8+ T cells with specific T cell receptor in 
the LN draining the site of virus entry and subsequent migration of these cells 
to the sites of the viral infection. L-selectin, a well characterized LN homing 
receptor, is variably expressed on virus peptide activated CD8+ T cells, 
regulated through two separate mechanisms of early ectodomain shedding and 
late gene silencing.  The role of L-selectin in homing of activated CD8+ T cells 
to sites of virus infection is not studies in detail. Here we show that despite 
being primed normally in the draining LN, there were a hierarchy in homing 
ability of adoptively transferred CD8+ T cells expressing mutant L-selectin 
(which resist shedding and gene silencing upon T cell activation), wildtype L-
selectin and deficient in L-selectin (Ko) to the site of virus infection. The L-
selectin specific recruitment was confirmed by using antibody blockade 
strategy and short-term competitive homing experiments. Furthermore, L-
selectin dependent homing of virus specific CD8+ T cells rather than hyper-
functional or hyperproliferative T cells conferred anti-viral immunity against two 
evolutionarily distinct viruses, vaccinia and influenza viruses which infect 
mucosal and visceral organs, respectively.  
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1. Introduction  
1.1. Immune system 
 
The immune system is a vital system of the body, where its main role is to protect 
against invading pathogens and cancer. The immune system is widely distributed 
in the body through its various cells and organs. The biological processes that 
are generated during an immune response are an interaction between the cells of 
the immune system, the organs of the immune system and the invading 
pathogens or cancer. The key importance in the immune system is its’ ability to 
specifically identify a wide range of invading pathogens; this makes the immune 
system unique and a vital system in the body (Janeway et al. 2001).  
 
Patients suffering from X-linked severe combined immunodeficiency disorder, 
which is a genetic disorder characterized by inability of the patient to produce T 
lymphocyte and natural killer cells (NK cells), clearly show the importance of the 
immune system, since these patients suffer from recurrent bacterial infection 
early during first three months of life and followed by viral infections (Allenspach 
et al. 2003).   
    
The organs of the immune system, which include bone marrow, thymus, spleen 
and lymph nodes, play important roles ranging from development of the various 
immune cells and providing an environment for the immune response reaction to 
occur between the immune cells and the pathogen. Bone marrow and thymus are 
sites of lymphocyte generation and maturation (Fig. 1.1). Spleen and lymph 
nodes are sites of lymphocyte activation and differentiation (Fig. 1.1). 
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Figure 1.1: Organs of the immune system. Immune system consists of a 
number of organs and cells. Organs include lymph nodes, spleen, tonsils, thymus 
and bone marrow.  
https://www.meb.uni-bonn.de/Cancernet/CDR0000258030.html  
 
The immune system can be classically categorized into innate and adaptive 
immune system. The innate immune system, which is also called first line of 
defence, consists of neutrophils, NK cells, macrophages and dendritic cells. 
Physical barriers such as the skin and other epithelial surfaces, mucous and hair, 
also constitute a major part of the innate immune system and participate in the 
very early protection of the body from entry of pathogens. Skin can also protect 
the body from the lethal factors in the surrounding environment such as 
irradiation, heat and poisonous substances (Alberts et al. 2002).  
 
Innate immune system do not require highly specific activation and differentiation 
that is why their action is much immediate with regards to responding to invading 
pathogens since they are either in the tissues such as dendritic cells and 
macrophages or they can be recruited directly from the blood stream such as 
monocyte, eosinophil, neutrophil and NK cell. 
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1.2. Adaptive immune system  
 
Any invading pathogens that are not eliminated by the innate immune system will 
be dealt with through the second line of defence, the adaptive immune system. 
This system is more specifically deal with the invading pathogens such as 
bacteria, viruses, fungi and parasites. It can distinguish between self and non-
self-antigens through specific receptors, which evolve during their maturation 
process. Also, the adaptive immune system has the long life protection scheme, 
which does not exist in the first line of defence through the generation of memory 
cells (Janeway et al. 2001).  
 
The cells of the adaptive immune system are T and B lymphocytes (which I refer 
here and after as T and B cell, respectively). The adaptive immune system cells 
have their own duty. B cell is one of the arms of the adaptive immune system; its 
main role, antibody production in the body, is highly important in the elimination of 
invading pathogens (Vazquez et al. 2015).  
 
T cell, similar to the other leukocytes, originate from pluripotent hematopoietic 
stem cells in the yolk sac, early during the embryo development, and later in 
foetal liver and bone marrow, and in adult, the bone marrow is the main first site 
of T cell generation unless there is a defect in the bone marrow which in turn 
makes the liver become haemopoietically active (Alberts et al. 2002). After their 
first generation step in the bone marrow as pro T cells, they migrate to the 
thymus for their maturation. A multistep processes in the thymus controls T cell 
development through production of the T cell receptor (TCR)(von Boehmer 
1994). The TCR molecules consist of either an alpha (α) and beta (β) chain or 
gamma (γ) and delta (δ) chain. The αβ or γδ TCR are originated through genes in 
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the variable region of the DNA called V(D)J rearrangement. The genes in these 
regions are encoding for the TCR. The VDJ encoding has to undergo 
rearrangement in order to generate a TCR that is specific for a conformational 
shape of certain peptides. The VDJ rearrangement occurs through the action of 
lymphoid-specific recombination activity enzyme, which is also called VDJ 
recombinase. The enzyme VDJ recombinase is the product of the genes called 
RAG1 or RAG2 (Schatz et al. 1992; Alt et al. 1992). T cells can recognize 
thousands of various infectious and non-infectious pathogens through their 
diverse TCRs.  
 
 
1.2.1. T cell immune surveillance and subsequent 
activation 
 
CD8+ T cells will not participate in an immune response unless they are 
specifically activated through their TCR. Taking the specific activation into 
consideration, CD8+ T cells with a given peptide specificity has to circulate 
continuously searching for its cognate antigen in order to be activated. The CD8+ 
T cells generated and matured in the thymus leave the site of their production 
and enter circulation. They migrate through blood and lymphatic entering the 
secondary lymphoid organs, such as spleen, lymph nodes and Peyer’s patches, 
searching for their cognate antigen in a process called surveillance. At this 
moment, since they have not seen any antigen, a part from self-antigens in the 
thymus, these CD8+ T cells are called naïve CD8+ T cells (Masopust & Schenkel 
2013).  
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As part of its immune surveillance, naïve CD8+ T cell enters the lymph node 
either via the afferent lymphatic or through the specialized blood vessels called 
high endothelial venules (HEV). Naïve CD8+ T cell has its characteristics and 
phenotype. They are identified through a number of activation molecules and cell 
adhesion surface receptors. Some of the well-characterized receptors are the late 
activation antigen (CD44) and the surface adhesion molecule also called lymph 
node homing receptor, L-selectin (CD62L). CD8+ T cells, which express low level 
of CD44 and high level of CD62L is phenotypically characterized as naïve CD8+ 
T cells (Sallusto et al. 1999).  
 
In order to enter the lymph node via HEV, naïve CD8+ T cells use the peripheral 
lymph node homing receptor CD62L binding to peripheral node addressin 
(PNAd). The CD62L-PNAd engagement allows the first capture of the CD8+ T 
cells and allows the cell to roll on the surface of the HEV (Gallatin et al. 1987). 
Furthermore, the cell will reach the stage of activation-induced arrest mediated by 
CC-chemokine receptor (CCR7) engagement with the CC-chemokine ligand 
(CCL21) and lymphocyte function-associated antigen-1 (LFA-1) engagement with 
intracellular adhesion molecule (ICAM-1)(Masopust & Schenkel 2013).  
 
Whereas, when naïve CD8+ T cells enter the lymph node via the afferent 
lymphatic, it first arrives to the lymph node sinus. Since T cells have its zone in 
the lymph nodes, then they enter the paracortex T cell zone in the lymph node in 
a chemokine dependent manner (CCR7)(Figure 1.2)(Masopust & Schenkel 
2013).   
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Figure 1.2: lymph node structure. Lymph node is one of the most important 
organs of the immune system. Structurally, It consists of the capsule, which also 
contains subscapular sinuses, cortex and medulla. The cortex is further divided 
into B and T cell zone and medulla contains mainly blood vessels.    
  
 
The fundamental achievement of T cell immune surveillance is the finding of 
antigen bearing cells by the naïve CD8+ T cells in the secondary lymphoid tissues 
such as in the paracortical T cell zone of lymph nodes. Naïve CD8+ T cells 
recognize peptide, which is derived from the pathogens, in the context of major 
histocompatibility complex (MHC) class I on antigen presenting cells (APCs) such 
as cells of the innate immune system, dendritic cells (Medzhitov & Janeway 
2000). In order for the naïve CD8+ T cells to perform its function, they must 
migrate to the site where they can find the peptide presented APCs (Germain & 
Stefanova 1999). CD8+ T cells have its unique TCR that recognizes specific 
peptide, except for a few CD8+ T cells that can recognize peptide from any 
pathogen.  
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The diversity of the TCR makes the adaptive immune system specific and potent 
with regards to long life immunity and specific protection of the body. The T cell 
repertoire has about 25-100 million unique TCR for a diverse range of antigens 
(Arstila et al. 1999). The APCs that gather information and peptide through out 
the body provide useful information for the naïve CD8+ T cells. Once naïve CD8+ 
T cells have been presented with their cognate antigen in the context of MHC 
class I in the presence of essential co-stimulation, the cell undergoes proliferation 
to produce thousand of its clone to fight the infection specifically. Naïve CD8+ T 
cells can be activated at any secondary lymphoid organs such as spleen, lymph 
node, tonsil and Peyer’s patches near to the site of the pathogen entry.  
 
 
 
Figure 1.3: T lymphocyte re-circulation and activation. Naïve CD8+ T cells re-
circulate in and out of secondary lymphoid organs via lymphatic or blood vessels 
searching for its cognate peptide. Once they have been presented with the 
antigen in the context of APCs, they will be activated, exit the lymph node, re-
enter the circulation and migrate to the site of infection. HEV play an important 
role in the recruitment of naïve CD8+ T cells into the lymph nodes.  
Ager and May, 2013 
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1.2.2. T lymphocyte differentiation 
 
Upon activation through cognate peptide in the context of MHC class I with 
appropriate co-stimulation, the CD8+ T cells differentiate into effector CD8+ T 
cells and later into memory CD8+ T cells. Cytokines play an important role in the 
process of CD8+ T cell differentiation. For example, IL-7 cytokine is required for 
CD8+ T cell differentiation and expansion during homeostatic proliferation, which 
is a process of maintaining the number of various immune cell in a balanced 
condition (Schluns et al. 2000), whereas the key cytokine that is controlling 
antigen-specific CD8+ T cells differentiation and clonal expansion is interleukin-2 
(IL-2) (Kalia et al. 2010).  
 
IL-2 engaging with its receptor, which is composed of 3 subunits α, β and γ, 
which are also called CD25, CD122 and CD132, respectively, stimulates CD8+ T 
cell proliferation. IL-2 can also cease clonal expansion by activation-induced cell 
death (Lenardo 1991). Upon an increase in the TCR binding to its cognate 
peptide MHC I on APCs, the level of high-affinity IL-2R (CD25) is increase and 
the amount of IL-2 production by the CD8+ T cells itself is also increase (Wong & 
Pamer 2014).  
 
Since IL-2 is an important factor in the process of CD8+ T cells clonal expansion, 
IL-2 has been approved for a numbers of metastatic cancers treatments such as 
melanoma and renal cancer. IL-2 has a short half-life in the body; combining IL-2 
with its monoclonal antibody provided promising results with regards to activated 
CD8+ T cells expansion (Tomala et al. 2009). IL-2 is not only having a short half-
life, IL-2 leads to adverse side effects including pulmonary damages which are 
caused by integration of IL-2 with its IL-2R on the lung endothelial cells (Krieg et 
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al. 2010). Using IL-2 in combination with its monoclonal antibody as a complex 
was increased its short half-life and also reduced the severe adverse effects 
(Tomala et al. 2009; Krieg et al. 2010).  
 
During the activation process of CD8+ T cells, which up-regulates low level of IL-2 
receptor (IL-2R), have the fate to turn into memory cells very early during the 
activation stage without fighting the infection and reside in locations through out 
the body (Laouar et al. 2008), and also cells which up-regulate high level of IL2R 
have the fate of terminal effector CD8+ T cells. One of the keys essential in the 
differentiation of effector to memory CD8+ T cells is the B-lymphocyte induced 
maturation protein-1 (Blimp-1). Cytokine such as IL-2 is inducing the Blimp-1 
expression that in turn induces the conversion of effector to memory cells (Boulet 
et al. 2014).  
 
IL-15 is a growth factor maintaining the memory CD8+ T cell’s pool (Ku et al. 
2000). Another factor controlling the naïve CD8+ T cells differentiation to effector 
cells is the physiological exposure to a various range of hyperthermia. A research 
study by (Mace et al. 2011) suggesting that exposing to a mild hyperthermia 
39.5°C prior to antigen specific activation of Pmel-1 CD8+ T cells was resulted in 
an increase in the numbers of the cells which eventually differentiated to effector 
CD8+ T cells.           
  
1.2.3. CD8+ T cells trafficking to peripheral tissues 
 
The leukocyte migration from blood and lymphatic to peripheral tissues and back 
to blood is controlled through a multi-cascade process involving a numbers of 
adhesion molecules and their counter ligands. Leukocyte extravasation from 
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blood to tissues and back to blood occurs continuously in order for the leukocytes 
to undergo their circulation and searching for antigen. Different vascular 
phenotype at different location and also the phenotype of the CD8+ T cells 
determine their fate and the end point of the cells during normal circumstances 
against situations where there is an infection at some part of the body (Brinkman 
et al. 2013). 
 
Various subsets of CD8+ T cells, such as naïve, effector and memory cells, have 
different migration or homing capacity. Naïve and memory CD8+ T cells, because 
of their functions of first to find their cognate antigen, are mostly found in the 
secondary lymphoid organs. They usually circulate and they are found either in 
circulation or in secondary lymphoid organs. Whereas the effector CD8+ T cells, 
in which its function is to fight the infection, are mostly found in the peripheral 
non-lymphoid tissue (Sallusto et al. 1999). Although Naïve CD8+ T cells, due to 
the nature of their function, are either usually found in the secondary lymphoid 
organs or their site of development such as thymus, these cells were found in the 
wall of aorta and liver (Golden-Mason et al. 2004; Galkina et al. 2006).  
 
The endothelium plays a major role in the attraction and recruitment of T cells 
into the site of infection. During immune surveillance, naïve CD8+ T cells use 
specialized blood vessels called HEV in the secondary lymphoid organs and, in 
particular lymph node, to enter and seek their cognate antigen. Whereas effector 
CD8+ T cells preferentially attracted to the site of the inflammation and use the 
conformation changes in the endothelium and post-capillary venules as a result 
of an inflammation, to enter (Streeter et al. 1988). 
 
Effector CD8+ T cells, critical for protection against viral infection, enter the lung 
interstitium from the pulmonary vasculature and retain for a long period of time 
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via other adhesion molecules such as leukocyte function antigen-1 (LFA-1). The 
function of these effector CD8+ T cells from the pulmonary vasculature into the 
lung interstitium in part is driven by the CC chemokine ligand 5 (CCL5) expressed 
by the lung (Galkina et al. 2005).       
 
Furthermore, T cells can use other mechanism in order to enter peripheral 
tissues. For example, a population of T cells called T regulatory cells (T reg) can 
enter the tissues via recognition of self-antigen, which is expressed in the context 
of MHC class II molecules on the surface of endothelium. This Treg recruitment 
phenomena relies on the IFN-γ mediated up-regulation of MHC Class II by the 
endothelium and the PI3K P110δ pathway activation via the TCR (Fu et al. 2014).   
 
Activated T cells use another chemokine interaction mechanism to enter the site 
of Graft Versus Host Disease (GVHD) in the skin. This mechanism relies on the 
interaction of C-X-C motif chemokine receptor 3 (CXCR3) expressed by the T 
cells binding to C-X-C chemokine ligand 9 and 10 (CXCL9) and (CXCL10) 
expressed by the epidermal cells of the skin (Villarroel et al. 2014). 
 
Whereas, at the peripheral non-lymphoid sites of tumour, or at the periphery of 
the tumour mass, HEV can develop and facilitate the recruitment effector CD8+ T 
cells to the site of infection (Bento et al. 2015). Because of the ligand and 
receptors expressed by the HEV, it is an ideal surface for the T cells to use in 
order to home to the site of interest. There was a strong correlation between the 
higher numbers of the infiltrating T cells with the higher numbers of the HEV in a 
mouse model of chemical carcinogenesis called methylcholanthrene (MCA) 
tumor (Gallimore et al. 2013). HEV not only allow the recruitment of either naïve 
T cells to the lymph node or effector T cells into the site of inflammation, if HEV 
exist at the site, but also, it allows the monocyte-derived macrophages to enter 
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the lymph node through monocyte chemoattractant protein-1 (MCP-1), which will 
act as APCs for the T cell activation and priming (Palframan et al. 2001).  
 
Moreover, cytokines such as IL-6 have been implicated in enabling effector CD8+ 
T cells infiltration into tumor microenvironments in mice and human. A research 
study by has shown that a systemic thermal therapy (39.5°C + 0.5°C) leads to an 
increase in the level of IL-6 secretion by the stromal cells which binds to the 
soluble IL-6 receptor-α that further leads to E/P-selectin- and ICAM-1-dependent 
recruitment of effector CD8+ T cells (Fisher et al. 2011).    
  
1.3. Adhesion molecules 
 
Adhesion molecules, such as members of selectin family, immunoglobulin 
superfamily (IgSF) and integrin family, play an important role in the process of T 
cell migration. In order for a T cell to enter the secondary lymphoid organs or 
peripheral sites of infection, it must undergo a multi-step process orchestrated by 
the adhesion molecules and their counterpart ligands. T cell itself expresses 
surface adhesion receptors, and endothelium of blood vessels also expresses a 
number of adhesion receptors. Although these cell adhesion molecules (CAMs) 
are mainly involved in the capturing and adhesion processes, they provide 
extracellular signalling communications.  
 
One the most common families of adhesion molecules is the integrin family. It is 
composed of a heterodimer of α and β chains. Both chains of the integrins are 
required in order to exert it’s binding and signalling function. The most common 
integrin’s involved in leukocyte-endothelial interaction cascade are a member of 
the β7 subfamily, three from the β2 and one from β1 subfamily (Hynes 1992).  
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Another family of cell adhesion molecules is the Immunoglobulin superfamily 
(IGSF). Intercellular adhesion molecule-1, 2 and 3 (ICAM-1, 2 and -3) are 
members of IGSF. They are receptors expressed by endothelial cells and 
leukocytes that mediate and participate in the leukocyte-endothelial cells 
interaction. Vascular cell adhesion molecule-1 (VCAM-1) is also a member of the 
IG superfamily (Pepinsky et al. 1992). Under normal circumstances, these 
adhesion receptors are very minimally expressed by endothelial cell lining blood 
vessels, in order to allow the normal flow of the immune cells to take place. In 
inflammation situation and in the presence of cytokine such as TNF-α and IL-1b, 
their expression is up-regulated near to the site of the inflammation and allows 
the enhanced recruitment of the necessary cohort of the cells to the site of the 
inflammation (Gearing & Newman 1993).    
 
The last family in the cell adhesion molecules is the selectin family. Members of 
the selectin family are L-, P- and E-selectin, which is expressed by leukocytes, 
platelet and endothelium, respectively. They are glycoprotein in nature and their 
participation in leukocyte-endothelial cell interaction is pivotal (Bevilacqua 1993). 
The cyclical expression status of members of selectin family varies according to 
the different members, for example, L-selectin is constitutively expressed by the 
leukocyte under normal circumstances, but it is expression is altered during the 
leukocyte activation. E- selectin is expressed in similar manner to the integrins 
family with a response to inflammatory stimuli, whereas the P-selectin is stored in 
the intracellular cytoplasmic compartments and up-regulated to the surface 
according to inflammatory stimuli. Selectins are first involved in capturing and 
rolling of leukocyte on the surface of the blood vessels. This sequential event of 
leukocyte-endothelium interactions, such as neutrophil recruitment during 
inflammation, is initiated through selectins expressed by the leukocyte called L-
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selectin binds to cutaneous lymphocyte antigen (CLA) and, selectins expressed 
by endothelial cells P- and E-selectin binds to P-selectin glycoprotein-1 (PSGL-1) 
on the leucocyte (Hill et al. 2003). This first process is called primary capturing of 
leukocytes on the surface of the endothelium. Where as in lymph nodes, L-
selectin expressed by T cells use PNAd binding to interact with the endothelial 
cells lining HEV within the lymph node.  
 
The process of capturing and rolling is followed by the next step, which is 
mediated by integrins and will lead to the integrin-mediated leucocyte arrest 
through integrin α4β7, leukocyte function-associated antigen-1 (LFA-1), very late 
antigen-4 (VLA-4) and macrophage antigen-1 (Mac-1). After that, leukocytes 
crawl along the wall of the blood vessels and later they have to transmigrate into 
the tissues using either of the two mechanisms which are mediated by integrins 
and IgSF. First mechanism is paracellular, in which the T cell transmigrates 
between two adjacent endothelial cells by dissociating the junction between the 
cells engaging with the junction adhesion molecules (JAMs, such as JAM-A, 
JAM-B), PECAM/CD31, ICAM-1, ICAM-2 and CD99.  In the second mechanism, 
T cells transmigrate in a process called transcellular migration, in which the T 
cells transmigrate through a single endothelial cell by engaging with F-actin 
containing VCAM-1 and ICAM-1 rich podosomes (Figure 1.4)(Vestweber 2007; 
Ager 2012). 
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Fig. 1.4: The role of L-selectin (CD62L) in lymphocyte migration across 
blood vessel wall. Tethering and rolling of lymphocytes occurs initially through 
L-selectin molecules. L-selectin is pivotal for most of the steps where it’s binding 
activate CC-chemokine receptor 7 (CCR7) and Leukocyte function associated-1 
(LFA-1), which are required for further rolling and firm adhesion. L-selectin also 
results in subsequent activation of the integrin family for transmigration. 
Ager, 2012  
1.4. L-selectin (CD62L) 
 
L-selectin is a C-type lectin receptor expressed by leukocytes. It is glycoprotein in 
nature composed of NH2 terminus, C-type lectin domain, and epidermal growth 
factor domain, this is followed by two short consensus repeating unit, proximal 
membrane region, transcellular region and a cytoplasmic tail (Ivetic 2013). The 
history of L-selectin dates back to 1989 when the cDNA sequences of the three 
members of the selectin family were identified. L-selectin is coded by a gene 
called SELL, which encodes a 70KD protein and it is found on the chromosome 1 
(Watson et al. 1990).   
 
L-selectin is characterized as a peripheral lymph nodes homing receptor. CD8+ T 
cells homing and migration across high endothelial venules (HEV) of lymph 
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nodes, which is essential for immune response strength, are regulated through L-
selectin (Grailer et al. 2009). L-selectin is crucial for the initial tethering and rolling 
of CD8+ T cell across the wall of blood vessels and, in particular, HEV of lymph 
nodes. Lymphocytes, in particularly CD8+ T cells, home to peripheral lymph 
nodes, and following activation, they re-enter the bloodstream and migrate to 
sites of infection, which are all requirements of a potent immune cell.  
 
 
 
 
 
 
 
 
Fig. 1.5: L-selectin structure. L-selectin is expressed by all leukocytes and is 
responsible for the initial rolling and tethering of lymphocytes across the blood 
vessel wall and high endothelial venules. L-selectin comprises an N-terminus, 
followed by a lectin domain where most of it’s ligands bind, epidermal growth 
factor-like domain, consensus repeating units, which vary in number among the 
selectin family members, a proximal membrane region, transmembrane domain 
and cytoplasmic tail.    
 
 
Naive CD8+ T lymphocytes express L-selectin on their surface in order to enter 
the lymph node through HEV using L-selectin-PNAd binding (Klinger et al. 2009). 
Injecting monoclonal antibodies specific for vascular addressin (PNAd) resulted in 
inhibition of the numbers of recruited lymphocyte to the peripheral lymph nodes 
without interfering with the homing of lymphocytes to the mucosal associated 
Peyer’s patches in the gut (Streeter et al. 1988). PNAd, defines a mixture of 
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glycoproteins including GlyCAM-1 (Glycosylation Cell Adhesion Molecule-1) 
which is a soluble ligand and the cell surface ligands CD34 and podocalyxin-like 
protein (PCLP). To enter intestinal secondary lymphoid organs, CD8+ T 
lymphocytes bind to MAdCAM-1 (Mucosal Addressin cell adhesion molecule-
1)(Ley et al. 2007)(Grailer et al. 2009).  
 
Using antibodies that target the lectin and epidermal growth factor domains of L-
selectin, called MEL-14, resulted in reduction in the lymphocyte-endothelial cell 
interaction, which is necessary for lymphocyte recruitment to the lymph nodes 
(Bowen et al. 1990). Also deletion of the epidermal factor domain, which leaves 
the lectin domain alone, resulted in loss of MEL-14 binding. This suggests that 
MEL-14 binds the lectin domain of L-selectin in the presence of epidermal factor 
domain. Further studies, in which mice were deficient for L-selectin, through gene 
targeting, showed a severe reduction in the numbers of leukocytes in peripheral 
lymph nodes, further revealing that L-selectin is an obligate peripheral lymph 
node homing receptor (Arbornes et al. 1994).  
 
However, in the absence of L-selectin, lymphocytes can use alternative 
mechanisms to enter lymph nodes through P-selectin expressed by activated 
platelets. P-selectin binds to PNAd on HEVs in a similar manner as L-selectin, 
and lymphocytes can undergo secondary tethering and rolling on captured 
platelets and other leukocytes to enter the lymph node (Diacovo et al. 1996). 
 
Furthermore, the importance of L-selectin has also been shown in the context of 
leukocyte homeostasis, in particular CD8+ T cells into lymphoid tissues. 
Abrogating the gene that codes for L-selectin in CD8+ T cells or suppressing the 
mRNA (let-b7) of L-selectin by mycolactone resulted in a considerable loss of 
CD8+ T lymphocyte homing to lymph nodes and accumulation in peripheral blood 
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(Guenin-macé et al. 2011).  Mice, which lack lymphocytes (T and B cells) (Rag-/-), 
are susceptible to homeostatic proliferation (HP) and L-selectin has a critical role 
in directing CD8+ T cells to lymph nodes, where CD8+ T cells undergo HP 
(Schuster et al. 2009).   
 
 
 
 
 
1.4.1. L-selectin expression on the surface of activated 
CD8+ T cells 
 
Naïve CD8+ T cells uniformly express a high level of L-selectin. An in vitro study 
has shown that upon CD8+ T cell activation through TCR engagement with 
cognate peptide in the context of MHC class I on the surface of APC, L-selectin is 
shed on the surface of the of the CD8+ T cells in the first 4 hours of activation by 
proteolytic cleavage and shedding. L-selectin is re-expressed within 48 hours due 
to an increase in the level of L-selectin mRNA. Following re-expression, L-
selectin expression is markedly reduced between day 5-7 post activation in vitro 
due to L-selectin gene silencing (Chao et al. 1997).   
 
L-selectin expression is controlled by the level of its mRNA transcription, 
translation and proteolysis of its full length structure i.e. two completely separate 
mechanisms of proteolytic cleavage and gene silencing control the expressions 
of L-selectin on the surface of CD8+ T cells (Chao et al. 1997). Why, L-selectin 
expression is very tightly regulated on the surface of CD8+ T cells and expression 
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varies between 0-8 days following activation, are questions, which are not fully 
understood.  
 
Furthermore, the level of L-selectin expression on the surface of lymphocytes 
such as CD4+ T cell is controlled by other mechanisms as well. It has been 
shown that viral proteins such as NEF and VPU, found in the Human 
Immunodeficiency Virus (HIV), are implicated in the down regulation of L-selectin. 
Both HIV proteins (NEF and VPU) were impeding the CD62L protein 
transportation onto the plasma membrane, retaining the CD62L protein in the 
perinuclear compartments. Increased CD62L down regulation were involved in 
the limitation of immune response against the virus (Vassena et al. 2015).  
 
Although leukocyte migrations is a multi-cascade process and a number of cell 
adhesion molecules play a major role in the process, L-selectin is the key initiator 
and it is responsible for the first tethering and rolling of lymphocytes across the 
HEV in LN (Mora & Andrian 2006). The current dogma of leukocyte migration is 
naïve CD8+ T cells express a high level of L-selectin on their surface and use it to 
enter the LN. Upon activation through TCR, L-selectin is shed on the surface 
allowing the CD8+ T cells to enrich at non-lymphoid peripheral sites of infection 
and preventing them from re-entering the lymphoid tissue during the course of 
the infection (Lefrancois 2006). Whereas the in vitro study by (Chao et al. 1997), 
clearly showed that L-selectin is re-expressed on the surface of CD8+ T cells 48 
hours post activation.  
 
1.4.2. L-selectin proteolytic cleavage by metalloproteinase 
ADAM family 
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A family of transmembrane proteinases called A Disintigrin and Metalloproteinase 
(ADAMs) play an important role in controlling the expression of various cell 
adhesion molecules on the surface of leukocytes. During the course of an 
infection; it is the responsibility of ADAMs to control migration and stationary 
patterns of leukocytes at various lymphoid and non-lymphoid tissues by 
controlling the expression of cell surface adhesion molecules.  
 
ADAM is a family of proteins consists of around 19 members ADAM’s main role 
in the immune system is the enzymatic cleavage of a numbers of cell adhesion 
molecules involved in leukocyte-endothelial cell interaction in the process of 
leukocyte migration (Edwards et al. 2008). ADAMs consists of a prodomain, 
metalloprotease, disintigrin-like, cysteine-rich and epidermal growth factor-like, 
transmembrane and cytoplasmic domains (Ager 2012). Various ADAMs that are 
responsible for cleaving various adhesion molecules have essential requirements 
in order to be able to perform their sheddase function, among the most important 
is structure of the substrate, substrate accessibility and the distance of the 
cleavage site from the cell membrane. Also, the ADAM structural conformation  
plays an important role in its sheddase activity. The C-shaped structure formed 
by the cysteine rich, and disintegrin domain pointed toward the metalloproteinase 
domain allows the ADAMs to easily engage with its substrate and perform its 
shaddase activity (Igarashi et al. 2007)(Wang et al. 2009).  
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Figure 1.6: ADAM family. A Disintegrin and Metalloproteinase is a family of 
peptidases, which is mainly responsible for shedding extracellular membrane 
proteins.   
Ager, 2012  
 
 
 
 
 
ADAM-17 cleaves L-selectin on the surface of leukocytes, such as neutrophils 
(Wang et al. 2009). Intracellular signals following leukocyte activation will lead to 
the activation of the enzymatic activity of ADAM-17, however, extracellular 
activation of mature ADAM17 is another possible way of its activation through 
oxidative agent H2O2, which leads to ADAM-17 dependent shedding of L-selectin. 
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L-selectin shedding and its involvement in leukocyte migration were first studied 
in 1989. Neutrophils treated with chemotactic factor complement C5a or phorbol 
ester resulted in an increase in the level of cleaved L-selectin, soluble L-selectin 
(Kishimoto et al. 1989). The loss of L-selectin on the surface of neutrophils 
resulted in their inability to migrate efficiently to the site of infection (Jutila et al. 
1989). In similar consistency with the neutrophil L-selectin shedding phenomena, 
lymphocytes lose L-selectin expression within 30 minutes upon treatment with 
phorbol ester (Jung & Dailey 1990).  
 
 
                         
 
 
Fig. 1.7: The process of L-selectin shedding by ADAM 17. Metalloproteinase 
(M) domain together with the cysteine rich (C), hypervariable region (HVR) and 
disintegrin (D) region are responsible for forming a C shaped molecule structure 
to bind the membrane proximal region of L-selectin. 
Ager, 2012 
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Other enzymes, such as recombinant human fibroblast collagenase (MMP-1) and 
to some extent stromelysin (MMP-3) can also cleave L-selectin from the surface 
of mouse leukocytes (Preece et al. 1996). Metalloproteinases, such as ADAMs, 
which are responsible for cleaving L-selectin upon leukocyte stimulation through 
phorbol ester, chemoattractants and L-selectin engagement, target the proximal 
membrane region of L-selectin, releasing a soluble fragment of L-selectin, which 
is consisting of lectin and epidermal growth factor domains (Preece et al. 1996). 
The amino acid specificity is not an absolute requirement for the proteolytic 
shedding of L-selectin to occur. A tertiary conformation of L-selectin with a certain 
distance of proximal membrane region from the plasma membrane allows the 
membrane-bound endoprotease to cleave L-selectin (Chen et al. 1995). Although 
the role of soluble L-selectin fragment released after its proteolytic shedding is 
not well understood, a study has shown that soluble L-selectin act as an 
adhesion buffer that have a distinct anti-adhesive function such as rapid 
dissociation of cell-cell interaction (Walcheck et al. 2003).  
 
The proximal membrane region of L-selectin consists of 15 amino acids (Chen et 
al. 1995). Although the specific amino acid sequence of the proximal membrane 
region is not necessary for the L-selectin proteolytic shedding to occur since the 
introduction of alanine scanning mutation did not prevent L-selectin from 
shedding after PMA treatment. Also, alteration in the putative primary cleavage 
site (K283-S284) of human L-selectin resulted in a partial inhibition of shedding 
during activation-induced shedding (Chen et al. 1995), The length of the gap of 
the proximal membrane region from the cell membrane was the most critical in 
order for the cleavage enzyme to perform the cleavage action. The deletion of 
amino- or carboxy-terminal half of the proximal membrane region of L-selectin, as 
in ΔK-N or ΔM-N L-selectin transfected 300.19 cells, resulted in complete 
inhibition of L-selectin shedding and the release of soluble L-selectin into the 
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supernatant (Chen et al. 1995). Collectively, the structure of proximal membrane 
region and its position at the cell membrane is key in order for its sheddase to 
cleave it at the cell surface.  
 
Since L-selectin is composed of a number of domains, L-selectin shedding by 
ADAM-17 or any other metalloproteinases at the proximal membrane region will 
leads to the release of soluble L-selectin into the circulation and leaving behind 
membrane retained fragment comprising of a shortened proximal membrane 
region, the transmembrane region and the cytoplasmic tail (Smalley & Ley 2005).  
 
Consist with other type I integral membrane proteins, such as amyloid precursor 
protein (APP) expressed by neurons in the brain, in which after its primary 
proteolysis by β-secretase, the Aβ fragment is further processed by γ-secretase, 
which leads to the release of a cytoplasmic tail (Vorobyeva et al. 2014), L-selectin 
membrane retained fragment could be further processed by γ-secretase. Release 
of a cytoplasmic fragment that might be implicated in a number of signalling 
pathways has yet to be studied.  
 
1.4.3. L-selectin gene transcriptional silencing 
 
Upon CD8+ T cell activation through its TCR, L-selectin is initially down-regulate 
by ectodomain proteolytic shedding. L-selectin has been shown to re-express 
during in vitro activation on the surface of CD8+ T cells (Chao et al. 1997). After 
re-expression, L-selectin gradually down regulates again. This time the L-selectin 
down-regulation is controlled by the rate of transcription of its gene through the 
transcription factor Kruppel-like factor 2 (KLF2)(Sinclair et al. 2008).  
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Naïve and memory CD8+ T cells maintain high level of L-selectin expression 
through continuous transcription of its gene in a rich IL-15 environment (Sinclair 
et al. 2008). Whereas, an IL-2 rich environment at the site of infection induces the 
inhibition of L-selectin gene transcription and effector CD8+ T cells harvested 
from the site of infection are L-selectin negative (Mobley & Dailey 1992). IL-2 
engaging with IL-2R (particularly CD25, IL-2 α-subunit) initiates a series of 
intracellular signals, which activate the phosphoinositide 3 kinase (PI3K)(Sinclair 
et al. 2008). PI3K is a family of enzymes that generate lipid messengers inside 
the cell and it is implicated in a number of cell functions. Among the most 
important are the activation and differentiation of T cells; collectively PI3K 
provides co-stimulation for T cell function (Okkenhaug & Vanhaesebroeck 2003). 
One of the in vivo studies in rats using PI3K blocking agents such as wortmannin 
or LY294002 has shown that PI3K blocking had a major immunosuppressive 
effect and also resulted in functional impairment to many organs (Gunther et al. 
1989)(Fruman et al. 1999).  
 
PI3K is classified into three major groups, Class I, II and III. PI3K require G-
coupled receptors or tyrosine kinase receptors in order to be activated. Class I 
PI3K, which is involved in L-selectin gene silencing pathway, consists of two 
subunits, a catalytic subunit (p110) and a regulatory subunit (p85). The p110 
subunit is further classified into a number of variants, p110α, p110β and p110δ. 
The p85 subunit is also classified into 5 different variants named, P85α, P55α, 
P50α, P85β and P55γ. One variant of each of catalytic and regulatory subunit 
forms a heterodimeric molecule to form a functional PI3K (Okkenhaug & 
Vanhaesebroeck 2003). 
 
The function of PI3K is to phosphorylate phosphatidylinositol bisphosphate (PIP2) 
and form phosphatidylinositol triphosphate (PIP3). PIP3 together with the 
 40 
mammalian target of rapamycin (mTOR) block the action of KLF2, which is 
responsible for the transcription of L-selectin gene (Sinclair et al. 2008). PI3K with 
mTOR, which is further blocking the action of KLF2, also leads to inhibition of the 
transcription of CCR7 and S1P1 gene. All three molecules (L-selectin, CCR7 and 
S1P1) are critical receptors in the process of leukocyte migration and exit into 
secondary lymphoid organs (LN)(Sinclair et al. 2008).  
 
 
 
 
 
 
 
 
Fig. 1.8: Phosphoinositide-3-OH kinase (PI(3)K) signals together with the 
mammalian target of rapamycin (mTOR) account for the L-selectin expression 
status on the surface of various T lymphocyte subsets. Upon T lymphocyte 
activation, inactive ADAM-17 (TACE-ADAM17) converts to an active form and 
results in L-selectin shedding. L-selectin is re-expressed on the surface of central 
memory T lymphocytes in order to home to lymph nodes. But if the stimulus, 
which could be a virus or any other microorganism persists, PI3K activation is 
sustained in effector T lymphocytes and L-selectin gene will not be transcribed 
due to lack of KLF-2 expression.  
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Another pathway has also been implicated in controlling gene transcription of L-
selectin and other adhesion molecules. Similar to PI3K and mTOR pathway, 
transcription factor forkhead box O 1 (FOXO1) is also functional in naïve T cells. 
FOXO1 in turn binds to KLF2 and allows the transcription of L-selectin and 
controls the level of L-selectin expression on the surface of naïve T cells. 
Inhibition of FOXO1 function is also controlled by downstream signalling of PI3K, 
which is activated only in naïve T cells primed with antigen (Fabre et al. 2008).  
 
Although PI3K signalling controls these transcription factors which in turn control 
the level of L-selectin expression and lymphocyte migration behaviour, another 
role for PI3K is in controlling activated CD8+ T cell homeostasis and the rate of 
proliferation and apoptosis. Another member of the FOXO transcription family, 
FOXO3, has been shown to control effector CD8+ T cell fate. In mice, where 
CD8+ T cells were deficient in FOXO3, there was a massive effector CD8+ T cell 
accumulation during the effector expansion phase of acute LCMV infection. The 
increase in the effector CD8+ T cells was not due to enhanced proliferation, but 
due to impairment in the rate of apoptosis (Sullivan et al. 2012). 
 
 
1.4.4. L-selectin ligands 
 
L-selectin was characterized as lymph nodes homing receptor on naïve CD8+ T 
cells (Gallatin et al. 1987). Defining the ligands for L-selectin originated from the 
early studies where they observed a special affinity binding between the 
lymphocyte and the cryostat-cut section of lymph nodes in vitro (Stamper & 
Woodruff 1976). The molecular basis of this binding allowed (Gallatin et al. 1983) 
to define a molecule on the surface of lymphocytes that enable this lymphocyte 
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entry into the LN first, and then allowed the opportunity for others to describe the 
counterpart ligand for L-selectin on the vascular endothelium of specialized blood 
vessels (HEV) in the LN that complete the binding complex.    
 
L-selectin, and other members of the selectin family, is able to recognizes a 
carbohydrate ligands on the cell surface because, all selectin members share a 
homology of N-terminal carbohydrate-recognition lectin domain. However, L-
selectin binds a sulfated form of sialyl Lewis x with higher affinity (Varki 1994). 
 
The first identified L-selectin ligand is the novel vascular addressin (commonly 
called Peripheral node addressin PNAd), which is well characterized to be 
involved in homing of T lymphocytes to peripheral lymph nodes (Streeter et al. 
1988). PNAd is a complex name used to identify any glycoproteins that are 
reactive with L-selectin on the HEV within the lymph nodes. Among the most 
characterized members of the PNAd complex are GlyCAM-1, CD34 and 
Podocalyxin. GlyCAM-1 is a secreted protein and also called soluble L-selectin 
ligand, whereas CD34 and Podocalyxin are type 1 membrane proteins. All the 
three L-selectin ligands are glycoproteins and they have multiple O-linked 
glycans. The discovery of these glycoprotein ligands of L-selectins, containing 
silaic acid or Fuc at the termini of O-linked or N-linked oligosaccharides, were 
inspired by works which showed that treatment of lymph nodes with mixed 
glycosidase including sialidase inhibited the lymphocyte binding to HEV (Rosen 
2004). Mucosal Addressin cell adhesion molecule-1 (MAdCAM-1) is originally 
identified as a ligand for α4β7 integrin. But cDNA cloning studies have shown that 
MAdCAM-1 has multiple functional sites, which can also support L-selectin 
binding (Berg et al. 1993). 
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There are conflicting literatures on the role of L-selectin in homing of lymphocytes 
to the site of infection and the presence of L-selectin ligands in peripheral tissues, 
which could support L-selectin dependent recruitment of lymphocytes into 
peripheral non-lymphoid tissues. First it has been shown that effector CD8+ T 
cells express low level of L-selectin at the site of infection (Kaech et al. 2002; 
Richards et al. 2008) and second, short term homing studies showed that L-
selectin is not a predominant receptor for homing of lymphocytes to the skin 
(Austrup et al. 1997; Hirata et al. 2002; Mobley & Dailey 1992; Mora & Andrian 
2006). However, it has been shown that L-selectin controls the migration of 
lymphocytes into sites of chronic inflammation. HEV like structures present in the 
inflamed synovium during rheumatoid arthritis were present which might allow the 
engagement of L-selectin with molecules expressed on the surface of these HEV 
like structures and enhance the infiltration of lymphocytes to the site of infection 
(Jin et al. 2012).  
 
Furthermore, transgenic mice expressing oncoprotein (Tag) in the islet β cells 
that elicit β cell hyperplasia with subsequent progression to tumor, showed that in 
the tumor surrounding area, there were ligands for L-selectin and α4β7, which 
support lymphocytic infiltration. Whereas L-selectin and α4β7 ligands were not 
expressed within the tumor, they were devoid of lymphocytic infiltration (Onrust et 
al. 1996).  
 
Also, in patients with neuropathy, it has been shown that there were 
sulfoglucuronyl glycosphingolipids (SNGL) that allowed the absorption of L and 
P-selectin chimeric proteins but not E-selectin. The presence of these lipids in the 
brain might work as ligand for L-selectin on the surface of lymphocytes and allow 
the recruitment of lymphocytes into the brain tissues (Needham & Schnaar 1993). 
The role of L-selectin and its ligands were further demonstrated in the brain. It 
 44 
has been shown that in a mouse model of multiple sclerosis, experimental 
autoimmune encephalomyelitis (EAE), induced by treatment of these mice with 
Myelin oligodendrocyte glycoprotein peptide, disease did not develop in mice 
deficient in CD62L. They have also shown that CD62L is required for the 
induction of the EAE, but the T and non-T effector cells did not require CD62L to 
migrate to the central nervous system parenchyma (Li et al. 2006). 
 
Finding ligands for L-selectin in the peripheral non-lymphoid tissues has been of 
interest to many scientists. Although the significant relevance of these ligands in 
the extravascular areas were not known yet, a number of ligands were identified 
in the past years. A research study has shown that there are ligands for L-
selectin in the kidney distal straight tubules. Amino acid sequencing, 
immunoprecipitation and western blotting studies showed that the nature of these 
ligands for L-selectin in the kidney tubules is Versican. They confirmed that the L-
selectin ligands, isolated from kidney tubule-derived cell line, bind to L-selectin 
chimeric protein (LEC-IgG) were blocked by using anti-L-selectin antibodies 
(MEL-14)(Kawashima et al. 1999).       
 
1.5. Adaptive immune response against virus infection  
 
The adaptive immune system orchestrates together to deal specifically with virus 
infections. Vertebrates born with severe defects in the adaptive immune system 
will die soon in case they were infected with viruses or any other pathogenic 
agents. Viruses are severely pathogenic because of their wide range of tissue 
tropism, pathologic lifecycles and their genomic DNA or RNA structure. Viruses 
are intracellular parasites, they utilize the infected cells to survive therefore 
interfere with the normal structure and function of the cell itself.  
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With the help of the innate immune response receptors such as TLR (Toll-like 
receptor), which detect viruses in extracellular compartments and NOD-like 
receptors (NLR) and AIM2-like receptors (ALRs) for intracellular viruses, Innate 
immune system cells are able to process the virus particles and seek the help 
from the adaptive immune system.  Using a wide range of cytokines such as IL-6, 
IL1β and TNF-α, innate immune system facilitates the recruitment of the adaptive 
immune system cells to fight specifically against the infection. Both humoral and 
cellular arms of the adaptive immune system have important roles in anti-virus 
immunity (Aoshi et al. 2011). B cells mainly participate in secreting antibodies in 
response to a specific recognition of the virus particles and the secreted 
antibodies bind the virus and avoid its further function, infecting cells, and, 
therefore, avoid its further expansion. Whereas, T cells participate in fighting 
against the viruses by secreting a range of cytokines such as IFN-gamma to 
either kill virus infected cells or interfere with virus conformation and impair its 
replication. 
 
Virus infection can be divided into 2 phases; first, the acute phase or primary 
infection, in which the NK cells and CD8+ T cell arm of the adaptive immune 
system play important role in the elimination of the virus and infected cells. In the 
second, chronic phase, the virus either persists or keeps replicating and the 
immune system fails to control the infection. Cellular immunity during virus 
infection can also be classified into a number of phases; priming, activation and 
effector phase, which is related to the acute phase of the virus infection. Second, 
death phase, which is either related to the viral clearance or persistence phase of 
the infection. Generation and establishment of memory cells will follow mainly, if 
the virus cleared or even if it is reached the latent phase (Wherry & Ahmed 2004; 
Kalia et al. 2010).  
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Figure 1.9: Time course of effector and memory CD8+ T cells generation 
during a course of virus infection. Upon recognition of the virus peptide, naïve 
CD8+ T cells activate and differentiate into effector CD8+ T cells early during the 
primary course of the infection, then these cells undergo a contraction phase and 
cells who survive suring the virus infection, turn into memory CD8+ T cells.     
Ahmed, 2010 
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Leukocytes learn to fight against viruses during their development in the bone 
marrow (Hermesh et al. 2011). CD8+ T cells play an important role in host 
defence against lymphocytic choriomeningitis virus (LCMV) infection (Althaus et 
al. 2007: Kotturi et al. 2007). CD8+ T cells play an important role in both murine 
and man host defence against the paramyxoviridae family member respiratory 
syncytial virus (RSV). In a murine model of RSV infection, CD8+ T cell depletion 
results in an increased persistence of the virus and adoptive transfer of primed 
CD8+ T cells is enough to clear the virus (Cannon et al. 1987). Also in 60% of 
human donors infected with RSV, CD8+ tetramer positive T cells were found 
against the immunodominant epitope (M) protein of the RSV virus (De Graaff et 
al. 2004).  
 
In the presence of sufficient numbers of mature peripheral dendritic cells in the 
lung, protective immune response against influenza infection is CD8+ T cell 
dependent (McGill et al. 2008). Also in mice, absence of CD8+ T cells results in 
an increase in the lethal effects of influenza virus (Bender et al. 1992), whereas, 
depletion of CD4+ T cells only results in a delay in viral clearance but full recovery 
(William Allan et al. 1990). CD8+ T cells use their cell adhesion molecules and 
chemokine receptors in order to perform their function. CD8+ T cells use CXCR3 
to localize to virus-infected cells at the site of infection in the skin (Hickman et al. 
2015). CXCR4+ T cells, in the presence of IL-1β secreting leukocytes (Primarily 
macrophages), use CXCL12 chemokine to infiltrate blood brain barrier and 
contribute to the clearance of West Nile virus (Durrant et al. 2014). 
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1.5.1. Vaccinia virus  
 
Vaccinia virus is a large, complex, double-stranded DNA virus. It belongs to the 
Poxviridae family. Among the most common member of the family is cowpox. 
Because it is a large enveloped virus, vaccinia virus replicates in the cytoplasm of 
the cells outside the nucleus. It has a 190kbp genome and it encodes for around 
250 genes. These genes translate to provide the virus with the necessary 
enzymes and proteins to survive in the host (Tolonen et al. 2001). Once it is 
enters the cytoplasm 2 hours post infection, vaccinia virus starts DNA synthesis. 
At 6 hours post infection, all the virions start to assemble. Vaccinia virus 
produces 4 types of virions, which differ according to location, role and structure. 
Intracellular mature virion (IMV) is the most common and it is responsible for the 
spread between hosts. Other virions produced by vaccinia virus are the 
intracellular enveloped (IEV), cell-associated enveloped (CEV) and extracellular 
enveloped (EEV)(Smith et al. 2002). 
 
The discovery of vaccination by Edward Jenner in late 17th century was a great 
achievement in the field of immunology. He immunized humans with the cowpox 
virus and provided protection upon infection with the smallpox virus. This 
pioneering experiment led other scientist to map different virus genomes and 
identify potential targets for virus eradication and successful vaccination. 
Heterologous viruses from the same family and recombinant viruses that express 
immunodominant epitopes from other viruses were used to understand cross-
protection by the host immune system against different viruses.  
 
Establishment of vaccinia virus infection in mice depends greatly on the dose of 
the virus and the route of virus inoculation (Briody 1959). A number of different 
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inbred strains of mice are susceptible to various strains of vaccinia virus. It has 
been shown that the neurovirulent, Western Reserve strain, killed mice when the 
virus was inoculated intranasally. The lung consolidation, a process in which 
liquid fills the alveoli of the lungs during pneumonia, seen in this experiment was 
accompanied by huge expansion of the virus, viremia and presence of the virus 
in the brain tissue at the terminal stages. In contrast, Copenhagen-glycerolated 
calf lymph Utrech, 1961 strain of vaccinia virus led to no detectable infection 
when inoculated intraperitoneally (Turner 1967). 
  
1.5.1.1. How vaccinia virus establishes its infection in the body 
 
Once the virus entered the body, mechanisms provided by the host help the virus 
to establish infection. In addition, viruses have evolved strategies that modulate 
several intracellular and extracellular signalling pathways that lead to a 
productive viral replication and viral spread. A research study has shown that the 
mitogen-activated protein kinase (MAPK) was up regulated during vaccinia virus 
infection. There was also enhanced expression of MAPK-negative regulator dual-
specificity phosphatase 1 (DUSP1) during vaccinia virus infection. The presence 
or absence of DUSP1 did not have an effect of the modified vaccinia virus Ankara 
(MVA) since the virus has lost its ability to replicate efficiently in most mammalian 
cells (Cáceres et al. 2013). 
 
Vaccinia virus uses other mechanisms to replicate and spread in the body during 
an acute infection. Macrophages are usually identified to provide a beneficial 
effect for the immune system as antigen presenting and phagocytic cells. During 
vaccinia virus infection, most of the macrophages such as granulocyte-
macrophage colony-stimulating factor (GM-CSF)-polarized M1 and macrophage 
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colony-stimulating factor (GM-CSF)-polarized M2 are permissive for the 
generation of extracellular enveloped virion (EEV) of the virus (Sánchez-puig et 
al. 2004; Byrd et al. 2014).   
 
1.5.1.2. Adaptive immune response against vaccinia virus 
infection 
 
Once the virus has disseminated through viremia and infected various tissues in 
the body, based on the pathogenicity of the strain of the virus, the next stage of 
the infection with vaccinia virus is a strong cellular and humoral immune 
response. Although humoral immune response dominates the protection process 
(Xu et al. 2004), cellular immunity still provides protection in various situations 
based on the virus entry route (Goulding et al. 2014).  
 
A number of proteins of the vaccinia virus are subject to the adaptive immune 
system response. Given this concern, defining candidate particles of virus that 
results in a strong adaptive immune response is important to improve vaccination 
strategy against other viruses and also it could help future eradication these 
viruses (Moutaftsi et al. 2006). H3L protein, an intracellular mature virion 
envelope protein, is one the main proteins targeted by the B cell arm of the 
adaptive immune system and high titer of antibodies against it protects the body 
against the lethal effect of vaccinia virus infection (Davies et al. 2005). Studies in 
mice using either passive transfer of serum containing anti-H3L antibodies or 
immunizing mice with H3L protein showed enhanced protection against the lethal 
effect of the wildtype Western Reserve strain of vaccinia virus (Davies et al. 
2005). Another protein found in the vaccinia virus structure that leads to a strong 
neutralizing antibody response is L1 protein. Anti-L1 antibodies neutralize 
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vaccinia virus in an isotype and complement independent manner (Kaever et al. 
2014).   
 
Reports have shown that a vast range of vaccinia virus epitopes can also induce 
strong cellular immunity during acute infection. The route of vaccinia virus entry 
into the body has a great influence on the immunodominant epitopes presented 
to CD8+ T cells (Lin et al. 2013). It has been shown that B8R20 (TSYKFESV) 
epitope of vaccinia virus is the immunodominant epitope for the CD8+ T cell 
response during intradermal (i.d.) and intraperitoneal (i.p.) route of virus entry 
(Tscharke et al. 2005; Moutaftsi et al. 2006; Lin et al. 2013).  
 
Another immunodominant protein of vaccinia virus is A47 epitope. It is encoded 
by A47L gene, and it accounts for 60% of the CD8+ T cells that are responsive 
against vaccinia virus (Tscharke et al. 2005; Yuen et al. 2010). Other epitopes 
from vaccinia virus were identified to influence a long lasting memory CD8+ T cell 
response. Also, some of these memory cells provide a cross-reactive immunity 
for other viruses. E7r130 and a11r198 are two epitopes encode by the vaccinia 
virus large genome. It has been shown that a11r198 provides cross-reactive CD8+ 
T cell for LCMV infection, whereas, E7r130 did not. Either epitopes influenced a 
good memory CD8+ T cell pool that was the solely protective immunity against 
secondary challenge of the vaccinia virus infection (Cornberg et al. 2007).  
 
Investigating the biological characterization of viruses is important to understand 
virus pathogenesis (Williamson et al. 1990). In order to study leukocyte migration 
during virus infections, it is important to identify which organs are involved in the 
pathogenesis of the virus. A virus that is inserted with genes from other viruses to 
produce a recombinant form of the virus is possible to change its virulence and 
pathogenesis (Williamson et al. 1990). Challenging DBA/2 (Dilute Brown Non 
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Agouti/2) mice i.n. with 106 pock forming units of WR vaccinia virus resulted in a 
lethal infection but mice were survived from the infection with inoculation of same 
amount of the recombinant vaccinia virus inserted with 340 genes of Epstein-Bar 
virus (Williamson et al. 1990). 
 
Although recombinant vaccinia virus is not able to produce a lethal infection, it 
can be used as a good tool for vaccination. Low dose (105 PFU) recombinant 
vaccinia virus Ankara (MVA), led to the generation of large amount of virus-
specific CD8+ T cells that were protective against secondary challenge with 
mousepox virus ectromelia virus infection (ECTV). The effect of the memory 
CD8+ T cell response in the vaccinated animals was measured by the complete 
disappearance of the symptoms and inability to detect the virus in various organs 
(Volz et al. 2014).    
 
1.5.2. Influenza virus  
 
Influenza virus is an RNA virus belonging to the family Orthomyxoviridae. It is 
classified into 3 major classes, Influenza class A, B and C. Influenza A is the 
most commonly described and it is responsible for most of the pandemic 
outbreaks that have occurred (Webster et al. 1992). Wild birds are the main 
natural host for the Influenza viruses. Mutations allow the virus to be transmitted 
to other animals, mainly poultry, and can also allow transmission to humans and 
cause devastating pandemic outbreaks (Hay et al. 2001). Influenza virus strain A 
has been widely used in experimental models of mice infection in order to 
understand the biological characteristics of the virus which helps to understand 
the pathogenesis of the virus in human and birds (Blazejewska et al. 2011).   
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An early study by Taylor, 1944, showed that Influenza virus A and B are almost 
structurally similar. Both viruses are mainly composed of protein, lipid, 
carbohydrates and nucleic acids. Chemical analysis revealed that lipid constitutes 
24% of the Influenza A virus structure, whereas Influenza B virus has less lipid 
structure. Cholesterol, phospholipids, carbohydrates and nucleic acids account 
for the rest of the virus complex (Taylor 1944).  
 
The influenza virus genome consists of eight segments of single-stranded 
negatively charged RNA. Influenza genome can encode 11 proteins, which 
participate in virus pathogenesis. Among the most common ones are the 
Hemagglutinin (HA), Neuraminidase (NA), Nucleoprotein (NP), polymerases PB1, 
PB2 and PA M1 and M2 proteins (Webster et al. 1992)(Ghedin et al. 2005). 
Influenza virus must have these proteins in order to be infective (Webster et al. 
1992).  
 
1.5.2.1. Influenza virus infection in human and role of 
pharmaceutically available inhibitors in the disease 
prevention 
 
The Influenza genome undergoes continuous mutations, which makes it difficult 
for a single vaccination strategy to be fully successful and protect from the annual 
epidemics. Antigenic shift, which occurs much less frequently, is responsible for 
the creation of new strain to which humans will have less protective immunity and 
account for the seasonal pandemics (Ghedin et al. 2005). HA and NA are 
glycoproteins that are found on the surface of the influenza virus. Since they are 
expressed externally, they participate in the internalization process of the virus 
into the host cell.  
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In 1984, Justewicz et al. has shown that monoclonal antibodies that have the 
ability to neutralize hemagglutinin but not nucleoprotein and matrix protein of 
influenza A or B virus, reduced the infectivity of the virus which was measured by 
virus-induced cell-mediated cytotoxicity (Justewicz & Lecomte 1984). Also, It has 
been shown that a broad spectrum-neutralizing antibody CH65 binds to the 
receptor binding pockets of the HA protein and minimize the infectivity of 30 out 
of 36 H1N1 strains of influenza virus (Whittle et al. 2011). These monoclonal 
antibodies, which reduce the infectivity of influenza virus through the viral protein 
HA is mediated by first binding to the HA which prevents the virus attaching and 
being released into the target cell. Further mechanisms exploited by these 
antibodies that are important to the life cycle of the virus are preventing fusion 
between the viral and endosomal membrane, which occurs internally. Also, 
prevention of proteolytic activation of the HA is another mechanism of these 
broad spectra antibodies that neutralize the influenza virus (Brandenburg et al. 
2013). 
 
Young children, elderly people and people with naturally occurring morbidities are 
at higher risk of infection with seasonal influenza virus (Jefferson et al. 2010). 
Vaccination is still a successful approach to reduce the risk of influenza virus 
infection, which is recommended by most physicians (Moscona 2005). Another 
key important protein in the influenza virus is the neuraminidase (NA) protein on 
the surface of the virus. Although there is controversy on the effectiveness of NA 
inhibitors, beneficial effects of these inhibitors in the prevention of seasonal flu 
has been documented in some countries (Michiels et al. 2013). NA enables the 
newly formed virions to be released from infected cells and allow a further spread 
of the virus in the targeted body and even further between individuals (Moscona 
2005). These NA inhibitors prevent the action of the influenza virus 
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neuraminidase enzymatic activity and, therefore, limit the spread of the virus. 
Two pharmaceutically available neuraminidase inhibitors are Oseltamivir, which 
can be inhaled because of the limited absorbability and Zanamivir, which can be 
taken orally (McNicholl & McNicholl 2001; Mckimm-breschkin 2012). 
 
1.5.2.2. Influenza virus infection in mice and role of 
adaptive immune system in its clearance 
 
The less common antigenic shift, which occurs occasionally, allows the influenza 
virus to adapt to a new host. This adaptation of the virus into a new host occur 
through reassortment in the co-infecting influenza A virus gene segments in 
conjunction with multiple adaptive mutations in various influenza A virus genes. 
The first important adaptation of the virus is the ability to be transmissible to the 
new host. The mouse-adapted Influenza virus A/Puerto Rico/8/34 has been used 
to infect guinea pigs to study the adaptation of the virus into the new host. During 
a number of nasal wash passaging, the influenza protein M1 and NP were the 
main determinants that mutated and allowed the virus to adapt into the new host, 
the guinea pig (Ince et al. 2013).   
 
The role of cellular immunity in the clearance of influenza infection has been 
studied in mice in order to understand the mechanism of the viral clearance in 
humans. Although cytotoxic activity of CD8+ T cells require time to develop, the 
vaccination strategy, using antibodies and inhibitors, to prevent the occurrence of 
the influenza infection still provides 40% protection (Michiels et al. 2011). 
Adaptive immune systems, including both humoral cellular immunity, play a 
complementary role to provide a strong immune response against influenza virus 
infection, but some parts of the adaptive immune system is more important in 
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direct clearance of the virus than others. Wu et al. 2010 have shown that 
chronically immunodeficient mice (RAG2-/-) mice, which lacks recombination 
machinery and are devoid of mature T and B cells, challenged with mouse-
adapted influenza virus A/PR/8/34 virus, had sustained viral clearance when 
compared with wild type mice. The RAG2-/- mice lost weight initially with similar 
kinetics to wildtype mice, but later, when the wildtype mice started to regain 
weight and survive the primary influenza virus infection, RAG2-/- mice lost further 
weight and culminated in death (Wu et al. 2010).  
 
Although CD4+ T cells are important for CD8+ T cells in providing necessary 
cytokine storm for the CD8+ T cell survival and functional enhancement during 
viral infection, monoclonal antibody mediated depletion of CD4+ T cells, in mice 
that were challenged with HKx31 variant of H3N2 influenza A virus, had no effect 
on the viral load. The CD4+ T cell depletion had little or no effect on the frequency 
of cytotoxic CD8+ T cells, which dominated both mediastinal lymph node and lung 
during the infection (William Allan et al. 1990). Further studies confirmed that the 
role of CD4+ T cells in primary influenza virus infection was inefficient in the 
absence of B and CD8+ T cells (Mozdzanowska et al. 1997; Topham & Doherty 
1998).  
 
Further studies dissecting the participation of various subsets of cellular immunity 
in the clearance of influenza virus infection were of great importance. The role of 
B cells in primary influenza virus clearance is not very clear as it depends on the 
dose of the virus and the type of the virus. It has been shown that mice with a 
targeted mutation in immunoglobulin mu heavy chain or µKo mice, which lack 
mature B cells, were more susceptible to lethal influenza virus A/JAPAN/57 
infection than wildtype C57BL/6 mice, whereas, using lower virus dose, B 
lymphocyte deficient mice survived the infection (Graham & Braciale 1997). Also, 
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adoptive transfer of virus-specific CD8+ T cells, but not CD4+ T cells, prevented 
the lethal effect of influenza virus A/JAPAN/57 infection in B-lymphocyte deficient 
mice (Graham & Braciale 1997). Further studies also showed that B cells 
contributed to the recovery of mice from lethal influenza virus A/PR8/34 infection 
in a T helper cell independent manner. µKo mice transferred with splenocytes 
from T helper cell-depleted mice reduced mortality to 0% (Mozdzanowska et al. 
1997). 
 
The concepts of designing vaccines that promote the CD8+ T cell arm of the 
adaptive immune system are always interesting. This is mainly because antibody 
B cell-mediated protection against influenza virus infection is narrow with regards 
to viral strain specificity (Epstein et al. 1998). A short report has shown that CD8+ 
T cell deficient mice lacking class I major histocompatibility complex, showed 
significantly delayed virus clearance after challenge with non-lethal form of the 
influenza virus A/Port Chalmers/1/73 (H3N2). Furthermore, challenging these 
CD8+ T cell deficient mice with a more lethal form of the influenza virus A/PR8/34 
resulted in high mortality rate (Bender et al. 1992). The role of the CD8+ T cell 
response in influenza virus clearance seems to be virus subtype dependent, 
because it has been shown that mice lacking CD8+ T cells, either through 
antibody depletion or lacking MHC class I, can eventually recover from influenza 
virus HKx31 (H3N2) infection (Eichelberger et al. 1991).   
 
Furthermore, a number of studies using adoptive cell transfer of virus-specific 
CD8+ T cells have shown that virus-specific CTL can protect mice from the lethal 
effect of the influenza virus A/WSN infection (McKenzie 1978). Non-glycosylated 
internal NP protein from influenza A virus serves as a potent target antigen for a 
cross-reactive T cell clone. Adoptive transfers of cytotoxic Influenza A virus NP-
specific cross-reactive T cell clone BA4 and T9/13 were able to protect BALB/c 
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mice by reducing the detectable viral titers following influenza virus A/JAPAN and 
HKx31 infection, respectively (Taylor & Askonas 1986). Also, during infection with 
virulent influenza A/PR8/34 infection, adoptive transfer of B4 T cell clone was 
able to protect C57BL/6 mice from the lethal effect of the infection (Taylor & 
Askonas 1986). The effect of the T9/13 NP-specific cytotoxic T cell clone was 
further determined by histological analysis of lung tissues from BALB/c mice 
infected with influenza virus A/X31. BALB/c mice, which received T9/13 cells, 
showed much reduced epithelial abnormalities compared with the control mice at 
day 6 post infection (Mackenzie et al. 1989). 
 
Similar to the antibody response against various subtypes and variants of 
influenza virus infection, T cell clones against influenza virus are specific too, 
since each clone has its TCR. It has been shown that simultaneous challenge of 
mice with lethal doses of two different influenza virus subtypes at the same time 
will lead to failure of the recovery and protection by adoptive transfer of subtype-
specific T cell clone, whereas the subtype-specific T cell clone was protective, if 
the mice were challenged with their target influenza virus (Lukacher et al. 1984).  
 
1.6. Role of co-stimulation during lymphocyte activation 
 
CD8+ T cell response against viruses and cancer is a critical part of the cellular 
immune system. Although CD8+ T cell requires activation through target antigen 
presented in the context of MHC class I antigen-presenting cells, CD8+ T cells will 
not be optimally activated without co-stimulatory signals (McAdam et al. 1998). 
The most common CD8+ T cell co-stimulation molecules are the CD28 molecules 
expressed by T cells and the B7 (CD80) molecules expressed by antigen 
presenting cells (Harding & Allison 1993). The engagement of CD28 and CD80 
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during T cell activation provides co-stimulatory signals for further T cell activation 
and also for T cell survival by secretion of cytokines such as IL-2 (Boise et al. 
1995).  
 
Originally, during CD8+ T cell activation through TCR, the co-stimulatory signals 
provided by engagement of CD28 on T cells with CD80 on APCs were thought to 
be an absolute necessity for T cell activation otherwise T cell will become 
anergic, which is an unresponsive T cell that fails to display certain functional 
properties (Schwartz 1990). Whereas, it has been shown that CD28-/- mice 
triggered a robust cytotoxic CD8+ T cell response when infected with lymphocytic 
choriomeningitis virus (Shahinian et al. 1993). Furthermore, naïve CD8+ T cell 
were fully activated in the presence of signal 1 only which is the engagement of 
TCR with its cognate peptide, as indicated by up- regulation of the activation 
makers, CD69, CD25 and CD44 (Pardigon et al. 1998).  
 
1.7. Role of L-selectin in co-stimulation during leukocyte 
activation 
 
The immune system has evolved to compensate for missing molecules and 
signals to some extent. It can adapt to the environment or find an alternative to 
organize its function. In the absence of CD28 engagement with CD80 co-
stimulation, T cells can benefit from other molecules for co-stimulation such as 
ICAM-1, 2 and 3, LFA-3, VCAM-1, OX40L and other tumor necrosis factor family 
members (Croft & Dubey 1997). 
 
Similar to other cell adhesion molecules, L-selectin has been implicated in 
intracellular signalling pathways upon engagement with its ligands (Stadtmann et 
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al. 2013). A recent study has shown that engagement of L-selectin with 
monoclonal antibodies or endothelial cell expressed ligand enhances chemotaxis 
of T cells to secondary lymphoid chemokine (Subramanian et al. 2012). L-selectin 
on the surface of neutrophils engaging with PSGL-1 on the surface of another 
neutrophil or other leukocytes lead to a series of intracellular signalling that 
activate LFA-1 integrin. The L-selectin-PSGL-1 complex dependent activation of 
integrin regulates rolling and recruitment of neutrophils under in vitro flow 
conditions (Stadtmann et al. 2013). Also, on the surface of lymphocytes, L-
selectin ligation by monoclonal antibodies has been shown to provide signals that 
enhance cell-cell interaction and lymphocyte recruitment (Steeber et al. 1997). 
Furthermore, it has been shown that L-selectin on the surface of freshly isolated 
human lymphocytes increases the surface expression of chemokine receptor, 
CXCR4 upon ligation with its ligands such as sulfatide or fucoidan, whereas, L-
selectin ligation with these ligands did not have any effect on the surface 
expression of CCR7, CCR5 and β2 integrin. This suggests that L-selectin co-
stimulation allows a selective enhancement in the expression of cell adhesion 
molecules, which will allow a selective recruitment of cells to various parts of the 
body (Ding et al. 2003).  
 
Intracellularly, a number of cytosolic partners have been reported to associate 
with L-selectin molecules. Among these partners is alpha-actinin, which binds to 
the carboxy terminal 11 amino acids of the L-selectin cytoplasmic tail. Alpha-
actinin further connects L-selectin to the actin cytoskeleton of the cell (Pavalko et 
al. 1995). Although the alpha-actinin connection between L-selectin and 
cytoskeleton is required to control leukocyte rolling, which is adhesion under flow 
conditions, the role of α-actinin in L-selectin dependent intracellular signalling and 
co-stimulation is not clear (Ivetic 2013).     
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Other molecules associated with L-selectin tail are Calmodulin (CaM) (Gifford et 
al. 2012) and Ezrin-Radixin-Moesin (ERM) (Ivetic et al. 2002). L-selectin naturally 
occurs as monomeric molecules in the lipid bilayer cell membrane. Upon 
engaging with its ligand, L-selectin clusters and forms a dimeric molecule (Dwir et 
al. 2002). Then, this L-selectin dimerization allows further engagement of Ras 
activator, Son of Sevenless (SOS), associated ion with ERM proteins and the 
small GTPase, Ras, associated with CaM. A study by Brenner et al., 1996, 
showed that upon L-selectin engagement by antibodies or glycomimetics, a 
series of signalling events were initiated through activation of Ras and eventually 
resulted in an increase in the level of free radical O2 synthesis in Jurkat T cells. 
 
Another important signalling cascade initiated through L-selectin occurs due to 
the presence of two serine residues in its tail. PKC including PKC isozyme θ and ι 
were found on the non-phosphorylated tail of L-selectin (Kilian et al. 2004). 
Following lymphocyte activation by cross-linking of CD3 or through TCR, PKC θ 
has been shown to be associated with PKC α and both were associated with L-
selectin tail, which ae phosphorylate the serine residues on L-selectin tail 
(Murakawa et al. 1992). In steady state, CaM cytosolic partner, binds L-selectin 
tail and prevent PKC phosphorylation of the serine residues. Serine 
phosphorylation in the cytoplasmic tail can be reversed by protein phosphatase 
2A. Also, dephosphorylation is controlled by the protein phosphatase 2A inhibitor 
Phap II, collectively CaM and phosphatases and PKC are responsible for the 
signals initiated and terminated from the tail of L-selectin (Fig 1.10)(Wedepohl et 
al. 2012).  
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Fig. 1.10: Mouse L-selectin tail structure. (A) Cytoplasmic tail of L-selectin 
consists of 17 amino acids. The tail is critical for the function of L-selectin. L-
selectin tail contains Alpha actinin, CaM and ERM binding sites, which are 
important functional molecules involved in the signaling pathways required to 
control leukocyte-endothelial cell interaction. (B) Upon CD8+ T cell activation and 
clustering of L-selectin molecules by ligand, ERM associates with Ras exchange 
factor, son of sevenless (SOS) and together with CaM it is hypothesized that L-
selectin forms clusters leading to Ras dependent signaling, which is considered 
essential for transendothelial migration of leukocytes. After Ras dependent 
signaling, these molecules are released from L-selectin tail allowing Protein 
Kinase C (PKC) to phosphorylate the serine residues in the tail, which leads to 
PKC dependent signaling essential for interstitial chemotaxis. 
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2. Material and Methods 
2.1. Mice 
 
Transgenic mice homozygous for mutant L-selectin on a C56BL/6 (B6) L-selectin 
deficient background (LΔP) were crossed with mice homozygous for transgenic 
F5 TCR on a B6 L-selectin deficient background (F5+/+L-sel-/-) to generate F5/LΔP 
mice as described previously (Galkina et al. 2007; Galkina et al. 2003). F5/B6 
mice, which express matched levels of F5 TCR and similar levels of L-selectin as 
F5/LΔP mice, were generated by crossing homozygous F5B6 mice (F5+/+L-sel+/+) 
with B6 and used as controls. Mice, which were homozygous for F5 TCR and 
mutant L-selectin (F5LΔP) were generated by crossing two heterozygous F5/LΔP 
mice and genotype their offspring to identify homozygous F5LΔP mice for further 
breeding. F5L-sel-/- mice, which were homozygous for F5 TCR and deficient in L-
selectin were generated by crossing homozygous F5 TCR mice with L-selectin 
deficient mice (Table 1 and 2).  
 
Thy 1.1 (CD90.1) and Rag1 and 2 -/- mice on a B6 background were bred in 
house. B6 recipient mice (CD90.2) were purchased from Harlan or Charles River 
Laboratories. All experiments were conducted according to institutional guidelines 
and U.K. home office regulation. 
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Table 2.1: The breeding strategy to generate mice with various F5, mutant L-
selectin, wildtype L-selectin and L-selectin knockout status.  
 
Parent 1 Parent 2 Progeny 
LΔP F5 F5/LΔP 
F5 B6 F5B6 
F5 L-sel-/- F5L-sel-/- 
F5B6 B6 F5/B6 
F5/LΔP F5/LΔP F5LΔP 
 
 
Table 2.1: The homozygosity or heterozygosity status of the F5 transgenic TCR, 
the levels of wildtype L-selectin and the presence or absence of mutant L-selectin 
LΔP.  
 
Mice F5    L-selectin LΔP 
F5/LΔP +/- -/- +/- 
F5LΔP +/+ -/- +/+ 
F5/B6 +/- +/+ - 
F5B6 +/+ +/+ - 
F5L-sel-/- +/+ -/- - 
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2.2. Viruses 
 
2.2.1. Recombinant vaccinia virus (vaccNP) 
 
Recombinant vaccinia virus expressing nucleoprotein peptide NP366-374 from 
influenza A strain E61-13-H17 virus (vaccNP)(Cerundolo et al. 1997) was a kind 
gift from Alan Townsend.  
 
2.2.1.1. Infecting mice with recombinant vaccinia virus (vaccNP) 
 
Mice were inoculated with 2x106 PFU vaccNP; briefly, mice were manually 
restrained on their back, and vaccNP in 400µl phosphate buffered saline (PBS) 
(stock 5x106/ml) were injected intraperitoneally using a 1ml syringe. The mice 
were kept in scantainer cages with a negative airflow in order to comply with 
health and safety regulations.   
 
2.2.1.2. Recombinant vaccinia virus (vaccNP) titer 
 
For recombinant vaccinia virus (vaccNP), ovary, liver, heart, and lung from 
infected mice were harvested at indicated time points and viral titers were 
determined using a plaque assay on 70-80% confluent TK- cells as described 
previously (Jones et al. 2003). Briefly, 1x105 TK- cells were re-suspended in 1ml 
complete DMEM media [DMEM media (Gibco-Invitrogen, Carlsbad, USA) added 
with 10% fetal calf serum FCS (Gibco-Invitrogen, Carlsbad, USA), penicillin-
streptomycin, L-glutamine, non-essential amino acids (life technologies-
Invitrogen, Carlsbad, USA)] and plated in a 24 well plates and incubated at 37°C 
5% CO2 for 24 hours, when the cells reached 70-80% confluent. Interested 
organs from vaccNP infected mice were homogenized with a sonicator (IKA T10 
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electric tissue homogenizer) and serially diluted from 1:10 to 1:1000,000 and TK- 
cells were incubated with 200µl of the diluted ovary homogenates for 2 hours. 
1ml complete DMEM media was added and the plate incubated overnight and 
stained with 0.01% crystal violet in 4% formaldehyde for 3 hours. The plates were 
washed with water and plaques counted using an inverted microscope. Total pfu 
was calculated based on the serial dilution, well with 30-300 pfu were considered 
countable. 
 
2.2.2. Influenza A virus 
  
Influenza A virus strain A/PuertoRico/8/34 (PR8, H1N1) and (H17, H3N2) was 
obtained from the National Institute for Medical Research (London, UK). Stocks 
were stored in -70°C. 
 
2.2.2.1. Infecting mice with Influenza A virus (H17 and PR8)  
 
Mice were inoculated with 50 FFU of either PR8 or H17; briefly, mice were put 
under general anesthesia and manually restrained on their back, 50 FFU 
Influenza virus in 50µl were inoculated drop wise into nostrils in a split dose of 
25µl each using a Gilson pipette fitted with a small tip, ensuring each drop was 
inhaled. The mice were kept in scantainer cages with a negative airflow in order 
to comply with health and safety regulations.   
 
2.2.2.2. Influenza strain A virus titer  (H17 and PR8) 
 
Lungs from mice infected with PR8 or H17 virus were harvested at day 8 post 
infection and viral load determined using a virus titration assay as previously 
described (Bachmann et al. 1999) but with minor modifications. Briefly, lungs 
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were homogenized in 1ml serum free IMDM media and serial 10–fold dilutions of 
lung homogenates were incubated with 1.4 x 105 trypsinized Luc9.1 clone of 
Madin Darby canine kidney (MDCK) cells (Hossain et al. 2010) and plated on a 
24-well plate. After 4 hours, a methyl cellulose overlay was added to prevent 
virus transmission between MDCK cells and plates incubated for 48 hours at 
37oC in 5% CO2. The plates were washed with PBS and fixed with 4% 
formaldehyde for 30 minutes and then permeabilized with 1% triton X100 for 30 
minutes. Following permeabilization, MDCK cells were incubated with a 
monoclonal antibody specific for the PR8 haemagglutinin, stained with 
horseradish peroxidase-conjugated secondary antibodies (Biorad, USA) and the 
plates developed using AEC (3-Amino-9-ethylcarbazole) reagents (Cat no. 
SLBG7194V, Sigma, USA). Each stained, influenza-infected MDCK cell was 
recorded immediately after staining as a single focus forming unit (ffu) and the 
total ffu per lung calculated.  
 
2.3. Cell isolation 
  
2.3.1. CD8+ T lymphocyte isolation using Miltenyi magnetic technology 
  
Mice were culled by schedule 1 (CO2 Euthanasia) and spleen and/or lymph node 
cell suspension was prepared by mashing the spleen or lymph node through a 
70µm cell strainer. Red blood cell lysis was performed for spleen cell suspension 
by adding 5ml (1X) RBC lysis buffer (10X stock, Biolegend) to the cells and 
incubating on ice for 5 minutes with occasional shaking. Cells were resuspended 
in MACS buffer (PBS, 0.5% FCS, 2mM EDTA) and CD8+ T lymphocytes were 
purified by positive or negative selection using magnetic bead MACS LS column 
(Miltenyi Biotech, Bergisch Gladbach, Germany). For positive selection, 107 cells 
were re-suspended in 90µL MACS Buffer and mixed with 10µL antibody/107cells 
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(Microbeads conjugated to monoclonal anti-mouse CD8a), the tube mixed well in 
order to allow the equal labeling of cells with their counterpart antibodies in the 
suspension. After 15 minutes incubation at 4-8°C, the cell suspension was 
washed and up to 108 cells were re-suspended in 500µL MACS buffer. Then 
sorting step performed by placing the LS column in the dedicated magnet and the 
column washed with 3ml MACS buffer. The cell suspension was applied to the 
column and unlabelled cells, which passed through the column were collected. 
The column was washed three times with 3ml MACS buffer and following that the 
column was removed from the magnetic field and 5ml MACS buffer layered on 
top. Labeled cells (CD8+ T cells) were collected by placing the plunger on top of 
the column and pushing hard to expel all the labeled cells. 
 
2.3.2. CD8+ T lymphocyte isolation using Stem Cell Technology 
 
The CD8+ T cells were alternatively purified using magnetic cell sorting technique 
from Stem Cell Technology (Vancouver, Canada) according to manufacturer’s 
instruction. Briefly, spleen and/or lymph nodes from desired donor mice were 
harvested. The mouse was culled by schedule 1 (CO2 Euthanasia), then, single 
cell suspensions were prepared by mashing the tissue through 70µm cell strainer 
and red blood cells lysed using 1x red blood cell lysis buffer (Biolegend, UK). 
1x108 lymphocytes were spun down and re-suspended in 1 ml cell sorting buffer 
and incubated with 50µl rat serum and 50µl antibody cocktail for 10 minutes, after 
that, the cells were incubated with 125µl bead microspheres for 2.5 minutes, then 
the cell suspension brought up to 2.5 ml in total and the cells were placed in the 
purple magnet (STEM CELL Ltd, Vancouver, Canada) for further 2.5 minutes. 
After incubation, the desired CD8+ T cells were poured into a tube by inverting 
the cells in the tube with the magnet in one direction. The purity of the cells then 
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checked by staining for CD8+ T cells using flow cytometry and cells were 
considered pure by achieving > 95-98% CD8+ T cells staining. 
 
2.4. Adoptive transfer of Naïve CD8+ T cells  
 
Naïve CD8+ T cells were isolated and purified from donor mice and adoptively 
transferred via tail vein into recipient mice. Mice were maintained in the heating 
chamber for 20-30 minutes in order to dilate the tail vein. Mice were restrained in 
specially built mouse restrainer in order to allow easy access to the tail vein. Prior 
to injection, the cells were washed with saline or PBS 3 times and desired 
numbers of cells, according to various experiments, were re-suspended in saline 
or PBS and injected into the tail using a 29g insulin syringe. After injection low 
pressure was applied on the injection site to cease the bleeding and to avoid any 
loss of the injected samples.  
 
2.5. Preparation of mouse tissues for donor and host cell analysis 
 
For all in vivo experiments, at the end point, mice were euthanized by CO2 
asphyxiation in a rising concentration chamber. The schedule 1 death was 
confirmed by dislocation of the neck at cervical region. The tissues were then 
removed and placed in vials containing PBS and placed on ice and transferred to 
the laboratory for further processing.  
 
2.5.1. Ovary 
 
Ovaries were excised from the peritoneal cavity and placed in vials containing 
PBS on ice until further processing. The ovaries were mashed through a 70µm 
cell strainer using a plunger of a 2ml syringe. The cell strainer was washed 3-4 
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times with ice-cold PBS containing 2%FCS to collect all isolated cells, the cell 
suspension was centrifuged at 400g for 5 minutes, the supernatant discarded and 
the cell pellet re-suspended in PBS for further analysis.    
 
2.5.2. Lung 
 
Lung was excised from the thoracic cavity and transferred to vials containing 5% 
FCS, 1mg/ml collagenase D (Roche, USA), 50µg/ml DNase (SIGMA-ALDRICH, 
USA) and 5mM CaCl2 and placed on ice until further processing. The lungs then 
transferred to the laboratory and incubated for 1 hour at 37°C, after incubation, 
lungs were mashed through 70µm cell strainer using the plunger of 2ml syringe 
and isolated cells collected as described above. Cell strainer was washed 3-4 
times with cold PBS to allow all the cells to go through. The cell suspension then 
centrifuged 400g for 5 minutes. Supernatant was discarded and the cell pellet 
were re-suspended in 5ml 1X RBC lyses buffer for 5 minutes on ice to lyse the 
red blood cells. The reaction was then stopped by adding 20 ml PBS. The cell 
suspension then centrifuged and the cell pellet was re-suspended in PBS for 
donor and host cell analysis. 
 
2.5.3. Lymph nodes 
 
Lymph nodes (axillary, brachial, inguinal, mediastinal, lumbar and mesenteric) 
were excised from their location and transferred into vials containing PBS and 
placed on ice. Single cell suspension was prepared similarly to ovary samples. 
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2.5.4. Spleen  
                      
The spleen was excised from the peritoneal cavity and transferred into vials 
containing PBS and placed on ice. Single cell suspension was prepared by 
mashing the lymph node through a 70µm cells strainer using a plunge of a 2ml 
syringe, The cell suspension was then centrifuged 400g for 5 minutes. 
Supernatant was discarded and the cell pellet was re-suspended in 5ml 1X RBC 
lyses buffer for 5 minutes on ice to lyse the red blood cells. The reaction then 
stopped by adding 20 ml PBS. The cell suspension was then centrifuged and the 
cell pellet was re-suspended in PBS for donor and host cell analysis. 
 
2.6. MEL-14 blocking strategy 
  
To inhibit L-selectin function, 250 µg of monoclonal antibody to mouse L-selectin 
(MEL-14, IgG2a)(BioXcell, West Lebanon, NH, USA) or rat IgG2a isotype control 
antibodies MAC193 (Price et al. 1997) or MAC 219 (Forsyth et al. 2000) were 
injected i.v. and/or i.p. either once or daily commencing 52 h post vaccNP or 
Influenza A virus infection. Donor cells were harvested from the ovary, ovdLN 
and spleen 5 days post infection during vaccNP infection to assess L-selectin 
involvement in the recruitment of these cells into the site of infection and donor 
cells were harvested from lung, mediastinal LN and spleen 4 and 8 days post 
infection during Influenza A infection.  
     
2.7. CD8+ T cell culture (Activation and Differentiation)  
 
CD8+ T cells were sorted by positive selection using Miltenyi technique as 
described previously. CD8+ T cells were re-suspended in complete DMEM 
medium (Gibco-Invitrogen, Carlsbad, USA) added with 10% fetal calf serum FCS 
 73 
(Gibco-Invitrogen, Carlsbad, USA), 100IU/ml penicillin, 100µg/ml streptomycin, 
2mM L-glutamine, 1mM sodium pyruvate (life technologies-Invitrogen, Carlsbad, 
USA) and 60µM 2β mercaptoethanol (2Me) (Sigma-Aldrich, St Louis, USA). 
CD8+ T cells were plated at 2x106 cells/well in a 24 well plate in 1ml complete 
DMEM media. CD8- T cell fraction (CD4+ T lymphocytes, B lymphocytes, NK, 
NKT cells) from positive selection sorting or unsorted splenocytes were used as 
antigen presenting cells (APCs). 6x106 APCs were resuspended in 1 ml complete 
DMEM media and incubated with 5µg freshly prepared NP68 peptide (stock at 
1mg/ml) for 1 hour at 37°C. APCs were irradiated at 3000 centri Grays to inhibit 
the growth of those cells in the culture. After that, 6x106 APCs in 1 ml media, 
loaded with NP68 peptide, were added to the CD8+T cells cultures totalling 2ml 
media/well. The cells were incubated at 37°C and 5% CO2 for 2 days and then 1 
ml of the medium was replaced with fresh complete DMEM medium added with 
2x 360 IU/ml human recombinant IL-2 (hrIL-2) to induce proliferation. The cells 
were kept in the culture for a desired length of time, up to 8 days. 
 
2.8. Short term competitive homing study 
 
F5LΔP and F5L-sel-/- CD8+ T cells were isolated and cultured as described 
above. Cells were harvested at day 7 post activation in culture, mixed 1:1 and a 
total of 5.58 x 106 cells (2.76 x 106 F5LΔP and 2.82 x 106 F5L-sel-/- determined 
using Cytocount beads) injected i.v. into 4 vaccNP infected CD90.1+ B6 mice (at 
day 3 post infection). After 3 hours, ovaries, ovdLNs, axillary lymph nodes, 
inguinal lymph nodes, mediastinal lymph node, spleen, peripheral blood were 
harvested, stained with CD8, CD90.2, and L-selectin and analyzed by flow 
cytometry for numbers and the L-selectin expression on donor CD8+, CD90.2+ 
cells. 
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2.9. Labeling cells with fluorescent conjugated dye 
 
2.9.1. Assessing Donor CD8+ T cell proliferation in vivo, using CFSE  
 
In order to assess adoptively transferred donor CD8+ T cell proliferation, naïve 
CD8+ T cells co-expressing transgenic F5 TCR and either wildtype F5/B6 or 
mutant L-selectin F5/LΔP were isolated and purified. 107 Cells were re-
suspended in 1ml PBS and mixed 1:1 with 1ml 10 µM CFSE in PBS to give a 
final concentration of 5µM CFSE. The cells were incubated with CFSE for 10 
minutes at room temperature in the dark, the reaction was quenched by adding 
10ml ice cold FCS. The cells then were washed extensively 3-4 times with ice-
cold PBS to remove the excess dye and re-suspended in normal saline and 
injected i.v. at 2 x 106 cells/mouse. 24 hours later, mice were inoculated with 2 x 
106 vaccNP i.p. and at days 1 and 2 post infection, various lymphoid tissues were 
harvested to assess donor cell proliferation by flow cytometry (FACS Canto II BD) 
based on the CFSE dye dilution. 
 
2.9.2. Labeling cells with EdU dye to assess proliferation in vivo 
 
The proliferation of donor virus specific CD8+ T cells during the course of the 
virus infection was also assessed through the incorporation of the DNA dye 5-
Ethynyl-2-deoxyuridine (EdU)(Life Technology, USA). Mice were injected with 
1mg EdU dye i.p. one day before organ harvest. Single cell suspensions were 
prepared as described above. Cells were stained for appropriate extracellular 
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markers and fixed with 4% formaldehyde (FA). Cells were then permeabilized 
with saponin buffer, and incorporated DNA dye EdU was detected through the 
Click-it plus EdU Alexa Fluor 647 flow cytometry assay kit according to 
manufacturer’s instructions (Life Technology, USA). Briefly, the cells were 
incubated with a 50µl cocktail of 0.25µl Alexa Fluor 647, 1µl copper sulphate 
(CuSO4), 1x Click-iT reaction buffer and 43.75µl 1x Click-iT EdU buffer additive. 
Cells were incubated with the cocktail for 20 minutes at room temperature in the 
dark, then washed twice and re-suspended in 2%FCS PBS buffer. 
 
2.9.3. Assessment of CD8+ T cell proliferation in vitro 
 
In order to assess CD8+ T cell proliferation in vitro, naïve CD8+ T cells co-
expressing transgenic F5 TCR and either wildtype F5/B6 or mutant L-selectin 
F5/LΔP were isolated and purified as described in section 2.3.1., cells were re-
suspended in PBS and mixed 1:1 with 4 µM CFSE in PBS to give final 
concentration of 2µM CFSE. The cells were incubated with CFSE for 10 minutes 
at room temperature in the dark, the reaction was quenched by adding 10ml ice 
cold FCS. The cells then were washed extensively 3-4 times with ice-cold PBS to 
remove the excess dye and re-suspended in complete DMEM. Cells then 
cultured as described in section 2.7. At days 4, 5 and 6 post culture, cells were 
harvested to assess CD8+ T cell proliferation by flow cytometry (FACS Canto II 
BD) based on CFSE dye dilution. 
 
2.9.4. Extracellular staining 
 
Cells were added to a 96 well U-bottom plate well. Cells were re-suspended and 
washed in PBS 2% FCS. Most of the steps were performed on ice to avoid 
internalization of the surface receptors, except for CCR7 staining which was 
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performed at 37°C for 30 minutes. Cells were stained for live/dead exclusion with 
aqua fluor amcyan (life Technology, USA) and incubated for 30 minutes at room 
temperature in the dark. After that, they were washed with PBS 2% FCS. The 
cells were then blocked with PBS, 5% Rat serum and 2% FCS and staining 
antibodies were added and incubated for 30 minutes at 4-8°C. Cells were again 
washed with PBS 2% FCS. Later, cells were fixed with 4% FA for 15 minutes at 
room temperature in the dark. Finally, cells were washed and re-suspended in 
200µl PBS 2% FCS and examined by Flow cytometry (FACS Canto II BD). 
FlowJo 9.7.6. was used to analyze the results (Table 2.3). 
 
2.9.5. Intracellular staining for IL-2, TNF-alpha, IFN-gamma and granzyme B 
 
CD8+ T lymphocytes, which were isolated and cultured for either 6 or 8 days, or 
CD8+ T cells harvested from ovary and/or spleen of vaccNP infected mice, were 
harvested and re-stimulated with NP68 2µg/ml for 4 hours in the presence of 
2µg/ml brefeldin A (Sigma- Aldrich, USA), which was added to the cells in order 
to stop the transportation of secreted cytokines by Golgi apparatus. After 
incubation, the cells were stained for appropriate extracellular surface molecules 
and fixed with FA 4%. Permeabilisation of the cells was carried out with saponin 
buffer at room temperature for 10 minutes, and then the cells were stained 
intracellularly with fluorescence-conjugated cytokines antibodies for 20 minutes at 
room temperature. The cells were washed and analyzed using flow cytometry 
(FACS Canto II BD)(Table 2.4).  
 
2.9.6. Intracellular staining for CD107a     
 
CD8+ T lymphocytes were isolated and cultured as previously described. CD8+ T 
cells were re-stimulated with NP68 peptide 2µg/ml and incubated at 37°C. Prior 
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to incubation, anti-CD107a FITC (Biolegend, UK) was added to the cell 
suspension. After 1 hour of incubation, 0.7µg/ml monensin (Golgi Stop) was 
added to stop recycling of the mobilized granules. The cells were further 
incubated for 4 hours at 37°C. After incubation, the cells were washed with PBS 
2% FCS and stained for appropriate extracellular surface molecules and fixed 
with FA 4%. The cells were washed and analyzed using flow cytometry (FACS 
Canto II BD)(Table 2.4).   
 
 
Table 2.3: Details of antibodies used for detection of cell surface-expressed 
proteins and markers by flow cytometry.  
 
Cell marker Fluorophore Clone Dilution Company 
αCD8a PerCP Cy5.5 53-6.7 1:250 BD Bioscience 
αCD8a APC-Cy7 53-6.7 1:250 eBioscience 
αCD62L PE MEL-14 1:100 R&D 
αCD62L PE-Cy7 MEL-14 1:500 Biolegend 
αCD44 FITC IM7 1:500 Biolegend 
αCD44 APC-Cy7 IM7 1:500 Biolegend 
αCCR7 APC 4B12 1:200 eBioscience 
αCD69 APC H1.2F3 1:200 Biolegend 
Streptavidin PE - 1:50 Life Technology 
αCD90.1 PE-Cy7 OX-7 1:200 Biolegend 
αCD90.2 Pacific Blue 53-2.1 1:200 Biolegend 
αVβ11 FITC KT-11 1:500 Biolegend 
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Table 2.4: Details of antibodies used for detection of intracellular cytokine 
secretion by flow cytometry. 
 
Cell marker Fluorophore Clone  Dilution Company 
αIL-2 Pacific Blue JES6-5H4 1:200  
αTNF-α PE-Cy7 TN3-19 1:200 eBioscience 
αIFN-γ PerCP Cy5.5 XMG1.2 1:200 Biolegend 
αGranzyme B FITC GB-11 1:20 Biolegend 
αCD107a FITC LAMP-1 1:200 Biolegend 
 
 
2.10. Acquisition using FACS Canto II Flow Cytometer and data analysis 
 
The flow cytometer BD FACS Canto II was used to acquire data throughout the 
whole study. Compensation was achieved by using antibody capture beads (BD 
Biosciences), which were singly stained with individual fluorochrome conjugated 
monoclonal anti-mouse antibodies used in each experimental staining panels. 
Fluorescence minus one (FMO), which is a flow cytometry staining control that 
contains all the fluorochromes in the staining panel except for the one that is 
going to be measured, was used to identify the positive gate for each stain. The 
absolute number of donor cells was counted using Cytocount bead (Dako, 
Denmark). Briefly, single cell suspensions were added with 10µl cytocount beads 
containing 1093 bead/µl. The numbers of donor cells were achieved using the 
following formula; the number of cells counted divided by the number of beads 
counted and then multiply with the bead number and dilution factor. Data was 
analyzed using Flow Jo software version 9.7.6. (TreeStar Inc, Ashland, OR).  
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2.11. Reagents and consumables  
 
2.11.1. Media and associated reagents  
 
Dulbecco’s modified Eagle’s minimal essential media (DMEM), Roswell Park 
Memorial Institute medium (RPMI), phosphate buffered saline (PBS), Hank’s 
balanced salt solution (HBSS), L-glutamine, penicillin, streptomycin, sodium 
pyruvate and 0.5% trypsin in HBSS were purchased from Gibco, Invitrogen 
[Paisley, U.K.]. 
 
2.11.2. Distilled Water (dH2O)  
 
Millipore, Milli-Q system, H2O was distilled by Millipore reverse osmosis system 
followed by filtration through two ions exchange resin columns.  
 
2.11.3. Foetal calf serum 
 
Foetal calf serum (FCS) was purchased from Sigma-Aldrich and PAA 
Laboratories Limited [Pasching, Austria], and unless done so by the supplier, it 
was heat inactivated at 56oC for 30 minutes. 
 
2.11.4. Interleukin-2 (IL-2) 
 
Recombinant human IL-2 was purchased as ‘Proleukin’ from Chiron Limited 
[Harefield, U.K.] and reconstituted to 1mg/ml under sterile conditions in ddH20, 
diluted to 20ng/ml in RPMI and stored in 1ml aliquots at -70oC. For continuous 
use, aliquots were thawed and stored at 4oC. 
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2.11.5. NP68 peptide  
 
The NP68 peptide (ASNENMDAM)(Peptide Synthetics, Hampshire, UK), from the 
Influenza A virus nucleoprotein A/NP/60/68 (also called NP366-374) binds to H-2Db 
and is recognized by the cytotoxic T cell receptor (F5 TCR). The peptide was 
obtained as a dry powder and reconstituted in PBS to make a 1mg/ml stock, 
which then was aliquoted and stored at -20oC. 
 
2.11.6. NP34 monomer 
 
The NP34 monomer (ASNENMETM), from Influenza A virus (strain A/Puerto 
Rico/8/1934 H1N1) nucleoprotein (NP366-374), binds to H-2Db was supplied by NIH 
tetramer facility (National Institute of Health, USA).  
 
2.11.7. Collagenase D 
 
Collagenase D was purchased from Roche, USA as a dry powder. It was 
dissolved in HBSS buffer at 50mg/ml, stocks were stored in -20°C until use.      
 
2.11.8. DNase 
 
DNase was purchased from Sigma Aldrich, USA as a dry powder. It dissolved in 
0.15M NaCl at 100mg/ml. Stocks were stored in -20°C until use.  
 
2.11.9. CaCl2 
 
CaCl2 was purchased from Sigma Aldrich, USA as a granule. 0.5M solutions 
were prepared by dissolving 7.3 g CaCl2 in 100ml ddH2O.  
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2.11.10. Sodium citrate  
 
Sodium citrate was purchased as a dry powder. 0.38 g Sodium citrate was 
dissolved in 100ml PBS. It was used as an anticoagulant in a 1:1 mix to collect 
blood either through heart puncture or tail bleeds for genotyping of donor CD8+ T 
cell analysis during the course of the viral infection.  
 
2.11.11. Red Blood cell lysis buffer  
 
Red blood cell lysis buffer (10X stock) was purchased from Biolegend, UK. It was 
used at 1X concentration by diluting with sterile ddH2O. It was used to lyse red 
blood cells in a single cell suspension from spleen, lung and peripheral blood. 
 
2.11.12. AEC (3-Amino-9-ethylcarbazole)    
 
AEC powder was purchased from Sigma Aldrich, USA. 25 mg was dissolved in 
2.5 ml DMF (Dimethyl Formamide). This solution was then added to 47.5 ml of 
50mM acetate buffer (pH 5.0). AEC solution was used as a substrate for the 
horseradish peroxidase enzyme during the influenza titer assay, which provides a 
brownish colour to detect the virus-infected cells. Just before use, 25 µl 30% 
hydrogen peroxide (H2O2) was added to the AEC solution.        
 
2.11.13. Rat Serum 
 
Rat serum was purchased from (Sigma Aldrich, USA) and aliquots of 250µl 
stored at  -20°C until use. A cocktail of 5% rat serum plus 2% FCS in PBS was 
used as Fc blocking agent during cell staining for cell surface-expressed proteins 
for flow cytometry analysis.   
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2.11.14. Formaldehyde (FA)  
 
Formaldehyde 37-40% was diluted in PBS to a final concentration of 4%. FA 4% 
was used to fix cells either for flow cytometry analysis or to fix TK- or MDCK cells 
in viral titer assays. 
 
2.11.15. β-mercaptoethanol 
 
2.11.16. MACS buffer 
MACS buffer was prepared fresh before starting the magnetic purification of 
CD8+ T cells using MACS technology. The cocktail was composed of PBS, 2mM 
EDTA and FCS. 
 
2.11.17. Saponin Buffer 
Suponin powder was purchased from (Sigma-Aldrich, USA). To make up 100ml, 
0.5g suponin powder was dissolved in PBS and supplemented with 0.05% 
sodium azide and 0.05% FCS.    
 
 
2.12. Cell membrane dye  
 
2.12.1. CFSE 
 
Carboxyfluorescein diacetate Succinyl Ester (CFSE) powder was purchased from 
(Invitrogen, USA) and suspended in Dimethyl sulfoxide (DMSO) to give a stock 
solution of 10mM. It was stored in 10µl aliquots at -20°C. The aliquots were 
thawed and used once for an experiment and were not refrozen.  
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2.12.2. Aqua live dye 
 
Aqua live dye was purchased from Invitrogen (USA) and suspended in DMSO 
according to manufacturer instruction, and then aliquots of 10µl were stored in  
-20°C until use. 
 
2.13. Cell lines  
 
2.13.1. Thymidine Kinase deficient (TK-) cells  
 
TK- cells, which are mouse fibroblast deficient in thymidine kinase enzyme, were 
used for the recombinant vaccinia virus (VaccNP) titer.   
 
2.13.2. MDCK luc9.1 
 
Madin-Darby Canine Kidney (MDCK) cells were a kind gift from Dr. M. Jaber 
Hossain (Influenza Division, Centers for Disease Control and Prevention, Atlanta, 
GA 30333, USA). MDCK cells were used for the influenza strain A (PR8, H1N1) 
virus titer.   
 
2.14. Cryopreservation of TK- and MDCK cells  
      
TK- or MDCK cells, which were 90-100% confluent, were frozen down for further 
and later use. Excess medium was removed by pipetting and the cells washed 
with 0.9% saline to remove excess media. 0.5% Trypsin-EDTA solution was 
added and incubated at 37°C 5% CO2. Cells were examined macroscopically and 
microscopically to ensure detachment. Cells were washed with PBS and re-
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suspended in complete FCS for viability count. 2 x 107 viable cells were re-
suspended in 1ml FCS and mixed with freeze mix (80% FCS mixed with 20% 
DMSO) at a ratio of 1:1 (volume/volume). 1ml was added to the previously 
labeled cryovial and placed into Nalgene cryo freezing container (Merc 
Laboratories supplies, Dorset, UK) and kept overnight at -80°C. Cryovials were 
transferred into liquid nitrogen and kept until further use.   
 
2.15. Thawing up TK- and MDCK cells  
 
A cryovial of either TK- or MDCK cells were removed from the liquid nitrogen and 
placed in a container with dry ice and brought to the laboratory. The cryovial 
placed in the water bath for 1-2 minutes in order to thaw quickly. pre-warmed 
complete DMEM medium was added to a  T75 flask,  the TK- or MDCK cells 
transferred to the T75 flask and incubated for 24 hours in order to reach 90-100% 
confluency. 
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3. Role of L-selectin in homing of activated CD8+ T cells to 
sites of infection. 
 
3.1. Introduction  
 
“Leukocyte migration is the heart of the adaptive immune system” (Andrian & 
Mackay 2000). The strength of the adaptive immune system against viral 
infection is inextricably linked to the number of the cytotoxic effector CD8+ T cells 
at the site of infection (Andrian & Mackay, 2000; Masopust & Schenkel, 2013). 
Although mechanisms of activation and differentiation controlling the generation 
of effector CD8+ T cells are important, the migration of these effector CD8+ T cells 
from the their site of priming to the site of infection is equally important for a 
successful immune response.   
 
The kinetics of L-selectin expression on the surface of CD8+ T cells during their 
activation through TCR at the time of viral infection has not been studied in detail. 
If L-selectin molecules on the surface of naïve CD8+ T cells is controlling the 
homing of these cells into the peripheral LN, whether re-expressed L-selectin on 
the surface of activated CD8+ T cells have any role in homing into the site of 
infection would be of great interest. In this chapter, the role of L-selectin 
molecules will be studied with regards to their participation in homing of activated 
CD8+ T cells to sites of infection. The role of L-selectin will be investigated by 
comparing CD8+ T cells expressing wildtype L-selectin with CD8+ T cells with a 
specific mutation that do not express L-selectin (Ko). Further to understand the 
role of L-selectin in homing of activated CD8+ T cells, wildtype L-selectin 
expressing CD8+ T cells will be compared with CD8+ T cells that have been 
genetically manipulated to constantly express L-selectin (LΔP).  
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3.2. Hypothesis  
 
L-selectin expression is variable during CD8+ T cell activation due to ectodomain 
shedding and gene silencing. Our hypothesis is, if various levels of L-selectin on 
the surface of activated CD8+ T cell is controlling homing of these cells into sites 
of viral infection, recruitment will be enhanced in constant L-selectin expression 
(LΔP), moderate recruitment in (WT; B6) and recruitment will be abrogated for 
CD8+ T cells that do not express L-selectin (Ko). 
 
3.3. Results 
3.3.1. Mouse model of viral infection; recombinant vaccinia virus 
expressing NP68 peptide 
 
The mouse adapted Western Reserve (WR) strain of vaccinia virus engineered to 
express nucleoprotein peptide NP366-374 from Influenza A strain E61-13-H17 was 
used in these studies and will be referred to as vaccNP.  CD8+ T cells expressing 
cognate F5 TCR for H2-Db NP366-374 were used to determine the role of L-selectin 
in CD8+ T cell activation and homing following primary infection with vaccNP. 
Genetic modification of vaccinia virus with NP peptide could alter the virulence 
and pathogenicity of the virus; therefore, we first determined the sites of vaccNP 
infection after intraperitoneal administration to C57BL/6 (B6) mice. Viral titers 
were determined in visceral organs such as ovary, spleen, liver, heart and lung at 
day 5 post virus infection (Fig. 3A). As described previously, high viral titers were 
found in the ovaries of C57BL/6 mice, but in contrast to the parental WR strain 
(Zhao et al. 2011), virus was not detected in other visceral organs (Fig. 3.1B).  
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Furthermore, to confirm the site of infection, histochemical studies were 
performed to compare ovaries from vaccNP infected mice with non-infected 
control. The analysis at day 5 post infection revealed a dense cellular infiltrate 
with signs of tissue destruction and necrosis in infected ovaries, but not in non-
infected ovaries (Fig. 3.1C). 
 
3.3.2. Mediastinal LN is the site of CD8+ T cells priming during recombinant 
vaccinia virus infection 
 
One of the critical steps in the adaptive immune response against viruses and 
other pathogens is the antigen presentation to the CD8+ T cells by the APCs in 
the secondary lymphoid tissues draining the site of pathogen entry and sites of 
infection. The sites of antigen presentation to CD8+ T cells during vaccNP 
infection were considered important in order to study the kinetics of CD8+ T cell 
priming and activation during the primary course of the infection. To identify the 
site of CD8+ T cells priming during vaccNP infection, CFSE labeled naïve F5 
CD8+ T cells were adoptively transferred into C57BL/6 mice. 24 hours later, mice 
were challenged with vaccNP. Draining and non-draining lymph nodes (LN), 
spleen and ovaries were harvested 1 and 2 days post-infection and CFSE-
labelled T cells analyzed by flow cytometry. CFSE-labeled T cells were present in 
all lymphoid organs analyzed. T cell priming as indicated by CFSE dilution was 
not detected until 2 days post infection and was only seen in the mediastinal LNs 
(Fig. 3.2). Though vaccinia virus replicates in ovaries, naïve or activated F5 CD8+ 
T cells were not detectable in ovaries and there was no evidence of priming in 
ovary draining LN (ovdLN) during the first 2 days following vaccinia infection. 
Therefore F5 CD8+ T cell priming to vaccNP occurs within the first 2 days and is 
restricted to a single LN, the mediastinal LN. 
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Figure 3.1: Ovaries are the major sites of recombinant vaccinia virus 
replication and infection. (A) Naïve C57BL/6 mice were inoculated i.p. with 2 x 
106 pfu recombinant vaccinia virus expressing NP68 peptide (vaccNP). 5 days 
later, ovary, heart, liver and lungs were harvested and viral titers in homogenized 
tissues determined by plaque assay. (B) Viral titers were compared in various 
internal organs. High titres were only found in the ovaries. Bars show median 
value of the viral titre and each symbol represents a single mouse (n=4-12). (C) 
Histological studies using Haematoxylin and Eosin (H&E) staining of vaccNP 
infected ovaries compared with non-infected control further revealed ovarian 
tissue destruction and lymphocyte infiltration. Developing follicles (arrows) and 
cellular infiltrates (arrowheads) are marked. Results show H&E staining of one 
representative mouse from a single experiment (n=3).   
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Figure 3.2: Mediastinal LN is the site of CD8+ T cell priming to recombinant 
vaccinia virus following i.p. inoculation. (A) Naïve CD90.2+ CD8+ T cells co-
expressing transgenic F5 TCR and wildtype L-selectin were isolated and stained 
with 10µM CFSE, and a total of 2 x 106 cells were adoptively transferred into 
naïve CD90.1 B6 recipient mice. 24 hours later, mice were inoculated with 2 x 
106 pfu vaccNP. At days 1 and 2 post infection, various lymphoid tissues were 
harvested for CD8+ T cell priming analysis. (B) CFSE labelling of F5 CD8+ T cells 
in mediastinal, axillary and ovary draining LN and spleen of vaccNP infected mice 
(solid green) were compared with control unlabelled cells (solid light green). 
Results show CFSE staining of F5 CD8+ T cells in one representative infected 
mouse in a single experiment (n=3). 
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3.3.3. Kinetics of L-selectin expression on the surface of CD8+ T cells 
during primary viral infection 
 
Analysis of donor cell recovered from the site of priming (mediastinal LN) at day 1 
p.i. showed that F5/B6 CD8+ T cells downregulated L-selectin. This has been 
previously reported during in vitro activation of T cells that initial loss of L-selectin 
is due to ectodomain shedding and proteolysis. Then, the following day (day 2 
p.i.), activated F5/B6 CD8+ T cells in mediastinal LN fully re-expressed L-selectin. 
Activated F5/B6 CD8+ T cells in the peripheral circulation at day 3 p.i., still 
expressed L-selectin and the first populations of activated F5/B6 CD8+ T cells 
entering the site of infection were also L-selectin positive. Virus specific CD8+ T 
cells started to down-regulate L-selectin from day 5 p.i. and CD8+ T cells were 
almost fully L-selectin negative on day 8 p.i. (Fig. 3.3). This finding clearly 
illustrating that L-selectin undergoes cyclical expression on the surface of CD8+ T 
cells upon activation in vivo concurrent with what have been found during T cell 
activation in vitro.  
 
The cyclical expression of L-selectin on the surface of endogenously generated 
virus specific CD8+ T cells was also investigated. Upon influenza A virus 
infection, virus specific CD8+ T cells harvested from Med LN at day 2 p.i. 
expressed only 30% L-selectin. Then they started to re-express their L-seletin 
(94%) by day 4 p.i.. Virus specific CD8+ T cells left the sequentially left the 
priming site (MedcLN) and entered the bloodstream started to downregulate their 
L-selectin on the surface (55%) and the first population of virus specific CD8+ T 
cells infiltrated the site of infection (lung) was also expressed significant amount 
of L-selectin (54%) at day 4 p.i.. The virus specific CD8+ T cells harvested at day 
8 p.i. was almost fully downregulated L-selectin on their surface (3%)(Fig. 3.4).   
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Figure 3.3: Cyclical expression of L-selectin during primary recombinant 
vaccinia virus infection. (A) Naive CD90.2+ or CD90.1+ CD8+ T cells co-
expressing transgenic F5 TCR and wildtype L-selectin were isolated and a total 
of 2 x 106 were adoptively transferred into CD90.1 or CD90.2+ recipient B6 mice. 
24 hours later, mice were inoculated with 2 x 106 vaccNP. At days 1, 2, 3, 5 and 8 
post infection, mediastinal LN (site of CD8+ T cell priming), peripheral blood, 
ovary (site of infection) were harvested for donor cells analysis. (B) 
Representative histogram plots showing the % CD62L+ donor virus specific CD8+ 
T cells at various times and location during primary vaccNP infection. (C) Bar 
chart showing mean + standard error of mean (SEM) of % CD62L+ donor CD8+ T 
cells of 3 mice in a single experiment.  
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Figure 3.4: Cyclical expression of L-selectin during primary influenza A 
virus infection. (A) Naive B6 mice were infected with 50 ffu influenza A virus 
(PR8). At days 2, 4 and 8 post infection, mediastinal LN (site of CD8+ T cell 
priming), peripheral blood, lung (site of infection) were harvested for virus specific 
CD8+ T cell analysis. (B) Representative histogram plots showing the % CD62L+ 
tetramer+ CD8+ T cells at various times and location during primary influenza A 
virus infection. (C) Bar chart showing mean + standard error of mean (SEM) of % 
CD62L+ tetramer+ CD8+ T cells of 4 mice in a single experiment.   
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3.3.4. Recruitment of CD8+ T cells to sites of recombinant vaccinia virus 
infection is L-selectin dependent 
 
To test the hypothesis whether L-selectin is involved in homing of activated CD8+ 
T cells to site of virus infection. Also, if L-selectin expression is manipulated 
through introducing a non-cleavable mutant form of the molecule into the cells, 
CD8+ T cells could home better to sites of infection. Naïve CD8+ T cells co-
expresing F5 TCR and either wildtype (F5/B6) or mutant L-selectin (F5/LΔP) (Fig 
3.5) were adoptively transferred into naïve B6 mice. 24 hours later mice were 
challenged with vaccNP. At days 5, 8 and 12, sites of vaccNP infection (ovary), 
ovary draining lymph nodes (ovdLN), and spleen were harvested to study the 
recruitment of CD8+ T cells to sites of infection and whether mutant L-selectin 
could promote homing. CD8+ T cells started to infiltrate to sites of vaccNP 
infection from day 3 post infection and onward (Fig. 3.2). At days 5 and 8 post 
infection, donor cell enumeration analysis showed that there was enrichment of 
F5/LΔP over F5/B6 CD8+ T cells (Figure 3.6), which reveal that there were L-
selectin dependent homing of the CD8+ T cells to the site of vaccNP infection and 
constant expression of L-selectin as in mutant L-selectin expressing cells, were 
promoting the recruitment. On day 12 p.i., there was no longer any statistical 
significant difference in the numbers of F5/LΔP and F5/B6 CD8+ T cells In the 
infected ovaries. In the ovdLN, although the difference were not statistically 
significant, there were more F5/LΔP CD8+ T cells compared to F5/B6 cells at 
days 5 and 8 but not at day 12 (Figure 3.6). We used the spleen as a negative 
control as homing of CD8+ T cells is not L-selectin dependent (Arbornes et al. 
1994). There were no differences in the numbers of the F5/LΔP and F5/B6 CD8+ 
T cells in the spleen at any time point analyzed during vaccNP infection (Fig 3.6).  
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Figure 3.5: Phenotypic characteristics of naïve CD8+ T cells co-expressing 
transgenic F5 TCR and either wildtype or mutant L-selectin. Spleen and/or 
lymph nodes from F5/B6 mice, in which CD8+ T cells co-express transgenic F5 
TCR and wildtype L-selectin or F5/LΔP mice in which CD8+ T cells co-express F5 
TCR and mutant L-selectin were harvested, and then mashed through 70 µM cell 
strainer and CD8+ T cells were isolated using magnetic cell sorting technique. 
After isolation and purification, cells were stained for CD8α, NP68 tetramer, Vβ11 
(KT-11), CD44 and CD62L to assess their naivety. Representative bivariate 
density plots shows CD8, NP68 tetramer and Vβ11 triple positive cells of F5/B6 
(Blue) and F5/LΔP (Red) compared with their FMO (light grey). Overlaid 
histograms show level of CD44 expression, bivariate density plots show CD8 and 
CD62L double positive compared with CD62L FMO. 
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Figure 3.6: L-selectin dependent homing of CD8+ T cells to sites of 
recombinant vaccinia virus infection. (A) Naïve CD8+ T cells co-expressing 
transgenic F5 TCR and either wildtype L-selectin, (F5/B6) or mutant L-selectin 
(F5/LΔP) were isolated and adoptively transferred into B6 mice. 24 hours later, 
mice were inoculated with 2 x 106 pfu vaccNP. At days 5, 8 and 12 post infection, 
ovary, ovdLN and spleen were harvested and analyzed for homed donor CD8+ T 
cells. (B) Donor cells were identified as CD8, NP68 tetramer and Vβ11 triple 
positive cells. Density plots shows F5/B6 (Blue) and F5/LΔP (Red) donor cells 
and their CD62L expression. (C) Absolute numbers of homed donor F5/B6 and 
F5/LΔP CD8+ T cells in ovary, ovdLN and spleen at 5, 8 and 12 days post 
infection. Results are mean + SEM (n=3). ** P<0.001, *** P<0.0001, Two-Way 
Anova.   
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3.3.5. L-selectin does not influence priming, activation and differentiation of 
virus-specific CD8+ T cells 
 
Although naïve CD8+ T cells expressing mutant or wild type L-selectin showed 
equal ability to home to lymph nodes (Galkina et al. 2003), enrichment of CD8+ T 
cells expressing mutant L-selectin in the ovaries of vaccinia virus infected mice 
raised the possibility that the presence of mutant L–selectin may co-stimulate the 
activation and differentiation of CD8+ T cells resulting in the generation of 
increased numbers of effector cells. This question was tested by determining the 
kinetics of T cell activation at the site of priming in the mediastinal LN and the 
time course of T cell differentiation during the course of viral infection. The early 
activation antigen CD69 was upregulated by day 1 and downregulated by day 2 
on wildtype F5/B6 CD8+ T cells in mediastinal LN. The kinetics of CD69 
upregulation and downregulation on F5/LΔP CD8+ T cell were similar, suggesting 
that expression of mutant L-selectin did not alter the timing of interactions with 
antigen presenting cells at the site of priming (Fig 3.7). To determine whether L-
selectin affects the differentiation of virus-specific CD8+ T cells, expression of the 
late activation antigen CD44 on donor cells was measured. Donor cells were 
harvested from the ovary, ovdLNs and spleen at 5, 8 and 12 days following virus 
administration. In comparison with pre-transferred naïve cells, CD44 expression 
on F5/B6 cells increased 20-fold by day 5 and was maintained at this level to day 
12 in the ovary and draining LN. F5/LΔP cells up-regulated CD44 to a similar 
extent and with identical kinetics indicating that both cell types activated and 
differentiated in a similar manner. Furthermore, the kinetics of CD44 upregulation 
in the spleen were also unaffected by expression of mutant L-selectin, thus 
collectively demonstrating that L-selectin did not influence T cell activation (Fig. 
3.8).  
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Figure 3.7: L-selectin expression does not influence the activation of virus-
specific CD8+ T cells. Naïve CD90.2+ CD8+ T cells co-expressing transgenic F5 
TCR and either wildtype L-selectin F5/B6 or mutant L-selectin F5/LΔP were 
isolated and adoptively transferred into CD90.1 B6 mice. 24 hours later, mice 
were inoculated with 2 x 106 pfu vaccNP. At days 1 and 2 post infection, 
mediastinal LN (site of CD8+ T cell priming) was harvested for donor CD8+ T cells 
analysis. (A) Representative histograms show the low level of the early activation 
marker, CD69, by naïve CD8+ T cells from F5/B6 (Blue) and F5/LΔP (Red), the 
up-regulation of CD69 at day 1 post virus inoculation and subsequent down-
regulation of CD69 at day 2. (B) Bar chart shows the kinetics of CD69 up-
regulation and down-regulation at day 1 and day 2 by F5/B6 and F5/LΔP CD8+ T 
cells during vaccNP infection. Results are mean + SEM (n=3). 
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Figure 3.8: L-selectin expression does not influence the differentiation of 
virus-specific CD8+ T cells during recombinant vaccinia virus infection. 
Naïve CD8+ T cells co-expressing transgenic F5 TCR and either wildtype F5/B6 
or mutant L-selectin F5/LΔP were isolated and adoptively transferred into B6 
mice. 24 hours later, mice were inoculated with 2 x 106 pfu vaccNP. At days 5, 8 
and 12 post infection, ovary, ovdLN and spleen were harvested for homed donor 
CD8+ T cell analysis. (A) Representative histograms show the low level of CD44 
expression by naïve pre-transferred cells and the up-regulation of CD44 on 
effector CD8+ T cells differentiation of F5/B6 (Blue) and F5/LΔP (Red) during 
primary vaccNP infection at days 5, 8 and 12 post infection in the ovary, ovdLN 
and spleen. (C) Bar charts show the mean + SEM of CD44 expression (n=3). 
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3.3.6. The impact of L-selectin on co-stimulating CD8+ T cell proliferation 
During viral infection, a naïve CD8+ T cell, from a specific clone, recognizes the 
viral peptide, and it enters the activation and expansion phase. This phase is 
responsible to generate large number of effector cells to fight the infection. It has 
been shown that type I transmembrane protein 4BB-1, influence CD8+ T cell 
proliferation (Shuford et al. 1997). L-selectin is a type I transmembrane 
glycoprotein and to test whether L-selectin influence on CD8+ T cells proliferation 
and also, presence of mutant L-selectin could strength the co-stimulation. Using a 
dilution sensitive dye (CFSE), the proliferation of F5/B6 CD8+ T cells was 
compared with the F5/LΔP cells. Furthermore, Enrichment of mutant L-selectin 
expressing CD8+ T cells at the site of vaccNP infection brought up another 
possibility that these cells proliferate faster. Adoptive transfer of CFSE labeled 
naïve F5/B6 and F5/LDP CD8+ T cells into B6 mice, and challenging the mice 24 
hours later with vaccNP tested these questions. In the first day following the 
vaccNP infection, as shown in fig 3.7, both F5/B6 and F5/LΔP CD8+ T cells were 
primed similarly in the mediastinal LN, as both upregulated the early activation 
antigen CD69 in a similar manner, but neither cell type had entered the 
proliferation cycle. Whereas at day 2 post viral challenge, both F5/B6 and F5/LΔP 
had entered the proliferation cycle but in contrast to our hypothesis, F5/B6 CD8+ 
T cells expressing wildtype L-selectin, entered the proliferation cycle earlier 
indicated by more CFSE dilution and higher division index than F5/LΔP cells. 
This finding indicates that the signal, which is co-stimulated proliferation, was 
provided by the regulated expression of the wildtype L-selectin rather than a 
constant expression. Therefore enrichment in the numbers of F5/LΔP CD8+ T 
cells at the site of vaccNP infection was not due to hyper-proliferation of these 
cells (Fig 3.9).  
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Figure 3.9: The impact of L-selectin on CD8+ T cell proliferation. (A) Naïve 
CD90.2+ CD8+ T cells co-expressing transgenic F5 TCR and either wildtype 
F5/B6 or mutant L-selectin F5/LΔP were isolated and stained with 10µM CFSE, 
and a total of 2 x 106 cells were adoptively transferred into naïve CD90.1 B6 
recipient mice. 24 hours later, mice were inoculated with 2 x 106 pfu vaccNP. At 
days 1 and 2 post infection, mediastinal LN were harvested for CD8+ T cell 
proliferation analysis. (B) Representative histogram plots showing the CFSE 
dilution of F5/B6 and F5/LΔP CD8+ T cells in the mediastinal LN at day 2 post 
vaccNP infection (unpaired t-test). (C) The absolute numbers of donor F5/B6 and 
F5/LΔP CD8+ T cells further revealing the early entry of F5/B6 CD8+ T cells 
compared with F5/LΔP CD8+ T cells and cells in the control mice with no virus 
infection in the mediastinal LN at day 2 post infection. Results are mean + SEM 
(n=3). 
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3.3.7. Recruitment of CD8+ T cells to site of recombinant vaccinia virus 
infection was abrogated in the absence of L-selectin 
 
To understand the role of L-selectin in homing of activated CD8+ T cells to sites 
of viral infection further, the homing ability of CD8+ T cells expressing wildtype L-
selectin F5B6 was compared with L-selectin ko F5L-sel-/- CD8+ T cells. The 
enrichment of CD8+ T cells expressing mutant L-selectin over wildtype, raised the 
question whether the homing of L-selectin ko CD8+ T cells to sites of infection will 
be abrogated. The same approach was used in which naïve F5B6 or F5L-sel-/- 
CD8+ T cells were adoptively transferred to B6 mice, 24 hours later; mice were 
challenged with vaccNP. At day 5 p.i., ovary, ovdLN and spleen were harvested 
for donor cell analysis. Interestingly, there were very low numbers of F5L-sel-/- 
CD8+ T cells at the site of vaccNP infection when compared with F5B6 CD8+ T 
cells. We also revealed that homing of CD8+ T cells to ovdLN is fully L-selectin 
dependent, as there was a significant difference between the numbers of F5L-sel-
/- and F5B6 CD8+ T cells. As described above, homing of CD8+ T cells to spleen 
is not L-selectin dependent and there were no differences between the numbers 
of F5L-sel-/- and F5B6 CD8+ T cells in the spleen (Fig 3.10).   
 
Furthermore, CD44 up-regulation was also compared between wildtype L-
selectin expressing CD8+ T cells and L-sel-/- cells. Both cell types upregulated 
CD44 in a similar manner at day 5 post infection in the ovary, ovdLN and spleen 
of vaccNP infected mice (Fig. 3.11), which further illustrates that the presence of 
L-selectin constantly (mutant L-selectin), variably (wildtype) or its absence (L-
selectin ko) did not impact CD8+ T cell activation and differentiation which, in turn, 
supports a role for L-selectin in the homing ability of these cells. 
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Figure 3.10: Enrichment of CD8+ T cells at sites of recombinant vaccinia 
virus infection is L-selectin dependent. (A) Naïve CD90.2+ CD8+ T cells co-
expressing transgenic F5 TCR and wildtype L-selectin (F5B6) or CD8+ T cells 
express F5 TCR and knockout for L-selectin (F5L-sel-/-) were isolated and 
adoptively transferred into CD90.1 B6 mice. 24 hours later, mice were inoculated 
with 2 x 106 pfu vaccNP. At day 5 post infection, ovary, ovdLN and spleen were 
harvested and analyzed for homed donor CD8+ T cells. (B) Representative 
bivariate plots shows donor CD90.2+ CD8+ T cells in the ovary of mice receiving 
F5B6 and F5L-sel-/- CD8+ T cells at day 5 post infection. (C) Bar charts show 
absolute numbers of F5B6 and F5L-sel-/- CD8+ T cells in the ovary, ovdLN and 
spleen at day 5 post infection. Results are mean + SEM from two in dependent 
experiment (n=6)(unpaired student t-test).  
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Figure 3.11: L-selectin expression does not influence the differentiation of 
virus-specific CD8+ T cells during recombinant vaccinia virus infection. 
Naïve CD90.2+ CD8+ T cells co-expressing transgenic F5 TCR and wildtype L-
selectin F5B6 or CD8+ T cells expressing F5 TCR and knockout for L-selectin 
F5L-sel-/- were isolated and adoptively transferred into CD90.1 B6 mice. 24 hours 
later, mice were inoculated with 2 x 106 pfu vaccNP. At day 5 post infection, 
ovary, ovdLN and spleen were harvested for donor CD8+ T cells analysis. Bar 
chart shows the similar kinetics of CD44 up-regulation by F5B6 (Blue) and F5L-
sel-/- (White) CD8+ T cells during vaccNP infection at day 5 from the ovary, ovdLN 
and spleen. Results are mean + SEM (n=6). 
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3.3.8. MEL-14, L-selectin specific antibody, blocked homing of CD8+ T cells 
to sites of infection 
 
Taking into consideration that L-selectin was re-expressed by activated CD8+ T 
cells once they leave the sites of priming and activation in the draining LN, and if 
L-selectin was involved in homing of CD8+ T cells to sties of infection, we 
hypothesized that CD8+ T cell homing to sites of infection would be abrogated by 
antibodies reactive to L-selectin. MEL-14 antibody binds to the lectin domain of L-
selectin and prevents it from engaging with its ligands, thus blocking all known 
functions of L-selectin (Gallatin et al. 1987). 
 
Based on the sites of priming and kinetics of CD8+ T cell activation (Fig 3.1), 
naïve CD8+ T cells were allowed to home and be primed and activated in the 
mediastinal LN before starting treatment with MEL-14. F5/LΔP CD8+ T cells were 
transferred to naïve B6 mice and one day later, mice were inoculated with 
vaccNP. Mice were injected with 250 µg MEL-14 or isotype control antibodies 52 
hours following virus inoculation, and donor cell analysis was performed day 5 
post infection. Strikingly, MEL-14 reduced the number of donor CD8+ T cells in 
infected ovaries by 85% compared to mice treated with control antibody. MEL-14 
also reduced the number of donor CD8+ T cells in the draining LNs by 80% but 
had no effect on donor CD8+ T cell numbers in the spleen. Also, to exclude the 
possibility that MEL-14 blocked the activation and differentiation of the F5/LΔP 
donor CD8+ T cells after the treatment, the activation status of F5/LΔP CD8+ T 
cells was assessed by the up-regulation of CD44. Donor cells in both, MEL-14 
and isotype control treated mice, up-regulated CD44 in a similar manner (Fig 
3.12). 
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Figure 3.12: MEL-14 antibodies blocked homing of CD8+ T cells to the site 
of vaccNP infection. (A) Naïve CD8+ T cells co-expressing transgenic F5 TCR 
and mutant L-selectin (F5/LΔP) were isolated and adoptively transferred into B6 
mice. 24 hours later, mice were inoculated with 2 x 106 pfu vaccNP. 52 hours 
following virus inoculation, 250µg MEL-14 or IgG2a isotype control antibodies 
were injected in split doses of 125µg i.p. and 125µg i.v., and at day 5 post 
infection, ovary, ovdLN and spleen were harvested for homed donor cell analysis. 
(B) Donor CD8+ T cells were identified as in figure 3.5., the bar charts showing 
the absolute numbers of homed donor CD8+ T cells in mice that received either 
MEL-14 (black bar) or isotype control antibodies (white bar) in the ovary, ovdLN 
and spleen at 5 days post infection. (C) The bar charts show the level of CD44 
expression by donor CD8+ T cells in mice receiving either MEL-14 or isotype 
control antibodies in ovary, ovdLN and spleen at day 5 post infection. Results are 
mean + SEM (n=3). * P<0.05, Un-paired student t test. 
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3.3.9. A short-term, competitive homing study further reveals the role of L-
selectin in homing of activated CD8+ T cells to site of infection  
 
A competitive short-term homing experiment was conducted using in vitro 
activated CD8+ T cells sufficient and deficient in L-selectin to understand the 
direct involvement of L-selectin in homing of activated CD8+ T cells to site of virus 
infection. As described in the material and methods, d7 in vitro or d5 in vivo 
activated CD8+ T cells from F5LΔP or F5L-sel-/- mice were mixed 1:1 and 
adoptively transferred into CD90.1 recipient mice, which have been infected with 
vaccNP 3 days before. Shortly after 3 hours, ovary, ovdLN, spleen and a number 
of peripheral and mucosal LN were harvested for donor cell analysis.  
 
At 3 hours post-transfer, L-selectin expressing CD8+ T cells were highly enriched 
over L-selectin deficient cells in the virally infected ovaries. The ratio of L-selectin 
positive and negative T cells circulating in peripheral blood remained 1:1 at this 
time point showing that the altered ratio in the ovaries was not simply due to 
depletion of L-selectin deficient T cells from the circulation. L-selectin positive 
CD8+ T cells represented nearly all donor cells in the ovdLNs, and also in two 
peripheral LNs known to be L-selectin dependent, the axillary and inguinal LNs 
(Arbornes et al. 1994).  L-selectin positive CD8+ T cells were not enriched in the 
mediastinal LN, which further confirms that L-selectin is not a dominant homing 
receptor for this LN.  The ratio of L-selectin positive to L-selectin negative CD8+ T 
cells in the spleen was similar to the pre-transfer population since homing to the 
spleen is independent of L-selectin (Arbornes et al. 1994). The enrichment of L-
selectin expressing activated CD8+ T cells in the recently recruited cell population 
in the ovary further demonstrates clearly that L-selectin controls recruitment of 
activated CD8+ T cells from the bloodstream into virus-infected tissues (Fig 3.13) 
(Fig 3.14). 
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Figure 3.13: in vitro activated L-selectin positive CD8+ T cells compete with 
the L-selectin deficient cells to home to sites of recombinant vaccinia virus 
infection. (A) Naïve CD90.2+ CD8+ T cells co-express transgenic F5 TCR and 
either mutant L-selectin (F5LΔP) or knockout for L-selectin (F5L-sel-/-) were 
isolated and cultured in vitro for 7 days in the presence of NP68 pulsed irradiated 
antigen presenting cells and IL-2, meanwhile, naïve CD90.1 B6 mice were 
inoculated with 2 x 106 vaccNP, On day 3 post vaccNP infection, mice were 
adoptively transferred with 1:1 mix of activated F5LΔP and F5L-sel-/- CD8+ T 
cells. 3 hours post T cells transfer, mice were euthanized and organs harvested 
for a competitive short-term homing of the F5LΔPHI and F5L-sel-/- CD8+ T cells 
analysis. (B and C) The representative bivariate plot shows percentage F5LΔP 
(CD90.2+ CD62L+) and F5L-sel-/- (CD90.2+ CD62L-) CD8+ T cells pre-transfer and 
post-transfer in the ovary, ovdLN, axillary, inguinal, mediastinal LN and spleen 
also in the peripheral blood at the time of harvest. (D) The chart shows the mean 
+ SEM (n=4)(Bonferroni test).    
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Figure 3.14:  in vivo activated L-selectin positive CD8+ T cell compete with 
the L-selectin deficient cells to home to sites of recombinant vaccinia virus 
infection. (A) Naïve F5LΔP and F5L-sel-/- mice were inoculated with 2 x 106 
vaccNP, at day 5 post infection, mice were euthanized and CD8+ T cells were 
isolated from spleen. Mean while, CD90.1 B6 mice were inoculated with 2 x 106 
vaccNP. On day 3 post vaccNP infection, mice were adoptively transferred with 
1:1 mix of in vivo activated F5LΔP and F5L-sel-/- CD8+ T cells. 3 hours post T 
cells transfer, mice were euthanized and organs harvested for a competitive 
short-term homing of the F5LΔP and F5L-sel-/- CD8+ T cells analysis. (B) The 
chart shows the mean + SEM of percentage F5LΔP (CD90.2+ CD62L+) and F5L-
sel-/- (CD90.2+ CD62L-) CD8+ T cells in the ovary, ovdLN, inguinal LN, mediastinal 
LN and spleen also in the peripheral blood at the time of harvest. (n=4) 
(Bonferroni test)    
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3.3.10. L-selectin dependent homing of virus specific CD8+ T cells to site of 
Influenza virus infection 
 
CD8+ T cells play an important role during respiratory virus infections. Influenza 
infection in particular, during both primary and secondary infection, requires a 
strong CD8+ T cell response. Since we have shown that early-activated CD8+ T 
cells express L-selectin, the role of L-selectin in homing of virus specific CD8+ T 
cell to sites of infection, other than ovary, became of interest. To understand the 
involvement of L-selectin in homing of virus specific CD8+ T cells to sites of 
influenza virus infection, naïve polyclonal B6 and LΔP mice were challenged with 
50 pfu influenza strain A (H1N1, PR8) virus and 8 days later, mice were 
euthanized and lungs and spleen were harvested for analysis of endogenous 
virus-specific CD8+ T cells. Consistent with the recombinant vaccinia virus 
adoptive transfer model, the numbers of endogenously produced NP34-tetramer 
specific CD8+ T cells were higher in the lungs at day 8 post infection in the 
polyclonal LΔP mutant L-selectin expressing mice compared with wildtype L-
selectin B6 mice (Fig 3.15). 
 
Also to confirm that the enrichment in the numbers of virus specific CD8+ T cells 
expressing mutant L-selectin in the influenza infected lungs of LΔP mice 
comparing to wildtype L-selectin expressing in B6 mice was not due to hyper-
differentiation, up-regulation of the late activation antigen CD44 was measured. 
Virus specific CD8+ T cells harvested from LΔP and B6 mice at day 8 post 
infection from the lungs and spleen, upregulated CD44 in a similar manner. 
Similar to recombinant vaccinia virus infection, CD44 up-regulation was lower on 
virus specific CD8+ T cells harvested from spleen compared to the cells 
harvested from lungs (Fig 3.16).      
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Figure 3.15: L-selectin dependent homing of CD8+ T cells to site of 
influenza virus infection. (A) Naïve B6 and LΔP mice were challenged with 50 
pfu influenza strain A (PR8, H1N1) virus. 8 days later, mice were euthanized and 
lung, spleen were harvested for analysis of endogenously generated virus 
specific CD8+ T cells. (B) The representative bivariate plots show the % NP34 
tetramer+ CD8+ T cells in the lungs of B6 and LΔP mice at day 8 post influenza 
infection. (C) The bar charts show the absolute numbers of NP34 tetramer+ CD8+ 
T cells in the lungs and spleen of B6 and LΔP mice at day 8 post influenza 
infection. Results are mean + SEM (n= 4).       
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Figure 3.16: L-selectin expression does not influence the differentiation of 
virus-specific CD8+ T cells during influenza infection. Naïve B6 and LΔP 
mice were challenged with 50 pfu influenza strain A (PR8, H1N1) virus. 8 days 
later, mice were euthanized and lungs and spleens were harvested for analysis of 
endogenously generated virus specific CD8+ T cells. Bar charts show similar 
levels of CD44 expression on virus specific CD8+ T cells in B6 and LΔP mice in 
the lung and spleen at day 8 post influenza infection. Results are mean + SEM 
(n-4).  
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3.3.11. MEL-14 blocked homing of endogenously generated virus specific 
CD8+ T cells to site of influenza virus infection 
 
To understand the role of wildtype L-selectin in homing of virus specific CD8+ T 
cells to site of virus infection, wildtype B6 mice were infected with 50 pfu 
influenza strain A (H1N1, PR8) virus and 52 hours later, when the CD8+ T cells 
were already primed in the mediastinal LN (Yoon et al. 2007), mice were injected 
with either MEL-14 or isotype IgG2a control antibodies. At days 4 and 8 post 
infection, lung, mediastinal LN and spleen were harvested and analyzed for 
endogenously produced virus specific CD8+ T cells. MEL-14 reduced the number 
of endogenously generated virus specific CD8+ T cells in the lungs at day 4 post 
infection by 40%. By day 8 post infection, MEL-14 resulted in a much greater 
reduction of 70% in the numbers of the virus specific CD8+ T cells in the lungs. 
Whereas, in the mediastinal LN, which is the major site of T cell priming following 
intranasal influenza administration (Yoon et al. 2007). The numbers of the virus 
specific CD8+ T cells were not affected by MEL-14 treatment at both days 4 and 8 
post infection, which confirms that homing of CD8+ T cell to this particular 
mucosal LN is not L-selectin dependent. Also, in the spleen, the numbers of virus 
specific CD8+ T cells were not affected by MEL-14 treatment as shown during 
vaccNP infection (Fig 3.17). Furthermore, to determine whether MEL-14 affected 
the differentiation of virus specific CD8+ T cells at various locations during the 
course of primary influenza infection, CD44 expression was measured. Virus 
specific CD8+ T cells in both MEL-14 and isotype control antibody treated mice 
up-regulated CD44 in a similar manner in the lung, mediastinal LN and spleen 
(Fig 3.18). These findings further support the hypothesis that L-selectin is 
involved in homing of virus specific CD8+ T cells to sites of infection but not in 
differentiation.  
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Figure 3.17: MEL-14 antibodies blocked homing of endogenously generated 
virus specific CD8+ T cells influenza virus infected lungs. (A) Naïve B6 mice 
were challenged with 50 pfu influenza strain A (PR8, H1N1) virus intranasally. 52 
hours following virus administration, mice were injected with 200µg MEL-14 or 
isotype IgG2a control i.v., followed by daily injection of MEL-14 and control 
antibodies i.p. At days 4 and 8 post infection, mice were euthanized and lungs 
(site of infection), mediastinal LN (site of CD8+ T cell priming) and spleen were 
harvested for analysis of endogenously generated virus specific CD8+ T cells. (B) 
Bar charts show absolute numbers of tetramer+ CD8+ T cells in the lung, 
mediastinal LN and spleen of mice treated with either MEL-14 or isotype control 
antibodies at day 4 and 8 post infection. Results are mean + SEM (n=5). ** P< 
0.001, Two-way ANOVA.   
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Figure 3.18: Differentiation status of virus specific CD8+ T cells during 
primary influenza virus infection. Naïve B6 mice were challenged with 50 pfu 
influenza strain A (PR8, H1N1) virus intranasally. 52 hours following virus 
administration, mice were injected with 200µg MEL-14 or isotype IgG2a control 
i.v., followed by daily injection of MEL-14 and control antibodies. At days 4 and 8 
post infection, mice were euthanized and lung (site of infection), mediastinal LN 
(site of CD8+ T cells priming) and spleen were harvested for homed 
endogenously generated virus specific CD8+ T cells analysis. Bar charts show 
CD44 upregulation by virus specific CD8+ T cells at (A) day 4 and (B) day 8 post 
infection in lung, mediastinal LN and spleen. Results are mean + SEM (n=5).  
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4. The role of L-selectin in anti-virus immunity 
 
4.1. Introduction  
 
The role of CD8+ T cells in protection against primary virus infection is well 
characterized. CD8+ T cells can directly kill the virus-infected cells or they can 
secrete cytokines in order to modify the virus replication system. Effector 
lymphocyte communication with the virus or virus-infected cells is key in a 
successful immune response. Also, the number of effector CD8+ T cells at the 
site of infection during virus infection determines the outcome. The level of cell 
adhesion molecules and their counterpart ligands on the infected cells and the 
lymphocytes determine the efficacy of the recruitment and therefore the number 
of effector cells at the site of infection. Improvement in effector CD8+ T cell 
generation and migration during an adaptive immune response against virus and 
cancer is one of the main concerns in the field of immunology.  
 
During virus infection, non-lymphoid infected tissues start to express various cell 
adhesion molecules, which allows the recruitment of virus-specific lymphocytes 
from the bloodstream to the site of infection (Roe et al. 2014), however the 
contributions of individual adhesion molecules to viral immunity have not been 
studied in detail. In this chapter, the role of L-selectin in conferring anti-virus 
immunity will be illustrated. 
 
4.2. Hypothesis 
 
The level of L-selectin on virus-specific CD8+ T cells controls anti-viral immunity. 
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4.3. Results   
 
4.3.1. Kinetics of recombinant vaccinia virus infection in C57BL/6 mice 
 
To test the hypothesis that L-selectin dependent homing of CD8+ T cells confers 
anti-virus immunity, the kinetics of the vaccNP infection in B6 mice and the 
components of the immune system that participate in viral clearance were 
dissected. Although it has been shown that clearance of wildtype Western 
Reserve (WR) vaccinia virus infection in B6 mice is CD4+ T cell and MHC class II 
dependent (Xu et al. 2004), CD8+ T cells show site dependent activation and 
generate effector and memory CD8+ T cells during the course of a primary 
vaccinia virus infection (Laouar et al. 2008)(Xiao et al. 2007).  
 
Viruses such as HIV-1 use mechanisms of L-selectin downregulation from the 
surface of CD4+ T cells, such as binding to proteins NEF and VPU (Vassena et 
al. 2015), to limit immune responses during the course of their infection. Vaccinia 
virus might adopt a similar mechanism to limit the numbers of CD8+ T cells 
recruited to sites of infection. Therefore, the immune system might find alternative 
pathways to control vaccinia virus infection, which are independent of CD8+ T 
cells.  
 
The kinetic of vaccNP infection in B6 mice was studied by challenging naïve B6 
mice with 2 x 106 pfu vaccNP. Since ovary is the main site of virus infection, fig 
3.1, the virus was allowed to replicate and infect the host, and at days 5, 8 and 12 
post infection, mice were euthanized and the site of virus replication and infection 
(ovary) was excised for viral titer by plaque assay (Fig. 4.1A). At the time points 
analyzed, vaccNP infection was highest titer at day 5 post infection. Viral titres fell 
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between day 5 and day 8 post infection by 2 logs, which reveals that the immune 
system started to clear vaccNP infection. Furthermore, at day 12 post infection, 
though the virus was not completely cleared from the ovaries, further signs of 
viral clearance were noticeable as the titer fell between day 8 and day 12 post 
infection (Fig. 4.1B). 
 
4.3.2. Recombinant vaccinia virus infection in immunodeficient mice  
 
After studying the kinetics of vaccNP infection in B6 mice, the role of lymphocytes 
and in particular, CD8+ T cells, in the clearance of vaccNP infection was of great 
interest. In order to test to what extent CD8+ T cells are participating in vaccNP 
clearance, vaccNP infection was studied in various types of CD8+ T cell depleted 
mice.  
 
First, immune competent B6 mice were manipulated to be acutely CD8+ T cells 
deficient. Mice were sub-lethally irradiated to eliminate circulating lymphocytes 
(Unsinger et al. 2009) and prepare the host for adoptive transfer of purified naïve 
CD8+ T cells from donor mice. We addressed a question that if sub-lethal dose of 
irradiation is able to eliminate the host circulating lymphocytes for a minimum of 
2-3 weeks, the adoptive transfer of naïve CD8+ T cells into these irradiated mice 
will help to understand the participation of the CD8+ T cell arm of the adaptive 
immune system in the vaccNP clearance. Naïve B6 mice were sub-lethally 
irradiated and challenged with vaccNP (Fig 4.2A). Unexpectedly, virus was not 
detectable 5 days post virus inoculation in the ovaries of irradiated mice (Fig 
4.2B).  
It has been shown previously that mice exposed to total body irradiation (acute, 
sub-lethal dose) and challenged with wildtype vaccinia virus resulted in a time lag 
in the virus infection characterized by a long delay in the virus replication and 
 120 
invasion (Simon & Werner 1979). Since X-irradiated B6 mice, challenged with 
recombinant vaccinia virus, were not able to produce a detectable vaccinia virus 
infection in the ovaries, therefore, mice that were chronically CD8+ T cells 
deficient as a result of a genetic failure to generate mature T and B cells (RAG-/-), 
were used to study the role of CD8+ T cells in vaccNP clearance and determine 
the impact of L-selectin in conferring anti-virus immunity (Fig 4.2C).  
 
The kinetics of vaccNP clearance from ovaries of B6 and RAG-/- mice were 
compared. Virus titres were similar in B6 and RAG-/- mice at day 5 post infection. 
Lymphocyte dependent clearance of virus in wildtype B6 mice was detectable at 
day 8 post infection when virus titers were lower than in RAG-/- mice which had 
sustained virus replication and impaired virus clearance (Fig. 4.2D).  
 
This finding clearly illustrating that the adaptive immune system, which is 
including T and B cells, participates in the clearance of the recombinant vaccinia 
virus infection. To what extend the T cell arm of the adaptive immune system is 
involved in the vaccNP clearance from the infected ovaries will be dissected in 
the following section.   
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Figure 4.1: Kinetics of recombinant vaccinia virus clearance in C57BL/6 
(B6) mice. (A) Naïve B6 mice were inoculated i.p. with 2 x 106 recombinant 
vaccinia virus expressing NP68 peptide (vaccNP). At days 5, 8 and 12 post 
infection, mice were euthanized and ovaries (site of infection) were excised for 
viral titer by plaque assay. (B) Kinetics of vaccNP clearance. Result shows titres 
in individual mice and median value from a single experiment (n=4-11). 
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Figure 4.2: Recombinant vaccinia virus infection in immunodeficient mice. 
(A) Naïve B6 mice were sublethally irradiated with 650 cGy. 24 hours later, mice 
were inoculated with 2 x 106 pfu vaccNP. At day 5 post infection, mice were 
euthanized, ovaries excised and virus titers determined in homogenized tissues 
by plaque assay. (B) Virus titres in irradiated and non-irradiated mice at day 5 
post vaccNP infection. (C) Naïve B6 and RAG1-/- mice were inoculated with 2 x 
106 pfu vaccNP. At days 5 and 8 post infection, mice were euthanized and 
ovaries were harvested for viral titre by plaque assay. (D) Virus titres in B6 and 
RAG1-/- mice at days 5 and 8 post vaccNP infection. Result shows titres in 
individual mice and median values from a single experiment (n=3-11)(One-Way 
ANOVA with post Tukey’s test). 
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4.3.3. The role of L-selectin in CD8+ T cell dependent anti-viral immunity 
 
The significant difference in the viral load between wildtype B6 and RAG-/- mice at 
day 8 post infection led us to design an experiment to reveal the participation of 
CD8+ T cells in the clearance of vaccinia virus infection. Also, the role of various 
levels of L-selectin expression on the surface of CD8+ T cells in improving anti-
virus immunity by enhancing the recruitment of CD8+ T cells to the site of 
infection were investigated.  
 
Naïve CD8+ T cells co-expressing F5 TCR and wildtype L-selectin (F5/B6) or 
mutant L-selectin (F5/LΔP) were isolated and adoptively transferred into RAG1-/- 
recipient mice and a group of RAG1-/- mice did not receive T cells and were used 
as control. 24 hours later, mice were challenged with 2 x 106 pfu vaccNP. Then 
mice were treated daily from days 2 to 6 with IL-2 to support CD8+ T cell survival 
and proliferation in the absence of CD4 helper T cells in RAG-/- mice (Fig 4.4A). 
Interestingly, adoptive transfer of F5 CD8+ T cells expressing mutant L-selectin 
improved viral clearance. RAG1-/- mice that received wildtype L-selectin 
expressing F5CD8+ T cells showed sustained virus replication and impaired viral 
clearance similar to control mice that did not receive T cells (Fig. 4.4B).  
 
This finding further revealed an important role for L-selectin in supporting the 
enrichment of CD8+ T cells at sites of viral infection and therefore enhancing anti-
virus immunity.  
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Figure 4.4: Mutant L-selectin on virus specific CD8+ T cells confers 
protection during recombinant vaccinia virus infection. (A) Naïve CD8+ T 
cells co-expressing transgenic F5 TCR and either wildtype (F5/B6) or mutant L-
selectin (F5/LΔP) were isolated and adoptively transferred into RAG1-/- mice. A 
group of RAG1-/- mice were also injected with saline and used as control. 24 
hours later, mice were inoculated with 2 x 106 pfu vaccNP. Mice were also treated 
with 150000 IU hrIL-2 from day 2 to day 6 post infection. At day 8 post infection, 
ovaries were harvested for viral titre using plaque assay. (B) Result shows viral 
titres in individual mice and median values pooled from 2 independent 
experiments (n=7). * P< 0.05, ** P< 0.001. One-Way ANOVA with post Tukey 
test.  
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4.3.4. L-selectin specific antibody MEL-14 blocks homing of virus specific 
CD8+ T cells to sites of vaccNP infection in RAG-/- mice 
 
The role of L-selectin in homing of virus specific CD8+ T cells to the site of 
vaccNP infection in RAG1 mice was determined using MEL-14 blocking antibody 
to L-selectin and the previously employed strategy used in B6 mice. F5/LΔP 
CD8+ T cells were transferred to naïve RAG1-/- mice and 24 hours later, mice 
were inoculated with 2 x 106 pfu vaccNP. Mice were injected with 250 µg MEL-14 
or isotype control antibodies starting 52 hours following virus inoculation, and 
donor cell analysis was performed at day 5 post infection. MEL-14 reduced the 
number of donor CD8+ T cells in infected ovaries (Fig. 4.5). MEL-14 treatment 
also reduced the number of donor CD8+ T cells in ovary draining LNs but had no 
effect on donor CD8+ T cell numbers in the spleen (Fig. 4.5B).  
 
To exclude the possibility that MEL-14 blocked the activation and differentiation 
of F5/LΔP donor CD8+ T cells, the activation status of F5/LΔP CD8+ T cells was 
assessed by up-regulation of CD44. Donor CD8+ T cells in both MEL-14 and 
isotype control antibody treated mice up-regulated CD44 in a similar manner (Fig 
4.5C). 
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Figure 4.5: MEL-14 antibodies blocked homing of virus specific CD8+ T cells 
to site of recombinant vaccinia virus infection in RAG1-/- mice. (A) Naïve 
CD8+ T cells co-expressing transgenic F5 TCR and mutant L-selectin (F5/LΔP) 
were isolated and adoptively transferred into RAG1-/- mice. 24 hours later, mice 
were inoculated with 2 x 106 pfu vaccNP. 52 hours following virus administration, 
mice were either treated with 250µg MEL-14 or IgG2a isotype control antibodies. 
At day 5 post infection, ovary, ovdLN and spleen were harvested for homed 
donor CD8+ T cells analysis. (B) Bar charts show absolute numbers of donor 
CD8+ T cells in ovary, ovdLN and spleen and (C) bar charts show the mean 
fluorescence intensity of CD44 expression on donor CD8+ T cells in ovary, ovdLN 
and spleen in mice treated either with MEL-14 or isotype control antibodies at day 
5 post infection (n=3). * P <0.05. Student unpaired t test.  
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4.3.5. Enhanced viral clearance by mutant L-selectin expressing CD8+ T 
cells was not due to hyper-proliferation 
 
Since the strength of the adaptive immune response against virus infection is 
linked to the generation of sufficient numbers of effector CD8+ T cells that can 
home to the site of infection, proliferation analysis of donor cells at the time of 
protection against the virus was of great interest. Taking into consideration that 
RAG-/- mice receiving mutant L-selectin expressing CD8+ T cells show improved 
protection against vaccNP infection, this raised the possibility that these cells 
might proliferate better than wildtype L-selectin expressing cells. Although mutant 
L-selectin expressing CD8+ T cells showed a delay in entering the proliferation 
cycle at day 2 p.i. (Fig 3.10), the presence of mutant L-selectin on the surface of 
CD8+ T cells could provide enhanced proliferation later during the infection. The 
rate of proliferation was assessed by administering the proliferation dye (EdU) at 
day 4 p.i., which is incorporated into the DNA of proliferating cells and analyzing 
donor cells in virus-infected ovaries at day 5 p.i..  
 
There was no statistical significant difference in the percentage of F5/B6 and 
F5/LΔP CD8+ T cells that incorporated EdU dye into their DNA, which shows that 
both cell types were proliferating at a similar rate. Collectively, these data show 
that L-selectin only provides early co-stimulatory signals for CD8+ T cells to enter 
the proliferation cycle but has no effect at later time points and therefore 
enrichment of F5/LΔP CD8+ T cells in virus-infected tissues was not due to 
enhanced proliferation (Fig 4.6). 
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Figure 4.6: L-selectin does not co-stimulate late proliferation of virus 
specific CD8+ T cells at the site of recombinant vaccinia virus infection. (A) 
Naïve CD8+ T cells co-expressing transgenic F5 TCR and either wildtype F5/B6 
or mutant L-selectin F5/LΔP were isolated and adoptively transferred into RAG1-/- 
mice. 24 hours later, mice were inoculated with 2 x 106 pfu vaccNP. Mice were 
also treated with 150000 IU hrIL-2 from day 2 to day 4 post infection. At day 4 
post infection, 1mg EdU dye was injected i.p. and ovaries were harvested at day 
5 for donor CD8+ T cell analysis. (B) Bivariate plots show the incorporation of 
EdU dye into the DNA of proliferating cells as CD8 and EdU double positive cells 
compared with the EdU FMO. (C) Bar charts show the mean + SEM (n=4).  
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4.3.6. Mutant and wildtype L-selectin expressing CD8+ T cells show equal 
ability to secrete various cytotoxic chemicals   
 
Cytokines provide both advantageous and adverse effects for the immune 
system. Cytotoxic CD8+ T cells participate in killing virus-infected cells through 
secretion of chemical mediators such as Interferon-γ, granzyme B and perforin 
(Rodriguez et al. 2003; (Johnson et al. 2003). Whereas, regulatory T cells is 
secreting immunosuppressive cytokines such as interlukin-10 (IL-10) and 
transforming growth factor-β (TGF-β) to reduce the effectiveness of the immune 
system (Taylor et al. 2006). Another explanation, other than efficient homing, for 
the enhanced viral clearance in RAG1-/- mice that received mutant L-selectin 
expressing CD8+ T cells, is that these cells secrete more cytotoxic chemicals at 
the site of vaccNP infection. To test the hypothesis, naïve F5/B6 or F5/LΔP CD8+ 
T cells were adoptively transferred into RAG-/- mice. 24 hours later, mice were 
challenged with vaccNP. At day 5 post infection, donor CD8+ T cells harvested 
from ovary and spleen were re-stimulated ex vivo in the presence of F5 TCR 
cognate peptide (NP68) to assess their abilities to secrete various cytotoxic 
chemicals necessary for CD8+ T cells to function during primary viral infection.  
 
F5/B6 and F5/LΔP CD8+ T cells harvested from the site of vaccNP infection 
synthesized similar levels of, IFN-γ, TNF-α, IL-2 and granzyme B (Fig. 4.7). 
Donor F5/B6 and F5/LΔP CD8+ T cells harvested from the spleen also 
synthesized similar levels of IFN-γ, TNF-α, IL-2 and granzyme B (Fig. 4.8). This 
finding further supports the hypothesis that L-selectin dependent enhancement of 
anti-virus immunity is not due to hyper-proliferation or hyper-functional CD8+ T 
cells.  
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Figure 4.7: L-selectin does not affect cytokine secretion by virus specific 
CD8+ T cells at the site of recombinant vaccinia virus infection. (A) Naïve 
CD8+ T cells co-expressing transgenic F5 TCR and either wildtype F5/B6 or 
mutant L-slectin F5/LΔP were isolated and adoptively transferred into RAG1-/- 
mice. 24 hours later, mice were inoculated with 2 x 106 pfu vaccNP. Mice were 
also treated with 150000 IU hrIL-2 from day 2 to day 4 post infection. At day 5 
post infection, donor CD8+ T cells were harvested from ovary and re-stimulated 
ex vivo for 4 hours in the presence of NP68 peptide and Brefeldin A. (B) 
Representative plots show IL-2, TNF-α, IFN-γ and granzyme B secretion as 
density plots (black) of F5/B6 and F5/LΔP CD8+ T cells overlaid on the FMO as 
dot plots (blue). (C) Bar chart shows percentage positive donor T cells as mean + 
SEM (n-4).  
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Figure 4.8: L-selectin does not affect cytokine secretion by virus specific 
CD8+ T cells in the spleen of recombinant vaccinia virus infected mice. (A) 
Naïve CD8+ T cells co-expressing transgenic F5 TCR and either wildtype F5/B6 
or mutant L-slectin F5/LΔP were isolated and adoptively transferred into RAG1-/- 
mice. 24 hours later, mice were inoculated with 2 x 106 pfu vaccNP. Mice were 
also treated with 150000 IU hrIL-2 from day 2 to day 4 post infection. At day 5 
post infection, donor CD8+ T cells were harvested from spleen and re-stimulated 
ex vivo for 4 hours in the presence of NP68 peptide and Brefeldin A. (B) 
Representative plots show the IL-2, TNF-α, IFN-γ and granzyme B secretion as 
density plots (black) of F5/B6 and F5/LΔP CD8+ T cells overlaid on the FMO as 
dot plots (blue). (C) Bar chart shows percentage positive donor T cells as mean + 
SEM (n-4).  
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4.3.7. Respiratory recombinant vaccinia virus infection in mice 
 
The vaccinia (i.p.) model employed so far was very informative for cellular studies 
of antiviral responses, but it is of limited clinical relevance. To determine whether 
L-selectin expression confers protection from virus infection in other organs, 
recombinant vaccinia virus infection in the respiratory system was studied. It has 
been shown that, following intranasal inoculation of wildtype Western Reserve 
(WR) vaccinia virus, replicating virus was detectable in lungs and CD8+ T cells 
exhibited a protective role, using IFN-gamma secretion mechanism to clear the 
virus (Goulding et al. 2014), whereas clearance of vaccinia following 
intraperitoneal administration is dependent on CD4+ T cells and antibodies (Xu et 
al. 2004). Therefore, we decided to challenge the mice through an intranasal 
route to establish a respiratory vaccinia virus infection to test the hypothesis that 
L-selectin regulates CD8+ T cell homing to sites of infection and confers anti-viral 
immunity. 
 
Naïve B6 mice were challenged with various doses of vaccNP intranasally. Body 
weights were monitored daily and at day 8 post infection; lungs were harvested 
for viral titer by plaque assay. The mice did not show signs of infection, as they 
did not lose weight and there was no detectable virus in the lungs (Fig. 4.9). This 
finding suggests that genetic manipulation of vaccinia virus causes the virus to 
lose its ability (Williamson et al. 1990) to infected mouse lungs.  
  
 133 
      
 
 
Figure 4.9: Respiratory recombinant vaccinia virus infection in C57BL/6 
mice. (A) Naïve B6 mice were intranasally inoculated with 1 x 104, 1 x 105 or 1 x 
106 pfu vaccNPunder light anaesthesia. Body weights were measured daily and 
at day 8 post virus administration, mice were euthanized and lungs excised for 
viral titre in homogenized tissue by plaque assay. (B) % Body weight loss or gain 
to the original body weight. (C) Viral titres in individual mice (n=4).    
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4.3.8. L-selectin expression promotes viral clearance during primary 
influenza virus infection. 
 
Having determined that vaccNP was not able to establish a measurable 
respiratory infection following intranasal challenge (Fig. 4.9), a more lethal form of 
respiratory viral infection was established with the Influenza strain A virus. 
Intranasal (i.n.) infection with influenza virus in mice can be considered closest to 
the natural route of human influenza infections. CD8+ T cells play an important 
role in immune response protection against influenza virus infection (Bender et al. 
1992).  
 
The impact of L-selectin expression on viral clearance from lungs following 
infection of various levels of L-selectin expressing mice with a pathogenic strain 
of influenza virus was determined. L-sel-/-, B6 and LΔP mice were infected i.n. 
with influenza virus (H1N1, PR8), mice weights were monitored daily and lungs 
were harvested for viral titer by plaque assay. At day 8 following viral challenge, 
LΔP mice had the lowest virus titers which were accompanied by a striking 
alleviation in weight loss. In contrast, L-sel-/- mice demonstrated sustained viral 
loads and more exaggerated weight loss compared to wild type B6 mice (Fig. 
4.10). These data therefore demonstrate that L-selectin is essential for the 
recruitment of protective, virus-specific CD8+ T cells into infected tissues. 
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Figure 4.10: L-selectin dependent homing of virus specific CD8+ T cells to 
site of influenza virus infection confers anti-viral immunity. (A) Naïve L-sel-/-, 
B6 and LΔP mice were administered with 50 ffu influenza strain A (PR8, H1N1) 
virus under light anaesthesia. Body weights were measured daily and at day 8 
post infection, lungs were excised from the thoracic cavity and viral titres were 
determined in homogenized tissue by focus forming unit assay. (B) Result shows 
viral titer in individual mice and median value from two independent experiments. 
(C) Mean + SEM % body weight loss from the original weight (n=9-11).  
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To further understand the role of L-selectin on the surface of activated CD8+ T 
cells in conferring anti-viral immunity, and to dissect the strength of CD8+ T cells 
involvement in clearing influenza A virus infection, first, L-sel-/-, B6 and LΔP mice 
were challenged i.n. with  a less virulent form of Influenza A virus (H3N2, H17). At 
day 8 post infection, lungs were harvested for viral titer. Interestingly, both B6 and 
LΔP mice showed enhanced viral clearance when compared with L-sel-/- mice. 
Whereas constant expression of L-selectin on the surface of activated CD8+ T 
cells in LΔP mice did not have any impact on the viral clearance compared to the 
regulated expression of L-selectin in wildtype mice (Fig. 4.11).  
 
Second, RAG2-/- mice, which is chronically lacking T and B cells, were 
replenished with purified CD8+ T cells from F5-L-sel-/-, F5B6 or F5LΔP mice. 24 
hours later, mice were i.n. challenged with influenza A Virus (H3N2, H17). At day 
7 post infection, lungs were harvested for viral titer. In similar consistency with 
previous studies, which shows that, the influenza virus virulence determines the 
necessity of various adaptive immune system compartments. RAG2-/- mice 
received F5LΔP showed enhanced viral clearance when compared with F5B6 
and F5L-sel-/-.  
 
Furthermore, to confirm the L-selectin dependent homing of activated CD8+ T 
cells and their involvement in the clearance of influenza A virus, F5L-sel-/-, F5B6 
and F5LΔP CD8+ T cells were activated in vitro in the presence of NP68 pulsed 
irradiated APCs for 7 days. Meanwhile, RAG2-/- mice were challenged i.n. with 
influenza A virus (H3N2, H17) and 2 hours post infection, d7 CTL from various 
groups were instilled i.n., 5 days post T cells transfer, lungs were harvested for 
viral titer. Interestingly, all 3 groups with localized activated CD8+ T cells in the 
lung were able to provide protection against influenza virus compared with the 
control group with no T cell transfer (Fig. 4.12).   
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Fig 4.11: level of L-selectin on the surface of CD8+ T cells determine the 
strength of anti-viral protection against influenza A virus infection. (A) 
Naïve L-sel-/-, B6 and LΔP mice were administered with 50 ffu influenza strain A 
(H17, H3N2) virus under light anaesthesia. At day 8 post infection, viral titres 
were determined in homogenized tissue by focus forming unit assay. (B) RAG-/- 
mice were adoptively transferred with naïve F5LΔP, F5B6 and F5L-sel-/- CD8+ T 
cells. 24 hours later, mice were administered with 50 ffu influenza strain A (H17, 
H3N2) virus under light anaesthesia. Mice were injected with hrIL-2 from day 2-5. 
Viral titers were determined at day 7 post infection. Data presented as median 
and each symbol represents a single mouse. (Oneway ANOVA with post Tukey’s 
test). .   
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Fig 4.12: L-selectin does not affect activation and differentiation of virus 
specfifc CD8+ T cells during influenza A virus infection. (A) naïve F5LΔP, 
F5B6 and F5L-sel-/- CD8+ T cells were activated in vitro with NP68 peptide pulsed 
irradiated APC fro 7 days in the presence of IL-2. Meanwhile, RAG-/- mice were 
infected with 50 ffu influenza strain A virus (H17, H3N2). 2 hours post infection; 
mice were instilled with d7 in vitro activated F5LΔP, F5B6 and F5L-sel-/- CD8+ T 
cells. Viral titers were determined at day 5 post infection by focus forming unit 
assay. (B) representative overlaid histogram shows CD44 expression and 
representative bivariate plots show the level of L-selectin on d7 in vitro activated 
F5LΔP, F5B6 and F5L-sel-/- CD8+ T cells prior to transfer. (C) viral titer in RAG-/- 
mice transferred with F5LΔP, F5B6 and F5L-sel-/- CD8+ T cells. Data presented 
as median and each symbol represents a single mouse. Oneway ANOVA with 
post Tukey’s test.   
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5. The role of L-selectin in CD8+ T cell co-stimulation 
 
5.1. Introduction 
 
During the course of a primary viral infection, naïve CD8+ T cells, which have a 
cognate TCR for the virus, have to differentiate and proliferate to generate 
enough effector cells to specifically fight the virus infection. CD8+ T cells also 
need to undergo these steps and to generate a good pool of memory cells to 
protect the body against secondary challenges by the same virus. A number of 
molecules have been implicated in CD8+ T cell co-stimulation during activation. 
OX40 expressed by CD8+ T cells is an important molecule for co-stimulation with 
regards to expansion and anti-viral cytokine production during vaccinia virus 
infection (Salek-Ardakani et al. 2008).  
 
Co-stimulation is necessary for CD8+ T cells to be able to fight against viral 
infection or to sustain effector functions against antigens including those 
presented by tumors. The presence of Ag, antigen presenting cells and CD28 co-
stimulation is critical for CD8+ T cell effector function not only early during CD8+ T 
cell priming but also during the entire effector phase (Dolfi et al. 2011). Therefore 
variations in L-selectin expression during CD8+ T cell differentiation to effector 
cells could provide different levels of co-stimulation supporting anti-viral cytokine 
secretion and degranulation. L-selectin signaling in neutrophils is critical during 
adhesion and degranulation impacting on neutrophil shape change, adhesion 
capacity and p38 mitogen-activated protein kinase (MAPK) dependent production 
of granules (Smolen et al. 2000).     
L-selectin expression is tightly regulated on the surface of CD8+ T cells by 
ectdomain shedding and gene silencing (Sinclair et al. 2008). Although it has 
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been shown that L-selectin is an obligate lymph node homing receptor for CD8+ T 
cells (Arbornes et al. 1994), L-selectin, engagement with its ligand, either cell-
associated or soluble, in order to perform its homing function, provides a co-
stimulatory signal for CD8+ T cells (Nishijima et al. 2005). L-selectin binding with 
its ligand also provide intracellular signals for actin cytoskeleton rearrangement 
and enhancement of integrin-dependent binding to HEV and extracellular matrix 
components (Wedepohl et al. 2012). Also, L-selectin is shed by a 
metalloproteinase such as ADAM-17 very early during CD8+ T cell activation, 
generating a cytoplasmic tail which could be processed further and contribute to 
CD8+ T cell co-stimulation.  
 
L-selectin could also provide a co-stimulus for CD8+ T cell during their activation, 
differentiation and cytokine secretion, since engaging with a ligand, stimulates a 
series of signaling pathway that support CD8+ T cell co-stimulation.  
              
 
5.2. Hypothesis  
 
CD8+ T cell activation through TCR and L-selectin engagement by its ligand 
leads to a series of downstream signaling, which co-stimulates CD8+ T cells. We 
hypothesized that if CD8+ T cells express non-cleavable L-selectin, the signaling 
will last longer and strengthen co-stimulation. 
 
 
 
 
 
 142 
5.3. Results 
 
5.3.1. Constant L-selectin expression does not enhance priming and 
activation of CD8+ T cells 
 
To determine whether constant expression of a non-cleavable form of L-selectin 
strengthens or accelerates CD8+ T cell priming and activation, naïve CD8+ T cells 
co-expressing F5 TCR specific for NP68 peptide and either wildtype L-selectin 
(F5/B6) or mutant L-selectin (F5/LΔP) were isolated and cultured in the presence 
of NP68 peptide pulsed irradiated antigen presenting cells (APCs).  
 
First, to confirm the L-selectin expression status of the F5/B6 and F5/LΔP CD8+ T 
cells, the kinetics of L-selectin expression were analyzed at 0, 1, 4 and 24 hours 
post activation in vitro. Prior to the cells going into the culture (0h), both F5B6 and 
F5/LΔP CD8+ T cells were fully L-selectin positive. At 1 and 4 hours post 
activation, F5B6 CD8+ T cell down-regulated L-selectin expression. Later at 24 
hours post activation, F5B6 CD8+ T cells started to re-express L-selectin. This 
was consistent with the study by Chao et al., 1997, in which they have shown that 
wildtype L-selectin undergoes ectodomain proteolytic cleavage and re-expression 
24-48 hours after TCR engagement. Whereas, L-selectin on the surface of 
F5/LΔP CD8+ T cells was constantly expressed at 1, 4 and 24 hours post CD8+ T 
cell activation (Fig. 5.1). Second, in order to test the hypothesis, F5/B6 and 
F5/LΔP CD8+ T cells, at 0, 1, 4 and 24 hours post activation in vitro, were 
analyzed for activation and priming. Both F5/B6 and F5/LΔP CD8+ T cells 
upregulated CD69 in a similar manner and with similar kinetics. This finding 
suggests that maintained expression of L-selectin did not affect early CD8+ T cell 
activation (Fig. 5.2).  
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Figure 5.1: Cyclical Expression of L-selectin during CD8+ T cell activation in 
vitro. (A) Naïve CD8+ T cells co-expressing transgenic F5 TCR and either 
wildtype F5/B6 or mutant L-selectin F5/LΔP were isolated and cultured in vitro in 
the presence of NP68 peptide pulsed irradiated APCs, and at 0, 1, 4 and 24 
hours post activation, cells were harvested and stained for CD8 and CD62L. 
Representative histograms show % CD62L+ from F5/B6 (blue) and F5/LΔP (red) 
CD8+ T cells, the % positives were gated based on the CD62L FMO (grey) 
histogram. (B) Bar chat shows mean + SEM (n=3).  
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Figure 5.2: CD8+ T cell activation is not affected by various level of L-
selectin expression (A) Naïve CD8+ T cells co-expressing transgenic F5 TCR 
and either wildtype F5/B6 or mutant L-selectin F5/LΔP were isolated and cultured 
in vitro in the presence of NP68 peptide pulsed irradiated antigen presenting cells 
(APC) at 1, 4 and 24 hours post activation, cells were harvested and stained for 
CD8 and CD69. Representative histograms show %CD69+ of F5/B6 (blue) and 
F5/LΔP (red) CD8+ T cells, the % positives were gated based on the CD69 FMO 
(grey) histogram. (B) Bar chart shows mean + SEM (n=3). 
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5.3.2. L-selectin co-stimulates early proliferation of CD8+ T cells 
 
To determine whether mutant L-selectin enhances co-stimulation, naïve F5/B6 
and F5/LΔP CD8+ T cells were isolated, labeled with the dilution sensitive dye 
(CFSE) to assess their proliferation ability. After incubation with CFSE, CD8+ T 
cells were cultured in the presence of peptide pulsed APCs and IL-2 for 6 days 
(Fig 5.3). Similar to the findings in vivo, CD8+ T cells expressing wildtype L-
selectin initiated the proliferation earlier than mutant L-selectin expressing CD8+ 
T cells. Earlier entry into the proliferation cycle was indicated by the significant 
difference in division indices between F5/B6 and F5/LΔP CD8+ T cells at day 4 
post activation, however, the effect was transient since both F5/B6 and F5/LΔP 
CD8+ T cells had similar division indices at day 5 post activation, illustrating that 
both cell types were proliferating at a similar rate (Fig. 5.3).  
 
Cytokines such as IL-2 are pivotal for the clonal expansion of CD8+ T cells. CD8+ 
T cells receive signals from the IL-2 receptor (IL-2R) upon engagement with IL-2 
in order to induce further cytokine secretion and differentiation into cytotoxic 
effector cells (Cheng et al. 2002). IL-2R is a heterotrimer composed of a 3 unique 
chains, α-chain (CD25), β-chain (CD122) and γ-chain (CD132). IL-2 and IL-15 
share the β-chain, and IL-2, IL-4, IL-7 and IL-15 share the γ-chain (Nelson & 
Willerford 1998). Since IL-2R α-chain is unique among the IL-2R binding to IL-2 
cytokine, we tested the expression of the IL-2R α-chain (CD25) by F5/B6 and 
F5/LΔP CD8+ T cells following activation in vitro. Earlier entry into proliferation 
cycle of wildtype L-selectin expressing CD8+ T cells was accompanied by an 
increased up-regulation of CD25 (IL2Rα), which is an important factor in the 
initiation of proliferation of CD8+ T cells (Fig 5.4).  
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Figure 5.3: Upon TCR activation, wildtype L-selectin expressing CD8+ T 
cells initiate proliferation earlier than mutant L-selectin expressing cell. (A) 
Naïve CD8+ T cells co-expressing transgenic F5 TCR and either wildtype F5/B6 
or mutant L-selectin F5/LΔP were isolated and stained with 2µM CFSE. Later, 
cells were cultured in vitro in the presence of NP68 peptide pulsed irradiated 
APCs and IL-2. Representative histograms show the CFSE dilution of F5/B6 and 
F5/LΔP CD8+ T cells at day 4 and 5 post activation. (B) Bar charts show the 
division index of F5/B6 and F5/LΔP CD8+ T cells at day 4 and 5 during in vitro 
activation, division index analyzed by flow jo software proliferation analysis tab. 
Result is from two independent experiments (n=3-6). * P <0.05, unpaired student 
t-test. 
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Figure 5.4: Wildtype L-selectin supports increased IL-2R up-regulation, 
which enhances entry into proliferation cycle. Naïve CD8+ T cells co-
expressing transgenic F5 TCR and either wildtype F5/B6 or mutant L-selectin 
F5/LΔP were isolated and cultured in vitro in the presence of NP68 peptide 
pulsed irradiated APCs and IL-2. Representative bivariate flow cytometry plots 
show the % IL-2R+ (CD25) by F5/B6 and F5/LΔP CD8+ T cells at day 3 post 
activation in the culture compared to their FMO (CD8 FMO and CD25 FMO). (B) 
Bar chart shows the % IL-2R+ by F5/B6 and F5/LΔP CD8+ T cells during 5 day 
culture. Results are means + SEM (n=3)(One-Way ANOVA with post Tukey’s 
test). 
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5.3.3. Mutant and wildtype L-selectin expressing CD8+ T cells differentiate 
similarly into effector cells.  
 
Classically, L-selectin is used as a marker of activation. L-selectin, in combination 
with other activation antigens such as CD44, is used to distinguish naïve CD8+ T 
cells and their differentiated forms of effector and memory populations. In our 
study, because the role of L-selectin was interested and wildtype L-selectin has 
been compared with a mutant form of L-selectin, in which L-selectin does not 
undergo shedding and gene silencing, an alternative means to identify effector 
and memory subsets of F5/B6 and F5/LΔP CD8+ T cells was required.  
 
To study the impact of mutant L-selectin on the differentiation of CD8+ T cells into 
effector cells, naïve F5/B6 and F5/LΔP CD8+ T cells were purified and cultured in 
the presence of NP68 peptide pulsed irradiated APCs and IL-2 for 7 days. Up-
regulations of late activation antigen CD44 in combination with expression of 
chemokine receptor 7 (CCR7) was used. Both naïve F5/B6 and F5/LΔP CD8+ T 
cells expressed low level of CD44 and high level of CCR7. F5/B6 and F5/LΔP 
CD8+ T cells activation status was measured by the up-regulation of CD44 and 
down-regulation of CCR7. At days 6 and 8 post activation, there were no 
statistical significant difference in the percentage of CD44hiCCR7low effector 
subset between F5/B6 and F5/LΔP CD8+ T cells (Fig. 5.6). This finding indicates 
that the presence of mutant L-selectin on the surface of CD8+ T cells does not 
affect the generation of effector and memory subsets of CD8+ T cells upon TCR 
activation. In order to determine the role of L-selectin in activation and 
differentiation of CD8+ T cells, wildtype L-selectin can be compared with an L-
selectin knock out CD8+ T cells to precisely determine the effect of L-selectin.  
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Figure 5.6: Mutant L-selectin does not impact on effector CD8+ T cell 
differentiation. (A) Naïve CD8+ T cells co-expressing transgenic F5 TCR and 
either wildtype F5/B6 or mutant L-selectin F5/LΔP were isolated and cultured in 
vitro in the presence of NP68 peptide pulsed irradiated APCs and IL-2. 
Representative bivariate flow cytometry plots show naïve F5/B6 and F5/LΔP 
CD8+ T cells at day 0, which express low level of CD44 and high CCR7, and 
differentiated effector CD8+ T cells at day 6 and 7, which express high CD44 and 
low CCR7. (C) Bar char shows % CD44 high CCR7 low for F5/B6 and F5/LΔP 
CD8+ T cells at various time points during in vitro activation. Results are means + 
SEM from two independent experiment (n=4). 
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5.3.4. Mutant L-selectin does not affects CD8+ T cell’s ability to secrete 
various cytokines. 
 
Various factors impact on CD8+ T cells differentiation into effector cytotoxic cells. 
L-selectin can co-stimulate CD8+ T cells and could impact on cytokine secretion 
by activated CD8+ T cells. To determine whether mutant L-selectin impacts CD8+ 
T cell differentiation, naïve F5/B6 and F5/LΔP CD8+ T cells were activated in vitro 
for 8 days. Activated CD8+ T cells at the indicated times (days 6 and 8) were re-
stimulated with cognate peptide for 4 hours in the presence of brefeldin A. Re-
stimulated F5/B6 and F5/LΔP activated CD8+ T cells at day 6 post activation 
secreted similar levels of IL-2, TNF-α and IFN-γ (Fig. 5.7). F5/B6 and F5/LΔP 
activated CD8+ T cells also secreted similar levels of the above cytokines at day 
8 post activation (Fig. 5.8).  
 
Immune cells secrete cytokines in order to communicate with each other, for their 
survival and also to lyse pathogen infected cells. For example, effector CD4+ T 
helper 1 cells secrete interferon-γ to activate macrophages (Sher & Coffman 
1992). Effector CD4+ and CD8+ T cells secrete IL-2 for their expansion and 
survival (Cheng et al. 2002) and effector CD8+ T cells mainly secrete cytokines 
such as tumor necrosis factor-α and IFN-γ to directly eliminate invading 
pathogens. This finding indicates that mutant L-selectin did not affect the 
secretion of various cytotoxic chemical mediators necessary for activated CD8+ T 
cells to function during an immune response. 
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Figure 5.7: L-selectin does not enhance cytokine secretion by early effector 
CD8+ T cells. (A) Naïve CD8+ T cells co-expressing transgenic F5 TCR and 
either wildtype F5/B6 (blue) or mutant L-selectin F5/LΔP (red) were isolated and 
cultured in vitro in the presence of NP68 peptide pulsed irradiated APCs and IL-2. 
At day 6 post activation, cells were re-stimulated with NP68 peptide in the 
presence of Brefeldin A for 4 hours, and then stained for CD8 and intracellularly 
for IL-2, TNF-α and IFN-γ. Representative bivariate flow cytometry plots show a 
similar level of cytokine secretion by F5/B6 and F5/LΔP CD8+ T cells at day 6 
post activation upon re-stimulation. (C) Bar chart show means+ SEM (n=3). 
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Figure 5.8: L-selectin does not enhance cytokine secretion by late effector 
CD8+ T cells. (A) Naïve CD8+ T cells co-expressing transgenic F5 TCR and 
either wildtype F5/B6 (blue) or mutant L-selectin F5/LΔP (red) were isolated and 
cultured in vitro in the presence of NP68 peptide pulsed irradiated APCs and IL-2. 
At day 8 post activation, cells were re-stimulated with NP68 peptide in the 
presence of Brefeldin A for 4 hours, and then stained for CD8 and intracellularly 
for IL-2, TNF-α and IFN-γ. Representative bivariate flow cytometry plots show a 
similar level of cytokine secretion by F5/B6 and F5/LΔP CD8+ T cells at day 8 
post activation upon re-stimulation. (C) Bar char shows mean + SEM (n=3). 
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Although F5/B6 and F5/LΔP CD8+ T cells secreted similar levels of individual 
cytokines at different time points during activation in vitro, the ability of a single 
cell to secrete all three cytokines and adopt a polyfunctional status, which has 
been correlated with protective immunity to invading pathogens (Precopio et al. 
2007), was acquired during prolonged culture. An increase in the percentage of 
F5/B6 cells that secrete all the three cytokines (+++) (IFN-γ, TNF-α and IL-2) was 
seen between days 6 and 8 with concomitant reductions in the proportions of 
cells that secrete two (++)(IFN-γ and TNF-α) or only one cytokine (+)(IFN-γ) (Fig. 
5.9). Also, increase in the proportion of (+++) and reduction of (++) and (+) 
cytokine secreting F5/LΔP CD8+ T cells were similar to F5/B6 cells. Time is a 
critical requirement for the cellular arm of the adaptive immune system to develop 
and generate a strength response against invading pathogens. 
 
 
5.3.5. L-selectin does not impact the degranulation of CD8+ T cells upon 
activation 
 
Granules are key characteristics of cytotoxic T cell. To examine whether mutant 
L-selectin has any effect on the level of degranulation, F5/B6 and F5/LΔP CD8+ T 
cells were cultured for either 6 or 8 days as previously described. They were then 
analyzed for cell surface expression of LAMP-1 (CD107a), which is a lysosomal 
associated glycoprotein within the cytotoxic granule membrane and can be used 
as an indicator of the ability of CD8+ T cells to degranulate upon activation. F5/B6 
and F5/LΔP CD8+ T cells de-granulated at similar levels upon re-stimulation on 
day 6 and day 8 post culture (Fig. 5.10).   
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Figure 5.9: Mutant L-selectin does not affect the development of cytotoxic 
CD8+ T cells. (A) Naïve CD8+ T cells co-expressing transgenic F5 TCR and 
either wildtype F5/B6 or mutant L-selectin F5/LΔP were isolated and cultured in 
vitro in the presence of NP68 peptide pulsed irradiated APCs and IL-2. At days 6 
and 8 post activation, cells were re-stimulated with NP68 peptide in the presence 
of Brefeldin A for 4 hours, and then stained for CD8 and intracellularly for IL-2, 
TNF-α and IFN-γ. Pie charts show the % triple positive (+++; IFN-γ, TNF-α, IL-2), 
double positive (++; IFN-γ, TNF-α) from F5/B6 and F5/LΔP CD8+ T cells at days 
6 and 8 post activation in vitro and re-stimulation. (B) Bar charts show the 
difference between day 6 and day 8 activated and re-stimulated CD8+ T cells 
from either F5/B6 or F5/LΔP CD8+ T cells in the % of single, double and triple 
positive. Results are mean + SEM (n=3).  
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Figure 5.10: Mutant L-selectin does not affect effector CD8+ T cell 
degranulation. (A) Naïve CD8+ T cells co-expressing transgenic F5 TCR and 
either wildtype F5/B6 or mutant L-selectin F5/LΔP were isolated and cultured in 
vitro in the presence of NP68 peptide pulsed irradiated APCs and IL-2. At days 6 
and 8 post activation, cells were re-stimulated with NP68 peptide and added with 
CD107a staining antibody. After 1 hour, cells were incubated with monensin and 
further re-stimulated for 4 hours. Cells then stained for CD8 as well. 
Representative bivariate flow cytometry plots show intracellular staining of F5/B6 
and F5/LΔP CD8+ T cells for CD107a at days 6 and 8 post activation in vitro and 
re-stimulation. (B) Bar chart show means + SEM (n=3).  
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6.  Discussion  
 
6.1. The role of L-selectin in homing of activated CD8+ T cells to virus 
infected organs. 
 
The human body can naturally defend itself against pathogens through its potent 
immune system. The functional diversity of the immune system originates from 
the specificity of the adaptive arm of the system. Upon entering the body, the 
virus, airborne, consumed or via skin, will be dealt with through the specialized 
antigen presenting cells (APCs) and particle of the virus will be presented on the 
surface in the context of either MHC class I or II molecules. Meanwhile, naïve 
CD8+ T cell’s continuous circulation through bloodstream and lymphatic in and 
out of secondary lymphoid tissues allow encounter between the APCs and the T 
cell in order for the T cell with cognate T cell receptor to activate and differentiate 
into cytotoxic CD8+ T cells (CTL)(Goulding et al. 2014). At this stage, the CTL is 
required to migrate to infected organs in order to provide protective immunity via 
a direct contact with the infected cells. 
 
The process of CD8+ T cell migration into lymphoid organs for immune T cell 
surveillance and priming, in the presence of an antigen, and further migration into 
sites of infection involve a number of adhesion molecules, chemokine receptors 
and their ligands (Ager & May 2015).  
 
Using recombinant vaccinia virus (vaccNP) expressing NP68 peptide (Townsend 
et al. 1986), which is recognized by F5 TCR, and influenza A virus allowed us to 
study the role of adhesion molecules L-selectin in the migration of virus specific 
CD8+ T cells to sites of infection. It has been shown that parental Vaccinia virus 
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Western Reserve strain infects a range of visceral organs when the virus is 
inoculated intraperitoneally (Zhao et al. 2011), therefore, we determined the site 
of vaccNP infection first. Upon vaccNP infection i.p., the virus replicated only in 
the ovaries whereas, the virus in the heart, liver and lungs were below the level of 
detection when determined by vaccinia virus plaque assay. The difference 
between the parental and the recombinant form of the virus may result from the 
recombination process, which has been shown to reduce the pathogenicity and 
infectivity (Williamson et al. 1990). The preferential replication and infectivity of 
vaccNP in the ovaries of mice were consistent with a previous finding, which 
reported that vaccinia virus replicates in ovaries following intraperitoneal 
administration (Zhao et al. 2011). 
 
The site of CD8+ T cell priming during vaccNP infection was identified. As it has 
been shown previously in a research study, in which mediastinal LN serve as a 
primary site of CD8+ T cells priming during lymphcytic choriomeningitis virus 
(LCMV) infection when the virus inoculated i.p.  (Olson et al. 2012), the main site 
of antigen presentation to CD8+ T cells during vaccNP infection was mostly 
restricted to Med LN. Med LN drains the site of influenza virus infection and 
influenza specific CD8+ T cell activation and priming occurs in the Med LN (Flynn 
et al. 1998) allowed us to study the kinetics L-selectin expression and its 
contribution in virus specific CD8+ T cell homing during two different virus 
infection with two distinct sites of replication and a site of priming to be 
investigated.  
 
It is clear that lymphocyte migration involves a complex and well-orchestrated 
process. Manipulation of these pathways could lead to enhancement of T cell 
infiltration into sites of virus infection in which the virus clearance is CD8+ T cell 
dependent. Various adhesion molecules and chemokine receptors have been 
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reported to play a role in homing of activated CD8+ T cells into peripheral non-
lymphoid tissues. The contribution of these molecules depends on the type and 
site of infection. For example, P and E selectins have been shown to play a role 
in homing of activated CD8+ T cells into the skin during hypersensitivity reaction 
(Hirata et al. 2002). Whereas, P and E selectin double knockout mice showed 
equal viral clearance in internal organs such as liver, lung and spleen during 
LCMV infection, which suggests that P and E selectins are not required for 
migration of activated CD8+ T cells to sites of virus infection (Bartholdy et al. 
2000). Chemokines such as CXCL12 secreted by newly infiltrated neutrophils 
play a prominent role in the migration of influenza specific CD8+ T cells into the 
trachea (Lim et al. 2015).          
 
The current dogma in immunology suggests that CD8+ T cells only utilize L-
selectin molecules on their surface to enter the peripheral lymph nodes for 
priming. L-selectin will be shed on the surface soon after CD8+ T cell activation 
via ectodomain proteolytic shedding and later, L-selectin is not thought to require 
for homing into sites of infection such as viruses, since virus specific CD8+ T 
cells, harvested from sites of infection late during the primary course of infection, 
expressed low level of L-selectin. 
 
In this study, we were able to map the cyclical expression of L-selectin during 
virus specific CD8+ T cell activation and differentiation in vivo during infection with 
two evolutionary distinct viruses, vaccinia and influenza virus which infect visceral 
and mucosal organs, respectively. L-selectin reversibly cycles between high and 
low expression during the course of a primary virus infection. L-selectin cyclical 
expression occurred when the virus specific CD8+ T cells are in different locations 
of the body. L-selectin expression was reduced when the CD8+ T cells were 
resident in the draining lymph node for priming during vaccNP and influenza A 
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virus infection. Re-expression of L-selectin occurred when the cells were still in 
the LN, virus specific CD8+ T cells left the LN entered peripheral blood circulation 
started to lose their L-selectin again. The first population of virus specific CD8+ T 
cells enriched the sites of virus infection, expressed a significant amount of L-
selectin on their surface and later, L-selectin was fully downregulated. The timing 
of cyclical expression of L-selectin during virus specific CD8+ T cell activation and 
differentiation in vivo in this study were almost comparable with what have been 
reported in vitro which mirrors the L-selectin early ectodomain shedding, re-
expression and later gene silencing (Chao et al. 1997).  
 
Since virus specific CD8+ T cells expressed a significant amount of L-selectin 
when they enter the sites of virus infection, mechanisms to maintain L-selectin on 
the surface of virus specific CD8+ T cells might play a significant role in the 
enhancement of T cell migration to sites of infection. A number of interventions 
are possible to maintain L-selectin on the surface, such as blocking A 
metalloproteinase and Disintigrins (ADAMs) responsible for L-selectin 
ectodomain shedding and proteolysis.  
 
Other mechanisms that maintain L-selectin expression on the surface is through 
manipulating L-selectin gene silencing through mTOR and PI3K inhibiting the 
action of KLF2 responsible for transcription of L-selectin gene (Sinclair et al. 
2008) intervention or using a mutant L-selectin transgene in which the 
ectodomain cleavage site was replaced with the one from P-selectin which is no 
longer vulnerable to shedding and expression controlled by human CD2 (hcd2) 
promoter which resists gene silencing (Galkina et al. 2007; Richards et al. 2008).  
 
When the hypothesis was tested maintained expression of L-selectin (LΔP) on 
the surface of virus specific CD8+ T cells showed enhanced homing ability into 
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vaccNP-infected ovaries at days 5 (5-fold) and 8 (10-fold) post infection when 
compared to its wildtype counterpart. The enhancement in homing was not due to 
retention of the virus specific CD8+ T cells expressing LΔP L-selectin since their 
numbers contracted at day 12 post infection. The role of re-expressed wildtype L-
selectin in homing of virus specific CD8+ T cells into site of infection was 
confirmed by comparing wildtype L-selectin expressing CD8+ T cells with L-
selectin knockout (L-sel-/-) cells. During a 5-day primary course of vaccinia virus 
infection, L-sel-/- cells showed impaired homing into the site of vaccNP infection 
(ovary) at day 5 post infection but not into spleen, since L-selectin is not a 
dominant homing molecule for leukocyte homing into the spleen (Arbornes et al. 
1994).  
 
Furthermore, when LΔP mice were challenged with influenza A virus, the number 
of endogenously generated virus specific CD8+ T cells were 2-fold higher than 
wildtype mice in the lungs 8 days post infection but not in the spleen. This finding 
was also consistent with the finding reported for LΔP mice during vaccNP 
infection that there was an increased number of endogenously generated vaccNP 
specific CD8+ T cells in the ovaries at day 8 post infection (Richards et al. 2008). 
 
Cell surface molecules can impact on the activation and differentiation of CD8+ T 
cells upon activation through its T cell receptor. For example, the signalling 
receptor, Notch, play a fundamental role in T cell differentiation (Backer et al. 
2014). Therefore, we tested whether constant expression of L-selectin on the 
surface of mutant L-selectin expressing CD8+ T cells affects the way these cells 
activate and differentiate into effector cells and, therefore, impact on the bulk of 
the cells generated. Having an increased number of cells generated during 
activation and differentiation stage could account for an increased end number of 
CD8+ T cells entering the sites of infection.  
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The early activation antigen, CD69, has been shown to be upregulated upon 
CD8+ T cell priming by antigen presenting cells (Alari-pahissa et al. 2012). CD69 
play an important role in holding the CD8+ T cells in the lymph node in order to 
receive the necessary signals and undergo activation and proliferation (Schenkel 
2014). The kinetics of CD8+ T cell activation expressing mutant, wildtype or 
deficient in L-selectin during an infection with vaccNP or influenza virus infection 
were tested by the kinetics of CD69 up-regulation. F5/LΔP CD8+ T cells up-
regulated CD69 at day 1 post vaccNP infection in the mediastinal LN, which 
drains the site of virus entry, in a similar manner as the wildtype L-selectin 
expressing cells F5/B6. Also, L-selectin deficient CD8+ T cell’s, F5L-sel-/-, CD69 
up-regulation at day 2 post infection with influenza virus were identical with the 
wildtype L-selectin cells. This finding is the first indicator that the increased 
number of mutant L-selectin expressing cells at the site of virus infection is due to 
the enhanced homing ability of the cells rather than the initial preferential 
activation in the draining lymph node.  
 
Next, the differentiation status of the cells was investigated. Cell surface receptor 
such as CD44, which is a well-characterized differentiation marker, involve in the 
migration of activated CD8+ T cells into peripheral tissues. CD44 expression 
increased with the stage of the CD8+ T cell differentiation during a primary virus 
infection or CD8+ T cell activation in vitro the cell activate through its T cell 
receptor (Wherry et al. 2007). The CD44 expression and up-regulation of F5/LΔP 
CD8+ T cells during 5, 8 and 12 days post infection with vaccNP were identical 
with F5/B6 CD8+ T cells in the ovary, ovdLN and spleen. CD44 up-regulation of 
L-selectin deficient CD8+ T cells, F5L-sel-/-, was also identical with F5B6 CD8+ T 
cells at day 5 post infection with vaccNP. Furthermore, endogenously generated 
virus specific CD8+ T cells from the mutant L-selectin mice, LΔP, was up-
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regulated the late activation antigen, CD44, in a similar manner with the cells 
from the L-selectin wildtype, B6, at day 8 post infection influenza virus in the 
lungs and spleen. These findings collectively indicate that L-selectin on the 
surface of CD8+ T cells does not affect the conjugate formation with the antigen 
presenting cells initially for the T cell activation and also the T cell differentiation 
during a primary course of the virus infection.  
 
The immune system is a diverse system. CD8+ T cells have T cell receptor with 
specificity for a foreign antigen from pathogens. Since naïve CD8+ T cells with 
specificity for a peptide are rare, massive proliferation capacity of the CD8+ T 
cells with the cytokine storm help from other cells is critical in purging the acute 
viral infection, limiting persistence infection and also, in the production of life-long 
protective immunity (Cox et al. 2013). Innate immune cells such as plasmacytoid 
dendritic cells (pDCs) play a role in driving CD8+ T cells proliferation during 
primary virus infection by secreting proinflammatory chemokines (Gilliet et al. 
2003). The molecule, such as 2B4 (CD244) is also important for CD8+ T cells 
proliferation (Kambayashi et al. 2001). Therefore, we tested the contribution of L-
selectin in enhancing the CD8+ T cell proliferation during primary virus infection 
with vaccNP. Interestingly, wildtype L-selectin expressing CD8+ T cells, in which 
L-selectin expression is controlled by separate mechanisms of shedding and 
gene silencing, started to proliferate earlier than the mutant L-selectin expressing 
cells in the mediastinal LN at day 2 post vaccNP infection. Constant expression 
of L-selectin does not provide enhanced proliferation. Therefore, the increased 
number of virus specific CD8+ T cells in the site of infection was not due to the 
enhanced proliferation but rather due to homing.  
 
L-selectin engaging with its ligand or antibody to initiate the signalling cascade 
has been shown to play a role in oxygen synthesis (Brenner et al. 1996). L-
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selectin shedding, re-expression and later gene silencing could play an important 
role in the CD8+ T cell proliferation and it might be manipulated to enhance the 
generation of effector CD8+ T cells to generate enough number of cells in a short 
period of time to specifically eliminate a virus from the body. 
 
Virus specific CD8+ T cells leaving the draining lymph nodes, entering the blood 
stream and infiltrating the site of infection expressed a significant amount of L-
selectin. We exploited a different method to determine whether L-selectin is 
involved in homing of virus specific CD8+ T cells into virus infected organs. The 
antibody blockade system to prevent the receptor for its known function allows 
demonstrating the involvement of L-selectin in migration pattern of CD8+ T cells. 
MEL-14, an antibody that was identified to bind to the NH2-terminal 53 amino 
acids of L-selectin’s lectin domain in the presence of its epidermal factor domain, 
binds to L-selectin and prevents it from all its known function (Bowen et al. 1990). 
MEL-14 has been shown to block homing of lymphocytes into peripheral lymph 
nodes (Gallatin et al. 1987), together with the L-selectin knockout finding, allowed 
the characterization of L-selectin as peripheral lymph node homing receptor. 
 
Since virus specific CD8+ T cells expressing either mutant or wildtype L-selectin 
were activated in the mediastinal LN at day 1 and 2 post infection with vaccNP 
and influenza virus, respectively, MEL-14 administration was started at 52 hours 
hours post virus administration in order to allow the cells to be primed in the 
draining lymph node, enter the bloodstream and start to infiltrate the site of virus 
infection. MEL-14 treatment significantly blocked homing of the donor virus 
specific CD8+ T cells in the ovaries and ovdLN compared to the IgG2a isotype 
control treated mice when the organs harvested at day 5 post infection. MEL-14 
treatment did not affect the number of donor cells that homed to the spleen 
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because lymphocyte migration into spleen is not L-selectin dependent (Arbornes 
et al. 1994).  
 
Furthermore, when wildtype B6 mice were infected with influenza A virus and 
then treated with MEL-14 daily started at 52 hours post infection. Because the 
endogenously generated virus specific CD8+ T cells just started to infiltrate the 
site of infection, at day 4 post infection, there was only a slight difference 
between the number of virus specific CD8+ T cells that infiltrated into the infected 
lungs in the MEL-14 treated mice and the IgG2a isotype control group. Whereas, 
interestingly, there was a significant blockade by MEL-14 treatment compared 
with the control group at day 8 post infection, which is a time, where the adaptive 
immune system CD8+ T cells play a pivotal role in the influenza virus elimination.  
 
Similar to the previous model, MEL-14 did not have any effect on the numbers of 
endogenously generated virus specific CD8+ T cells homing into the spleen 
neither at day 4 or day 8 post infection with influenza virus infection. Also, the 
number of virus specific CD8+ T cells was not affected by the MEL-14 treatment 
in the mediastinal LN. This finding was consistent with the previous study by 
(Caucheteux et al. 2013), showing that lung CD4+ T cells use other mechanisms 
to enter the mediastinal LN rather than L-selectin pathway. Similar to mesenteric 
lymph node, in which CD8+ T cells utilize α4β7 binding to MAdCAM-1 in order to 
enter (Shyjan et al. 1996), suggest that homing of CD8+ T cells to these particular 
mucosal lymph nodes are not L-selectin dependent.  
 
Further to test the hypothesis that L-selectin is directly involved in homing of virus 
specific CD8+ T cells into the site of virus infection. A short term homing assay to 
investigate the role of L-selectin in the migration of virus specific CD8+ T cells 
directly from the blood vessel into the site of infection was used.  
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Short term homing assays have been used widely to investigate the role of 
various adhesion molecules. For example, Using cell membrane dyes, CFSE and 
CMTMR, to track donor cells in a short term homing assay, naive mutant L-
selectin (LΔP) expressing CD8+ T cells can home equally as the wildtype L-
selectin expressing cells into peripheral lymph nodes, in which the homing is L-
selectin dependent (Galkina et al. 2003). The role of L-selectin in homing of virus 
specific CD8+ T cells into sites of infection was investigated using a similar 
strategy. Instead of using fluorescent dyes, the congenic CD90.1/CD90.2 
markers were used to identify the donor cells within the host and exploited the 
non-shedding mutant L-selectin expression to differentiate them from the L-
selectin knockout cells.   
 
L-selectin sufficient and deficient CD8+ T cells were either activated in vitro, using 
cognate peptide pulsed irradiated APCs for 7 days, or activated in vivo using 
recombinant virus expressing cognate peptide and harvested from spleen 5 days 
post infection. After that, both activated mutant L-selectin and L-selectin knockout 
CD8+ T cells were mixed 1:1 and intravenously transferred into vaccNP infected 
mice (day 3 post infection) and then very shortly, after 3 hours, site of vaccNP 
infection (ovary), a range of L-selectin dependent and independent lymphoid 
organs such as ovdLN, Axillary, inguinal lymph nodes and spleen were harvested 
for homed donor CD8+ T cells analysis. Compared to the circulating L-selectin 
sufficient and deficient CD8+ T cells in the peripheral blood at the time of harvest 
(50% F5LΔP/ 50% F5L-sel-/-), there was a significant enrichment of L-selectin 
sufficient CD8+ T cells in the ovaries of vaccNP infected mice compared with the 
knockout cells when the invitro activated cells were used (3-fold; 70% F5LΔP/ 
30% F5L-sel-/-). The L-selectin dependent sites such as inguinal and axillary 
lymph nodes showed a full L-selectin dependency (100% F5LΔP) and L-selectin 
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independent sites such as spleen and mediastinal lymph node showed L-selectin 
independent migration (50% F5LΔP/ 50% F5L-sel-/-).   
 
Interestingly, when the in vivo activated CD8+ T cells were used, there was a 
much stronger L-selectin dependency in homing of the cells into the site of 
infection (6-fold; 86% F5LΔP/ 14% F5L-sel-/-). This finding reveals that it is 
important for lymphocyte migration assays that the cells are activated in vivo 
rather than in vitro. All the necessary signals may not exist in vitro and CD8+ T 
cells activation in vitro could drive through a different differentiation pathway.   
 
The diversity and the strength of the immune system originates from the adaptive 
arm of the system. T cells, in particular, CD8+ T cells, play a pivotal role in the 
elimination of viruses from the body (Thimme et al. 2003). Although virus specific 
CD8+ T cells, upon direct contact with the infected cells, use specific mechanisms 
to eliminate the virus from the infected tissues such as IFNγ secretion (Goulding 
et al. 2014) and granzyme B (Zajac et al. 2003), the virus specific CD8+ T cells 
must migrate to the site of infection first.  
 
Cells of the immune system orchestrate each other to provide an efficient 
protection during a virus infection. It has been shown recently that neutrophils, 
cells from the innate immune system that participate in early events during a virus 
infection, leave trails containing chemokine CXCL12, which guide the virus 
specific CD8+ T cells to the trachea during influenza virus infection to participate 
in the virus elimination (Lim et al. 2015). Other cells such as CD4+ T cells, 
through the secretion of cytokines such as IFN-γ, help the virus specific CD8+ T 
cells to mobilize to the site of infection in order to provide antiviral protection 
(Nakanishi et al. 2010).  
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6.2. The impact of various level of L-selectin on the surface of CD8+ T cells 
in providing anti-viral immunity. 
 
It is clear that lymphocyte homeostasis, during normal circumstances, and 
lymphocyte migrations to the site of infection, during a virus infection, are 
complex processes. Adhesion molecules and chemokine receptors play an 
important role in the lymphocyte migration process. Since the virus specific CD8+ 
T cells enriched at the site of virus infection were expressing L-selectin, therefore, 
the role of various level of L-selectin on the surface of virus specific CD8+ T cells 
were tested in providing antiviral immunity against two evolutionary distinct 
viruses, vaccinia and influenza, which infect mucosal and visceral organs, 
respectively.  
 
It has been shown that inserting genes from different viruses into other, in order 
to express the peptide of interest, can affect the pathogenicity of the virus. First, 
we determined the kinetics of vaccNP clearance in a normal C57BL/6 mouse. 
Based on our finding that vaccNP mainly replicates in and infects ovaries, B6 
mice infected with vaccNP i.p. were euthanized at day 5, 8 and 12 post infection 
and ovaries were harvested for vaccNP titer by plaque assay. At the time point 
analyzed, the B6 immune system appear to significantly clear the virus from the 
infected ovaries as there was 2 log difference between day 5 and 8 post infection 
in the virus titer. Although the virus was not completely cleared, there were 
further signs of viral clearance at day 12 post infection. This finding was 
comparable to the previous finding with the parental Western Reserve vaccinia 
virus infection in ovaries in which the titer fell between day 7 and 15 post infection 
(Zhao et al. 2011).  
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The various immune system compartments in clearing vaccinia virus have been 
investigated in details. Based on the site of virus entry and the strain of the virus, 
antibody and CD4+ T cell mediated viral clearance versus CD8+ T cells can vary. 
When the Western Reserve vaccinia virus was inoculated intraperitoneally, CD4+ 
T and antibody mediated viral clearance dominate the CD8+ T cell antiviral 
immunity (Xu et al. 2004). Whereas, intranasal inoculation of the virus leads to a 
robust CD8+ T cell response that clears the virus through IFN-γ secretion by the 
CTLs (Goulding et al. 2014).  
 
In order to investigate to what extent CD8+ T cells contribute to the clearance of 
vaccinia virus infection, mice were either acutely depleted of circulating 
lymphocytes, by using a sublethal dose of irradiation, or chronically depleted, by 
using mice that are knockout for the recombination activating gene (RAG). Then, 
adoptive transfer of purified CD8+ T cells only into these lymphocyte-depleted 
mice was performed to investigate the role of CD8+ T cells in controlling virus 
infection and, whether L-selectin on the surface of CD8+ T cells could enhance 
virus clearance.  
 
Mice acutely depleted of circulating lymphocytes by sublethal irradiation were no 
longer susceptible to vaccNP infection. There was no detectable virus in ovaries 
at day 5 post infection. The irradiation could have affected the ovarian tissues 
and made them no longer susceptible to virus entry into the ovarian cells and 
subsequent infection. Therefore, RAG-/- mice were used for further investigation 
of the role of CD8+ T cells and impact of L-selectin in protection against the virus.  
 
First, the ability of the complete immune system in B6 mice was compared with 
that in RAG-/- mice that lack T and B lymphocytes. When both groups were 
infected with the vaccNP i.p., there was no difference between B6 and RAG-/- 
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mice in the viral titer at day 5 post infection, which suggests that the lymphocyte 
dependent viral clearance was not yet involved. Whereas by day 8 p.i., there was 
a significant difference in the viral titers between the B6 and RAG-/- mice in which 
the B6 mice started to clear virus by 2 logs compared to the RAG-/- mice that had 
a similar virus titer as day 5 p.i.. This finding suggests that there is a window for 
lymphocyte dependent antiviral activity that can be used to study the impact of L-
selectin in homing of virus specific CD8+ T cells and therefore on the antiviral 
protection. 
 
The involvement of CD8+ T cells was then investigated by adoptive transfer of 
purified naïve CD8+ T cells expressing either wildtype or mutant L-selectin into 
RAG-/- recipient, and a group was left with no T cell transfer and used as a 
control. Then mice were challenged with vaccNP and 8 days later, ovaries were 
harvested for viral titer by plaque assay. We have shown that upon vaccNP 
inoculation intraperitoneally, wildtype L-selectin expressing CD8+ T cells did not 
provide protection against the vaccNP infection in the ovaries when compared 
with the control no T cell transfer group. This result is consistent with the previous 
finding that vaccinia virus clearance in the ovaries depends on CD4+ T cells and 
antibody protection from B cells (Xu et al. 2004). Whereas, mutant L-selectin 
expressing CD8+ T cells provided a significantly enhanced level of protection 
against vaccNP as the F5LΔP CD8+ T cell transfer group showed lower viral titers 
in the ovaries when compared wildtype L-selectin CD8+ T cell transfer and control 
groups.  
 
Although we have shown that wildtype L-selectin expressing CD8+ T cells homed 
to the site of vaccNP infection, their inability to provide protection against vaccNP 
infection might be due to the limited numbers of cells that are homed to the site of 
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virus infection which in turn due to the limited amount of L-selectin expressed on 
their surface by the time that is started to enrich at the site of infection.   
 
Since mutant L-selectin expressing CD8+ T cells provided protection against 
vaccNP infection in the ovaries of RAG-/- mice, L-selectin dependent homing of 
these cells into the site of the vaccNP infection was confirmed using L-selectin 
specific antibody blockade strategy. RAG-/- mice were adoptively transferred with 
mutant L-selectin expressing CD8+ T cells and 24 hours later, after the T cells 
equilibrated in the body environment, vaccNP inoculated i.p. then, mice were 
injected with MEL-14 antibodies at 52 hours p.i.. At day 5 p.i., ovaries, ovdLN and 
spleen were harvested for homed CD8+ T cells enumeration by flow cytometry. 
Interestingly, similar to the wildtype B6 host, MEL-14 blocked homing of the virus 
specific CD8+ T cells expressing mutant L-selectin into the ovaries of RAG-/- mice 
as well as into the ovdLN. Whereas the number of the cells was identical in the 
spleen between the MEL-14 treated mice and the IgG2a isotype control group. 
Using MEL-14 blockade strategy, together with the short-term homing 
experiments further revealed that homing of CD8+ T cells into the ovdLN are L-
selectin dependent. Although ovdLN is not a peripheral or cutaneous LN, it is 
interesting that lymph node which is located in the peritoneal cavity and 
lymohocyte migration to this particular lymph node is L-selectin dependent. This 
is further revealing the diversity of L-selectin function in enabling CD8+ T cells to 
specifically migrate to certain parts of the body at various times such as normal 
homeostasis or during a primary or secondary viral infection.  
 
Various molecules have been reported to play an important role in driving the 
CD8+ T cell expansion during vaccinia virus infection. TNF receptor family 
member OX40 plays a pivotal role in driving the primary CD8+ T cell response 
and cytokine production (Salek-Ardakani et al. 2008). Therefore, the impact of L-
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selectin on the CD8+ T cell proliferation during primary vaccNP infection was 
tested to exclude the possibility that the enhanced antiviral protection by the 
mutant L-selectin expressing CD8+ T cells was due to enhanced proliferation 
rather than their enhanced ability to home to the site of infection. The experiment 
was conducted by adoptive transfer of purified CD8+ T cells expressing either 
wildtype or mutant L-selectin into RAG-/- recipient mice. Mice were inoculated with 
vaccNP and then they were treated with IL-2 to drive CD8+ T cell expansion in 
the absence of CD4+ helper T cells. At day 4 p.i., 24 hours prior to harvest, mice 
were injected with EdU (5-Ethynyl 2-deoxyuridine), which is incorporated into the 
DNA of proliferating cells, to investigate the proliferative state of the cells in vivo. 
In support of the hypothesis, both wildtype and mutant L-selectin expressing 
CD8+ T cells harvested from the ovaries of vaccNP infected mice incorporated a 
similar level of EdU into their DNA, which suggests that both cell types expanded 
equally in response to the vaccNP infection.   
 
Upon vaccinia virus infection, CD8+ T cell shows site dependent heterogeneity of 
functional responses. It has been shown that OT-I T cells, which recognize the 
class I epitope, can expand robustly against i.p. infection with recombinant 
vaccinia virus expressing OVA-peptide. OT-I T cells start to secrete IFN-γ as they 
proliferate and differentiate in the lymph node and spleen. They secrete TNF-α 
upon recognition of the virus (Xiao et al. 2007). Even if CD8+ T cells do not 
participate in direct protection against the virus (Xu et al. 2004), this cytokine 
storm is necessary to initiate various responses against the virus. Therefore, it 
was necessary to understand that whether a various level of L-selectin on the 
surface of CD8+ T cells have an impact on the secretion of various cytokines and 
chemical mediators during the primary course of vaccNP infection. RAG-/- mice 
were adoptively transferred with CD8+ T cells expressing either wildtype or 
mutant L-selectin and then challenged with vaccNP, both cell types responded to 
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the virus in a similar way with regards to cytokine secretion such as IL-2, TNF-α, 
IFN-γ and granzyme B at day 5 p.i. the ovaries. Also, adoptively transferred virus 
specific CD8+ T cells harvested from the spleen are secreted similar level of IL-2, 
TNF-α, IFN-γ and granzyme B as in the ovaries.  
 
More recently, research has shown that CD8+ T cells play a dominant role in the 
clearance of highly virulent vaccinia virus infection when the virus is administered 
intranasally (Goulding et al. 2014). Other studies also concluded that there was a 
robust intrapulmonary CD8+ T cell response upon an intranasal infection with 
vaccinia virus (Mathew et al. 2008). Therefore, the role of CD8+ T cells in clearing 
vaccNP was tested in the context of intranasal infection. B6 mice were 
challenged with vaccNP i.n., lungs were harvested at day 8 post infection for viral 
titer by plaque assay. However, there was no detectable vaccNP in the lung, 
even high inoculating dose of 106 pfu, whereas the parental wildtype Western 
Reserve vaccinia virus is reported to cause severe lung infection using 104 pfu 
(Goulding et al. 2014). Also, in order to confirm the inability of vaccNP to produce 
a lung pathology when administered i.n., body weights were measured during the 
course of the primary vaccNP infection. There were some signs of initial distress 
and infection with the high doses of 105 and 106 pfu during the first 2 days, but 
the mice gained weight again from day 3 onward. Using 104 pfu, there was no 
weight loss during 8 days following intranasal administration of the virus.  
 
Since vaccNP did not establish a lung infection, which is consistent with the 
finding that genetic manipulation of viruses leads to changes in pathogenicity 
(Williamson et al. 1990), a more virulent lung virus was used to study the impact 
of L-selectin on homing of these virus specific CD8+ T cells into the site of 
infection for protective antiviral immunity.   
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The more virulent viruses used were influenza A viruses including serotypes 
(H1N1, PR8) and (H3N2, H17). It has been reported that CD8+ T cells play a 
pivotal role in clearing influenza virus-induced pneumonia (W Allan et al. 
1990)(Graham & Braciale 1997). Therefore, the endogenous immune response 
against influenza A virus was studied in the mutant, wildtype and L-selectin 
knockout mice. Influenza A virus (PR8, H1N1) was administered i.n. into mutant, 
wildtype and L-selectin knockout mice, body weights were measured daily and 
lungs were harvested at day 8 p.i. for viral titer by focus forming unit assay. 
Interestingly, there was a hierarchy in virus clearance based on the level of L-
selectin expression. The mutant L-selectin mice, in which the L-selectin is 
selectively expressed on T lymphocytes and expression is maintained following T 
cell activation (Galkina et al. 2003)(Richards et al. 2008), provided highest level 
of protection with the lower level of virus in the lungs compared with the wildtype 
and L-selectin knockout mice. Wildtype L-selectin expressing mice showed a 
moderate level of protection compared with the other groups, whereas L-selectin 
knockout mice provided the least level of protection. The virulence of the PR8 
strain and the impact of level of L-selectin were further confirmed by the 
differences in the body weight loss which accompanied the primary infection. The 
mutant L-selectin mouse had the lowest level of weight loss across the 8 days of 
primary influenza A virus PR8 infection compared with the wildtype and L-selectin 
knockout mice.    
 
Mutant and wildtype L-selectin mice and the L-selectin knockout mice were also 
challenged with a less virulent strain of the influenza A virus (H17, H3N2) and 
viral titers were measured in the lungs at day 8 p.i.. Wildtype L-selectin 
expressing mice showed enhanced virus clearance when compared with L-
selectin knockout mice which clearly shows a role for L-selectin in controlling the 
virus replication. However, mutant L-selectin expressing mice did not show  
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enhanced protection compared with wildtype mice. One possibility is that the 
necessity of L-selectin on the surface of CD8+ T cells and its impact on virus 
clearance may rely on the virulence of the virus. When the mouse has its 
complete immune system, other cells can participate in clearance of the virus and 
reduce the dependency on CD8+ T cells. It has been shown that CD8+ T cells 
play an important role in influenza virus infection, but the involvement of other 
immune cells such as CD4+ T cells and B cells in virus clearance depends on the 
virulence of the virus (Mozdzanowska et al. 2000).  
 
To further understand the role of L-selectin on the surface of CD8+ T cells in 
clearing influenza virus infection, immunodeficient RAG-/- mice, which chronically 
lack T and B cells, were adoptively replete with purified naïve CD8+ T cells co-
expressing F5 transgenic TCR and either mutant or wildtype L-selectin or 
knockout for L-selectin. Then mice were challenged with influenza A virus (H17, 
H3N2) and virus clearance was measured by focus forming unit assay 7 days 
p.i.. Similar to the highly virulent influenza A virus, PR8, RAG-/- mice that were 
complemented with mutant L-selectin expressing CD8+ T cells provided 
enhanced H17 influenza virus clearance when compared with the RAG-/- mice 
transferred with wildtype L-selectin expressing or L-selectin knockout CD8+ T 
cells. L-selectin knockout CD8+ T cell’s complemented RAG-/- mice showed no 
signs of viral clearance when compared with the no T cell transfer control group.  
 
Although it was clear from the vaccinia model that L-selectin did not impact on 
the activation and differentiation of the virus specific CD8+ T cells during the 
primary vaccNP infection, CD8+ T cells co-expressing F5 TCR and various levels 
of L-selectin were activated in vitro for 7 days and instilled directly into the lungs 
of influenza A virus infected RAG-/- mice. T cells delivered intratracheally were 
able to clear virus when compared with no T cell transferred group and the level 
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of protection was not dependent on L-selectin expression. Therefore, the inability 
of in vivo primed L-selectin knockout T cells to clear virus was not due to their 
functional inability rather due to their inability to home to the site of infection.  
 
 
6.3. L-selectin impacts on CD8+ T cell co-stimulation  
 
L-selectin expression is tightly regulated on the surface of CD8+ T cells. Shedding 
and gene silencing are two mechanisms that account for the level of L-selectin on 
the surface of naïve and activated CD8+ T cells (Chao et al. 1997)(Sinclair et al. 
2008). L-selectin has been implicated in a number of signalling processes during 
CD8+ T cells undergoing its developmental changes upon activation through a 
peptide MHC class I on the surface of an APC. (Brenner et al. 1996), have shown 
that cross-linking L-selectin with the antibody (Dreg56) leads to shedding of the 
L-selectin on the surface, this process has been reported to induce signalling 
which is important for a number of functional activity including Ceramide and 
kinases function such as the p56LCK kinase. Ceramide is involved in cellular 
function, development and differentiation and apoptosis. Whether L-selectin 
shedding on the surface leads to the initiation of the signalling cascade or further 
processing of the tail of L-selectin by other enzymes results in the initiation of the 
signalling cascade is not known.   
 
Although we have investigated the impact of various levels of L-selectin such as 
higher than normal level in mutant L-selectin (LΔP) and normal level of L-selectin 
as in wildtype on the biology of CD8+ T cells activated in vivo through virus and 
looking at the endogenous response or T cells co-expressing various levels of L-
selectin and F5 transgenic TCR through the recombinant virus expressing 
peptide of interest, mutant L-selectin enhances on the CD8+ T cell’s proliferation, 
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activation and differentiation upon in vitro activation with a cognate peptide MHC 
class I complex with an APC was investigated. Furthermore, we have also 
evaluated the amount and types of cytokines secreted by CD8+ T cells 
expressing either wildtype or mutant L-selectin.  
 
CD8+ T cells expressing the mutant form of L-selectin (F5/LΔP) show no 
significant difference from the wild type (F5/B6) with regards to very early 
activation (first 24 hours) in the culture system upon stimulation with a cognate 
peptide NP68. As both CD8+ T cells showed a similar rate of CD69 up-regulation.  
 
Another aspect of our investigation was a detailed proliferation analysis. L-
selectin has been shown to play an important role during CD8+ T cell proliferation 
and cytokine secretion. A study has shown that mice lack L-selectin (L-selectin -/-) 
are impaired in the level of IL-2, IL-4 and IFN-γ secretion and also they have 
shown that CD8+ T cells proliferate more slowly than wild type cells (Xu et al. 
1996).     
 
Although we have shown that wildtype L-selectin expressing CD8+ T cells 
entered the proliferation cycle earlier upon in vivo activation, CD8+ T cells 
expressing various levels of L-selectin were activated in vitro and the proliferation 
cycle were investigated in detail. Using proliferation sensitive dye, CFSE, both 
cell types, wildtype and mutant L-selectin expressing CD8+ T cells, started to 
proliferate equally at day 1 post activation indicated by equal dilution of the CFSE 
dye. Whereas, the regulated expression of wildtype L-selectin, including initial 
ectodomain proteolytic cleavage and shedding and later gene silencing, 
enhanced the CD8+ T cell’s proliferation cycle same as CD8+ T cells started to 
proliferate during in vivo activation. F5/B6 CD8+ T cells showed higher division 
index and more CFSE dilution at day 4 post activation when compared with 
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F5/LΔP cells, whereas at day 5 post activation, there were no significant 
difference between their division indices and CFSE dilution ability, indicated that 
both cells were became proliferating in a similar manner. It has been reported 
that CD8+ T cells enter the proliferation cycle independent on interleukin-2 (IL-2) 
for the first proliferation cycle (D’Souza & Lefrançois 2003), which is consistent 
with our finding as both cell types started to proliferate in a similar manner at day 
1 post activation. During the wildtype L-selectin expressing CD8+ T cells showed 
enhanced ability to proliferate ad day 4 post activation, we also showed that 
these cells upregulated the IL-2 receptor (IL-2R) earlier at day 3 and 4 post 
activation, whereas at day 5 post activation, the level of IL-2R became identical 
between the two cell types. Regulated expression of L-selectin in the wildtype 
may lead to an intracellular signalling event, which may be important for IL-2R 
upregulation, which can be investigated in detail in the future. Mutant L-selectin 
(LΔP) expressing CD8+ T cells was delayed in entering the IL-2 dependent 
proliferation cycle only. Similar to the previous research study by (Xu et al. 1996), 
CD8+ T cells will find an alternative mechanism to compensate for the missing 
signals and co-stimulation that suppose to be provided by the regulated 
expression of L-selectin.    
 
Upon naïve CD8+ T cells activation through peptide MHC class I on the surface of 
an APC, CD8+ T cells undergo developmental changes that lead to the rise of the 
distinct subset of CD8+ T cells classified as effector and memory CD8+ T cells 
(Brinkman et al. 2013). Effector and memory CD8+ T cells have different 
functions and migratory pattern during an on going immune response (Brinkman 
et al. 2013)(Laouar et al. 2008). Therefore, it was necessary to study the impact 
of mutant L-selectin expression on the concurrent generation of effector and 
memory CD8+ T cells. We have shown, upon activation in vitro, that the CD8+ T 
cells on which L-selectin expression is maintained during T cell activation and 
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differentiation (F5/LΔP) can be classified into effector and memory subsets based 
on the cell surface markers such as CD44 and CCR7, as the expression of those 
markers changes upon activation with a cognate peptide MHC class I with an 
APC. There was not any significant difference in the generation of effector CD8+ 
T cells between the F5/LΔP and F5/B6 CD8+ T cells.  
 
Cytokine secretion by various subsets of CD8+ T cells is considered pivotal for 
various stages of the adaptive immune response. Effector and memory CD8+ T 
cells secrete almost the same cytokines but at a different rate according to their 
necessity. Although CD4+ T cells are the main T cell responsible for cytokine 
secretion and providing co-stimulation and help, CD8+ T cells can secrete various 
types of cytokines and show their cytotoxic abilities (Kristensin et al. 2004). 
Furthermore, the types and the amount of cytokines secreted by CD8+ T cells 
expressing mutant or wild type L-selectin upon in vitro activation were 
investigated. The presence of mutant L-selectin did not show any impact on the 
rate of cytokine secretion and there was no significant difference between mutant 
(F5/LΔP) and wild type L-selectin (F5/B6) CD8+ T cells with regards to cytokine 
secretion upon re-stimulation.    
 
Furthermore, the degranulation ability of CD8+ T cells expressing either mutant or 
wild type L-selectin molecules were also investigated. The result showed that 
there was no significant difference between the two types of cells with regards to 
intracellular CD107a staining. Degranulation is a characteristic ability of activated 
CD8+ T cells. After activation and differentiation of naïve CD8+ T cells, both 
effector and memory CD8+ T cells can degranulate but the protein content of their 
granules (most commonly perforins and granzymes) can vary and perform a lytic 
activity in the case of effector population (Wolint et al. 2004). 
 
 180 
The presence of mutant L-selectin (LΔP) on the surface of CD8+ T cells did not 
show any significant impact on the way these cells activate, differentiate and 
proliferate upon activation through a specific peptide transgenic TCR recognition 
in vitro apart from a short delay (24 hours) in the onset of IL-2 dependent 
proliferation. L-selectin is well defined for its adhesion function, it facilitate the 
initial tethering and rolling of leukocytes, such as neutrophils, across both wall of 
blood vessels and T lymphocytes across HEVs in the lymph nodes. CD8+ T cells 
expressing mutant L-selectin showed its impact within in vivo environment. A 
potent immune response depends on cells that can home to lymph nodes and the 
site of infection. As we have shown during in vivo activation of the CD8+ T cells 
through a virus infection, Presence of mutant L-selectin is promoted CD8+ T cells 
homing to sites of infection and, therefore, provided enhanced antiviral immunity.  
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6.4. Conclusion  
 
In conclusion, L-selectin first identified as a lymph node homing molecule 
(Gallatin et al. 1983), also, a recent study has further shown that L-selectin is an 
important molecule for migration of chronic lymphocytic leukaemia cells into the 
lymph nodes through high endothelial venules (Lafouresse et al. 2015). Beside its 
characterization as a lymph node homing molecule, L-selectin has been used as 
a marker of T lymphocyte activation by a wide range of immunologist. L-selectin 
expression is controlled by two separate mechanisms of ectodomain shedding 
and gene silencing, it is not a reliable marker to access level of activation very 
early during CD8+ T cells activation, primary first 7-8 days of primary infection. A 
recent study has also concluded that percentage L-selectin expression by CD4+ T 
cells is not a reliable marker to predict the risk of developing progressive 
multifocal Leukoenchephalopathy since its expression varies on the surface of 
the CD4+ T cells during the time course of the infection (PML)(Lieberman et al. 
2015).  
 
It is time to consider the re-expressed L-selectin on the surface of activated CD8+ 
T cells as an important molecule for homing into the site of virus infection as well. 
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6.5. Future studies 
 
In the present study, we have shown that L-selectin is variably expressed on the 
surface of CD8+ T cells during the course of a primary virus infection, further 
studies to underpin when the L-selectin ectodomain shedding and gene silencing 
occur would give interesting results. Then using pharmacologic inhibitors to 
interfere with the shedding and gene silencing could be a great potential to 
maintain L-selectin expression on the surface of CD8+ T cells to enhance homing 
of the virus specific CD8+ T cells to the site of virus infection and, therefore, 
enhance anti-viral immunity. 
 
It has been shown that viruses such as HIV use mechanisms of L-selectin 
retaining in the cytoplasm to limit the number of immune cells migrating to the 
lymph node for priming and activation, using its protein Nef and Vpu (Vassena et 
al. 2015), it is important to further investigate other viruses as well whether they 
use different mechanisms to enhance the gene silencing to limit the recruitment 
of activated CD8+ T cells into sites of infection. 
 
L-selectin is a transmembrane adhesion molecule composed of glycoprotein in 
nature. L-selectin binds to a wide range of O and N-linked oligosaccharide 
ligands. L-selectin recognizes its ligands in a glycosylation-dependent manner. 
The fucose or sialic acid in the oligosaccharide structure has to be sialylated or 
fucosylated then L-selectin able to bind (Varki 1994). It is clear that the nature of 
L-selectin binding to its ligand is a complex process and it may happen at 
different times during the course of a primary virus infection and there may be a 
peak where their carbohydrates are in the correct form for L-selectin binding, 
Identifying L-selectin ligands on the inflamed blood vessels supplying blood to the 
site of infections or within the inflamed virus infected tissues are potential findings 
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to understand the mechanism of L-selectin dependent homing of virus specific 
CD8+ T cells to site of infection.  
 
Recombinant soluble L-selectin or antibodies against known ligand may be an 
ideal approach to study and identify the L-selectin ligands in various virus-
infected tissues. This could be done either in vivo, by injecting the soluble L-
selectin or antibodies into mice infected with influenza A or vaccinia viruses in 
order to identify the ligands in the lung and ovary, respectively, or in vitro, by 
culturing cells from the ovarian tissues and the lung and incubate with soluble L-
selectin or antibodies. Bound ligand can be investigated using protein purification 
techniques to identify what L-selectin binds to in these virus infected tissues.      
 
Further studies to identify sites of infection, other than lung and ovary, that are L-
selectin dependent for homing of virus specific CD8+ T cells is important. Re-
expressed L-selectin on the surface of virus specific CD8+ T cells may be 
important for homing to all peripheral tissues. Using other virus infection in mice 
that target common sites of infection could be another important future studies in 
order to understand whether the proinflammatory cytokine and chemokine storm 
play a role in recruiting virus specific CD8+ T cells in L-selectin dependent 
manner. Also, there is no doubt that response from memory CD8+ T cells is 
important for vaccination strategies and for recurrent infections with the same 
virus, whether L-selectin play a pivotal role during virus specific CD8+ T cells 
recruitment to peripheral tissues is important to investigate.   
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Gating strategy for flow cytometry analysis 
 
 
 
For flow cytometry analysis, population of interest was analyzed by creating a 
Boolean gate which was made of cell, based on the forward scatter (FSC-A) 
versus side scatter (SSC-A), singlet, based on the foreword scatter height (FSC-
H) versus (SSC-A) and live based on the cells staining with aqua live dye 
(amcyan).   
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